Document:

EX-4.3

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Exhibit 4.3 
  

 
  

LEVI STRAUSS & CO., 

as Issuer 
 3.375% Senior
Notes due 2027 
  
  

INDENTURE 
 Dated as of
February 28, 2017 
 WELLS FARGO BANK, NATIONAL ASSOCIATION, 

as Trustee 
  

 
  

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 TABLE OF CONTENTS 

Page 
 ARTICLE I 

Definitions and Incorporation by Reference 
  

							
	 Section 1.01.
	 	Definitions	  	 	1	 
	 Section 1.02.
	 	Other Definitions	  	 	25	 
	 Section 1.03.
	 	Incorporation by Reference of Trust Indenture Act	  	 	26	 
	 Section 1.04.
	 	Rules of Construction	  	 	26	 
	ARTICLE II	  			
		
	The Notes	  			
			
	 Section 2.01.
	 	Amount of Notes; Issuable in Series	  	 	26	 
	 Section 2.02.
	 	Form and Dating	  	 	27	 
	 Section 2.03.
	 	Execution and Authentication	  	 	28	 
	 Section 2.04.
	 	Registrar and Paying Agent	  	 	28	 
	 Section 2.05.
	 	Money Held by the Paying Agent	  	 	28	 
	 Section 2.06.
	 	Noteholder Lists	  	 	29	 
	 Section 2.07.
	 	Replacement Notes	  	 	29	 
	 Section 2.08.
	 	Outstanding Notes	  	 	29	 
	 Section 2.09.
	 	Temporary Notes	  	 	29	 
	 Section 2.10.
	 	Cancellation	  	 	30	 
	 Section 2.11.
	 	Defaulted Interest	  	 	30	 
	 Section 2.12.
	 	ISIN or Common Code Numbers	  	 	30	 
	ARTICLE III	  			
		
	Redemption	  			
			
	 Section 3.01.
	 	Notices to Trustee	  	 	30	 
	 Section 3.02.
	 	Selection of Notes To Be Redeemed	  	 	30	 
	 Section 3.03.
	 	Notice of Redemption	  	 	31	 
	 Section 3.04.
	 	Effect of Notice of Redemption	  	 	31	 
	 Section 3.05.
	 	Deposit of Redemption Price	  	 	31	 
	 Section 3.06.
	 	Notes Redeemed in Part	  	 	32	 
	ARTICLE IV	  			
		
	Covenants	  			
			
	 Section 4.01.
	 	Covenant Suspension	  	 	32	 
	 Section 4.02.
	 	Payment of Notes	  	 	32	 
	 Section 4.03.
	 	SEC Reports	  	 	32	 
	 Section 4.04.
	 	Limitation on Debt	  	 	33	 
	 Section 4.05.
	 	Limitation on Restricted Payments	  	 	36	 
	 Section 4.06.
	 	Limitation on Liens	  	 	38	 
	 Section 4.07.
	 	Limitation on Asset Sales	  	 	38	 

  
 -i- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

							
	 Section 4.08.
	 	Limitation on Restrictions on Distributions from Restricted Subsidiaries	  	 	42	 
	 Section 4.09.
	 	Limitation on Transactions with Affiliates	  	 	43	 
	 Section 4.10.
	 	Designation of Restricted and Unrestricted Subsidiaries	  	 	44	 
	 Section 4.11.
	 	[Reserved]	  	 	45	 
	 Section 4.12.
	 	Change of Control	  	 	45	 
	 Section 4.13.
	 	Further Instruments and Acts	  	 	46	 
	 Section 4.14.
	 	Future Subsidiary Guarantors	  	 	46	 
	 Section 4.15.
	 	Payment of Additional Amounts	  	 	46	 
	 Section 4.16.
	 	Maintenance of Listing	  	 	48	 
		
	ARTICLE V	  			
		
	Successor Company	  			
			
	 Section 5.01.
	 	When Company May Merge or Transfer Assets	  	 	48	 
		
	ARTICLE VI	  			
		
	Defaults and Remedies	  			
			
	 Section 6.01.
	 	Events of Default	  	 	49	 
	 Section 6.02.
	 	Acceleration	  	 	51	 
	 Section 6.03.
	 	Other Remedies	  	 	51	 
	 Section 6.04.
	 	Waiver of Past Defaults	  	 	51	 
	 Section 6.05.
	 	Control by Majority	  	 	51	 
	 Section 6.06.
	 	Limitation on Suits	  	 	52	 
	 Section 6.07.
	 	Rights of Holders to Receive Payment	  	 	52	 
	 Section 6.08.
	 	Collection Suit by Trustee	  	 	52	 
	 Section 6.09.
	 	Trustee May File Proofs of Claim	  	 	52	 
	 Section 6.10.
	 	Priorities	  	 	53	 
	 Section 6.11.
	 	Undertaking for Costs	  	 	53	 
	 Section 6.12.
	 	Waiver of Stay or Extension Laws	  	 	53	 
		
	ARTICLE VII	  			
		
	Trustee	  			
			
	 Section 7.01.
	 	Duties of Trustee	  	 	53	 
	 Section 7.02.
	 	Rights of Trustee	  	 	54	 
	 Section 7.03.
	 	Individual Rights of Trustee	  	 	56	 
	 Section 7.04.
	 	Trustee’s Disclaimer	  	 	56	 
	 Section 7.05.
	 	Notice of Defaults	  	 	56	 
	 Section 7.06.
	 	Reports by Trustee to Holders	  	 	56	 
	 Section 7.07.
	 	Compensation and Indemnity	  	 	56	 
	 Section 7.08.
	 	Replacement of Trustee	  	 	57	 
	 Section 7.09.
	 	Successor Trustee by Merger	  	 	58	 
	 Section 7.10.
	 	Eligibility; Disqualification	  	 	58	 
	 Section 7.11.
	 	Preferential Collection of Claims Against Company	  	 	58	 

  
 -ii- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 ARTICLE VIII 

Discharge of Indenture; Defeasance 
  

							
	 Section 8.01.
	 	Discharge of Liability on Notes; Defeasance	  	 	58	 
	 Section 8.02.
	 	Conditions to Defeasance	  	 	59	 
	 Section 8.03.
	 	Application of Trust Money	  	 	60	 
	 Section 8.04.
	 	Repayment to Company	  	 	60	 
	 Section 8.05.
	 	Indemnity for Government Obligations	  	 	60	 
	 Section 8.06.
	 	Reinstatement	  	 	60	 
		
	ARTICLE IX	  			
		
	Amendments	  			
			
	 Section 9.01.
	 	Without Consent of Holders	  	 	61	 
	 Section 9.02.
	 	With Consent of Holders	  	 	61	 
	 Section 9.03.
	 	Compliance with Trust Indenture Act	  	 	62	 
	 Section 9.04.
	 	Revocation and Effect of Consents and Waivers	  	 	62	 
	 Section 9.05.
	 	Notation on or Exchange of Notes	  	 	63	 
	 Section 9.06.
	 	Trustee To Sign Amendments	  	 	63	 
	 Section 9.07.
	 	Payment for Consent	  	 	63	 
		
	ARTICLE X	  			
		
	Miscellaneous	  			
			
	 Section 10.01.
	 	Trust Indenture Act Controls	  	 	63	 
	 Section 10.02.
	 	Notices	  	 	63	 
	 Section 10.03.
	 	Communication by Holders with Other Holders	  	 	64	 
	 Section 10.04.
	 	Certificate and Opinion as to Conditions Precedent	  	 	64	 
	 Section 10.05.
	 	Statements Required in Certificate or Opinion	  	 	65	 
	 Section 10.06.
	 	Annual Officer’s Certificate as to Compliance	  	 	65	 
	 Section 10.07.
	 	When Notes Disregarded	  	 	65	 
	 Section 10.08.
	 	Rules by Trustee, Paying Agents and Registrar	  	 	65	 
	 Section 10.09.
	 	Legal Holidays	  	 	65	 
	 Section 10.10.
	 	Governing Law; Jury Trial Waiver; Submission to Jurisdiction	  	 	66	 
	 Section 10.11.
	 	No Recourse Against Others	  	 	66	 
	 Section 10.12.
	 	Successors	  	 	66	 
	 Section 10.13.
	 	Multiple Originals	  	 	66	 
	 Section 10.14.
	 	Table of Contents; Headings	  	 	66	 
	 Section 10.15.
	 	Force Majeure	  	 	66	 
	 Section 10.16.
	 	U.S.A. Patriot Act	  	 	66	 
	 Section 10.17.
	 	Judgment Currency	  	 	67	 

  

			
	Appendix A	  	- Provisions Relating to Initial Notes and Exchange Notes

 EXHIBIT INDEX 
  

			
	Exhibit A	  	- Form of Initial Note
	Exhibit B	  	- Form of Transferee Letter of Representation

  
 -iii- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 CROSS-REFERENCE TABLE 

 

			
	 TIA

Section
	  	 Indenture

Section

	310(a)(1)	  	7.10
	 (a)(2)
	  	7.10
	 (a)(3)
	  	N.A.
	 (a)(4)
	  	N.A.
	 (b)
	  	7.08; 7.10
	 (c)
	  	N.A.
	311(a)	  	7.11
	 (b)
	  	7.11
	 (c)
	  	N.A.
	312(a)	  	2.06
	 (b)
	  	1.03
	313(a)	  	7.06
	 (b)(1)
	  	N.A.
	 (b)(2)
	  	7.06
	 (c)
	  	7.06; 10.02
	 (d)
	  	7.06
	314(a)(1)	  	4.03
	 (a)(2)
	  	1.03
	 (a)(3)
	  	1.03
	 (a)(4)
	  	10.06
	 (b)
	  	N.A.
	 (c)(1)
	  	10.04
	 (c)(2)
	  	10.04
	 (c)(3)
	  	N.A.
	 (d)
	  	N.A.
	 (e)
	  	10.05
	315(a)	  	7.01
	 (b)
	  	7.05; N.A.
	 (c)
	  	7.01
	 (d)
	  	7.01
	 (e)
	  	6.11
	316(a) (last sentence)	  	N.A.
	 (a)(1)(A)
	  	6.05
	 (a)(1)(B)
	  	6.04
	 (a)(2)
	  	N.A.
	 (b)
	  	6.07
	317(a)(1)	  	6.08
	 (a)(2)
	  	6.09
	 (b)
	  	2.05
	318(a)	  	10.01

 N.A. Means Not Applicable. 

Note: This Cross-Reference Table shall not, for any purposes, be deemed to be part of this Indenture. 

  
 -iv- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 INDENTURE dated as of February 28, 2017 between LEVI STRAUSS & CO., a Delaware
corporation (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of America, as Trustee (the “Trustee”). 

Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of (i) 3.375% Senior
Notes due 2027 (the “Initial Notes”), to be issued from time to time in one or more series as in this Indenture provided and (ii) if and when issued pursuant to a registered or private exchange for the Initial Notes, the exchange
notes (the “Exchange Notes” and, together with the Initial Notes, the “Notes”): 
 ARTICLE I. 

Definitions and Incorporation by Reference 

SECTION 1.01 Definitions. 

“Additional Assets” means: 

(a) any Property (other than cash, cash equivalents, securities and inventory) to be owned by the Company or any Restricted
Subsidiary and used in a Related Business; or 
 (b) Capital Stock of a Person that becomes a Restricted Subsidiary as a
result of the acquisition of that Capital Stock by the Company or another Restricted Subsidiary from any Person other than the Company or an Affiliate of the Company; provided, however, that, in the case of this clause (b), the Restricted Subsidiary
is primarily engaged in a Related Business. 
 “Affiliate” of any specified Person means: 

(a) any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with that
specified Person, or 
 (b) any other Person who is a director or officer of that specified Person. 

For the purposes of this definition, “control” when used with respect to any Person means the power to direct the management and policies of that
Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. For purposes of
Section 4.07 and Section 4.09 and the definition of “Additional Assets” only, “Affiliate” shall also mean any Beneficial Owner of shares representing 10% or more of the total voting power of the Voting Stock (on a fully
diluted basis) of the Company or of rights or warrants to purchase that Voting Stock (whether or not currently exercisable) and any Person who would be an Affiliate of any Beneficial Owner pursuant to the first sentence hereof. 

“Agents” means the Paying Agents, the Registrar, the transfer agent and the Authenticating Agent. 

“Asset Sale” means any sale, lease, transfer, issuance or other disposition (or series of related sales, leases, transfers,
issuances or dispositions) by the Company or any Restricted Subsidiary, including any disposition by means of a merger, consolidation or similar transaction (each referred to for the purposes of this definition as a “disposition”), of:

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (a) any shares of Capital Stock of a Restricted Subsidiary (other than
directors’ qualifying shares), 
 (b) all or substantially all the assets of any division or line of business of the
Company or any Restricted Subsidiary, or 
 (c) any other assets of the Company or any Restricted Subsidiary outside of the
ordinary course of business of the Company or such Restricted Subsidiary, 
 other than, in the case of clause (a), (b) or (c) above, 

(1) any disposition by a Restricted Subsidiary to the Company or by the Company or a Restricted Subsidiary to a Restricted
Subsidiary, 
 (2) any disposition that constitutes a Restricted Payment permitted by Section 4.05, 

(3) any disposition effected in compliance with the first paragraph in Section 5.01, 

(4) a sale of accounts receivables and related assets of the type specified in the definition of “Qualified Receivables
Transaction” to a Receivables Entity, 
 (5) a transfer of accounts receivables and related assets of the type specified
in the definition of “Qualified Receivables Transaction” (or a fractional undivided interest therein) by a Receivables Entity in connection with a Qualified Receivables Transaction, 

(6) a transfer of accounts receivable of the type specified in the definition of “Credit Facilities” that is
permitted under clause (b) of the second paragraph of Section 4.04, 
 (7) any disposition that does not (together
with all related dispositions) involve assets having a Fair Market Value or consideration in excess of $100.0 million, and 

(8) any disposition that, but for this clause (8), would be an Asset Sale, if consummated at a time when, after giving pro
forma effect thereto, (x) the Consolidated Total Leverage Ratio is less than or equal to 3.25 to 1.00 and (y) no Default shall have occurred and be continuing or occur as a consequence thereof. 

“Attributable Debt” in respect of a Sale and Leaseback Transaction means, at any date of determination, 

(a) if the Sale and Leaseback Transaction is a Capital Lease Obligation, the amount of Debt represented thereby according to
the definition of “Capital Lease Obligation,” and 
 (b) in all other instances, the greater of: 

(1) the Fair Market Value of the Property subject to the Sale and Leaseback Transaction, and 

(2) the present value (discounted at the interest rate borne by the Notes, compounded annually) of the total obligations of the
lessee for rental payments during the remaining term of the lease included in the Sale and Leaseback Transaction (including any period for which the lease has been extended). 

  
 -2- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Authenticating Agent” means an institution, reasonably acceptable to the Company,
appointed by the Trustee to authenticate the Notes as set forth in this Indenture. 
 “Average Life” means, as of any date of
determination, with respect to any Debt or Preferred Stock, the quotient obtained by dividing: 
 (a) the sum of the product
of the numbers of years (rounded to the nearest one-twelfth of one year) from the date of determination to the dates of each successive scheduled principal payment of that Debt or redemption or similar payment
with respect to that Preferred Stock multiplied by the amount of the payment by 
 (b) the sum of all payments of this kind.

 “Beneficial Owner” means a beneficial owner as defined in Rule 13d-3 under the Exchange
Act, except that: 
 (a) a Person will be deemed to be the Beneficial Owner of all shares that the Person has the right to
acquire, whether that right is exercisable immediately or only after the passage of time, 
 (b) for purposes of clause
(a) of the definition of “Change of Control,” Permitted Holders will be deemed to be the Beneficial Owners of any Voting Stock of a corporation or other legal entity held by any other corporation or other legal entity so long as the
Permitted Holders Beneficially Own, directly or indirectly, in the aggregate a majority of the total voting power of the Voting Stock of that corporation or other legal entity, and 

(c) for purposes of clause (b) of the definition of “Change of Control,” any “person” or
“group” (as those terms are defined in Sections 13(d) and 14(d) of the Exchange Act or any successor provisions to either of the foregoing), including any group acting for the purpose of acquiring, holding, voting or disposing of
securities within the meaning of Rule 13d-5(b)(1) under the Exchange Act, other than any one or more of the Permitted Holders, shall be deemed to be the Beneficial Owners of any Voting Stock of a corporation
or other legal entity held by any other corporation or legal entity (the “parent corporation”), so long as that person or group Beneficially Owns, directly or indirectly, in the aggregate a majority of the total voting power of the Voting
Stock of that parent corporation. 
 The term “Beneficially Own” shall have a corresponding meaning. 

“Board of Directors” means the Board of Directors of the Company (or, in the case of clause (b) of the first paragraph of
Section 4.09, the applicable Restricted Subsidiary) or any committee thereof duly authorized to act on behalf of such Board of Directors. 

“Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been
duly adopted by the Board of Directors and to be in full force and effect on the date of such certification. 
 “Business Day”
means each day that is not a Legal Holiday. 
 “Capital Lease Obligation” means any obligation under a lease that is required to
be capitalized for financial reporting purposes in accordance with GAAP; and the amount of Debt represented by that obligation shall be the capitalized amount of the obligations determined in accordance with GAAP; and

  
 -3- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
the Stated Maturity thereof shall be the date of the last payment of rent or any other amount due under that lease prior to the first date upon which that lease may be terminated by the lessee
without payment of a penalty. For purposes of Section 4.06, a Capital Lease Obligation shall be deemed secured by a Lien on the Property being leased. 

“Capital Stock” means, with respect to any Person, any shares or other equivalents (however designated) of any class of corporate
stock or partnership interests or any other participations, rights, warrants, options or other interests in the nature of an equity interest in that Person, including Preferred Stock, but excluding any debt security convertible or exchangeable into
that equity interest. 
 “Capital Stock Sale Proceeds” means the aggregate net proceeds (including the Fair Market Value of
property other than cash) received by the Company from the issuance or sale (other than to a Subsidiary of the Company or an employee stock ownership plan or trust established by the Company or the Subsidiary for the benefit of their employees) by
the Company of its Capital Stock (other than Disqualified Stock) after the Issue Date, net of attorneys’ fees, accountants’ fees, initial purchasers’ or placement agents’ fees, discounts or commissions and brokerage, consultant
and other fees actually incurred in connection with the issuance or sale and net of taxes paid or payable as a result thereof. 

“Change of Control” means the occurrence of any of the following events: 

(a) if any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act or
any successor provisions to either of the foregoing), including any group acting for the purpose of acquiring, holding, voting or disposing of securities within the meaning of Rule 13d-5(b)(1) under the
Exchange Act, other than any one or more of the Permitted Holders, becomes the Beneficial Owner, directly or indirectly, of 50% or more of the total voting power of the Voting Stock of the Company; or 

(b) the sale, transfer, assignment, lease, conveyance or other disposition, directly or indirectly, of all or substantially all
the assets of the Company and the Restricted Subsidiaries, considered as a whole (other than a disposition of assets as an entirety or virtually as an entirety to a Wholly Owned Restricted Subsidiary or one or more Permitted Holders) shall have
occurred, or the Company merges, consolidates or amalgamates with or into any other Person (other than one or more Permitted Holders) or any other Person (other than one or more Permitted Holders) merges, consolidates or amalgamates with or into the
Company, in any event pursuant to a transaction in which the outstanding Voting Stock of the Company is reclassified into or exchanged for cash, securities or other Property, other than a transaction where: 

(1) the outstanding Voting Stock of the Company is reclassified into or exchanged for other Voting Stock of the Company or for
Voting Stock of the surviving corporation or transferee, and 
 (2) (i) the holders of the Voting Stock of the Company
immediately prior to the transaction own, directly or indirectly, not less than a majority of the voting power of the Voting Stock of the Company or the surviving corporation or transferee immediately after the transaction and in substantially the
same proportion as before the transaction or (ii) immediately after the transaction no holder of the Voting Stock of the Company or the surviving corporation or transferee owns, directly or indirectly, more than 50% of the voting power of the
Voting Stock of the Company or the surviving corporation or transferee; or 

  
 -4- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) the shareholders of the Company shall have approved any plan of
liquidation or dissolution of the Company. 
 “Code” means the Internal Revenue Code of 1986, as amended. 

“Commodity Price Protection Agreement” means, in respect of a Person, any forward contract, commodity swap agreement, commodity
option agreement or other similar agreement or arrangement designed to protect that Person against fluctuations in commodity prices. 

“Company” means the party named as such in this Indenture until a successor replaces it pursuant to the applicable provisions hereof
and, thereafter, means the successor and, for purposes of any provision contained herein and required by the TIA, each other obligor on the indenture securities. 

“Consolidated Current Liabilities” means, as of any date of determination, the aggregate amount of liabilities of the Company and
its consolidated Restricted Subsidiaries which may properly be classified as current liabilities (including taxes accrued as estimated), after eliminating: 

(a) all intercompany items between the Company and any Restricted Subsidiary or between Restricted Subsidiaries, and 

(b) all current maturities of long-term Debt. 

“Consolidated Fixed Charges” means, for any period, the total interest expense (net of interest income) of the Company and its
consolidated Restricted Subsidiaries, plus, to the extent not included in such total interest expense, and to the extent Incurred by the Company or its Restricted Subsidiaries, 

(a) interest expense recorded for such period attributable to leases constituting part of a Sale and Leaseback Transaction and
to Capital Lease Obligations, 
 (b) amortization of debt discount, 

(c) capitalized interest, 

(d) non-cash interest expense, 

(e) commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptance
financing, 
 (f) net costs associated with Interest Rate Agreements (including amortization of fees) (it being understood
that any net benefits associated with Interest Rate Agreements shall be included in interest income), 
 (g) Disqualified
Stock Dividends, excluding dividends paid in Qualified Capital Stock, 
 (h) Preferred Stock Dividends, 

(i) interest Incurred in connection with Investments in discontinued operations, 

(j) interest accruing on any Debt of any other Person to the extent that Debt is Guaranteed by the Company or any Restricted
Subsidiary, and 

  
 -5- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (k) the cash contributions to any employee stock ownership plan or similar
trust to the extent those contributions are used by the plan or trust to pay interest or fees to any Person (other than the Company) in connection with Debt Incurred by the plan or trust. 

Notwithstanding anything to the contrary contained herein, (i) amortization or write-off of debt
issuance costs, deferred financing or liquidity fees, commissions, fees and expenses, call premiums, (ii) any expensing of bridge, commitment and other financing fees and (iii) commissions, discounts, yield and other fees and charges
Incurred in connection with any transaction (including, without limitation, any Qualified Receivables Transaction) pursuant to which the Company or any Subsidiary of the Company may sell, convey or otherwise transfer or grant a security interest in
any accounts receivable or related assets of the type specified in the definition of “Qualified Receivables Transaction” shall not be included in Consolidated Fixed Charges. 

“Consolidated Fixed Charges Coverage Ratio” means, as of any date of determination, the ratio of: 

(a) the aggregate amount of EBITDA for the most recent four consecutive fiscal quarters ending at least 45 days prior to such
determination date to 
 (b) Consolidated Fixed Charges for those four fiscal quarters; 

provided, however, that: 

(1) if: 

(A) since the beginning of that period the Company or any Restricted Subsidiary has Incurred any Debt that remains outstanding
or Repaid any Debt, or 
 (B) the transaction giving rise to the need to calculate the Consolidated Fixed Charges Coverage
Ratio involves an Incurrence or Repayment of Debt, 
 Consolidated Fixed Charges for that period shall be calculated after giving effect on a pro forma
basis to that Incurrence or Repayment as if the Debt was Incurred or Repaid on the first day of that period, provided that, in the event of any Repayment of Debt, EBITDA for that period shall be calculated as if the Company or such Restricted
Subsidiary had not earned any interest income actually earned during such period in respect of the funds used to Repay such Debt, and 

(2) if: 

(A) since the beginning of that period the Company or any Restricted Subsidiary shall have made any Asset Sale or an
Investment (by merger or otherwise) in any Restricted Subsidiary (or any Person which becomes a Restricted Subsidiary) or an acquisition of Property which constitutes all or substantially all of an operating unit of a business, 

(B) the transaction giving rise to the need to calculate the Consolidated Fixed Charges Coverage Ratio involves an Asset Sale,
Investment or acquisition, or 

  
 -6- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (C) since the beginning of that period any Person (that subsequently became
a Restricted Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of that period) shall have made such an Asset Sale, Investment or acquisition, 

EBITDA for that period shall be calculated after giving pro forma effect to the Asset Sale, Investment or acquisition as if the Asset Sale,
Investment or acquisition occurred on the first day of that period. 
 If any Debt bears a floating rate of interest and is being given pro
forma effect, the interest expense on that Debt shall be calculated as if the base interest rate in effect for the floating rate of interest on the date of determination had been the applicable base interest rate for the entire period (taking into
account any Interest Rate Agreement applicable to that Debt if the applicable Interest Rate Agreement has a remaining term in excess of 12 months). In the event the Capital Stock of any Restricted Subsidiary is sold during the period, the Company
shall be deemed, for purposes of clause (1) above, to have Repaid during that period the Debt of that Restricted Subsidiary to the extent the Company and its continuing Restricted Subsidiaries are no longer liable for that Debt after the sale.

 “Consolidated Net Income” means, for any period, the net income (loss) of the Company and its consolidated Subsidiaries
(excluding any net income (loss) attributable to noncontrolling interests), determined in accordance with GAAP; provided, however, that there shall not be included in such Consolidated Net Income: 

(a) any net income (loss) of any Person (other than the Company) if that Person is not a Restricted Subsidiary, except that the
Company’s equity in the net income of any such Person for that period shall be included in such Consolidated Net Income up to the aggregate amount of cash distributed by that Person during that period to the Company or a Restricted Subsidiary
as a dividend or other distribution, 
 (b) any gain (or loss) realized upon the sale or other disposition of any Property of
the Company or any of its consolidated Subsidiaries (including pursuant to any Sale and Leaseback Transaction) that is not sold or otherwise disposed of in the ordinary course of business, 

(c) any gain or loss attributable to the early extinguishment of Debt, 

(d) any extraordinary gain or loss or cumulative effect of a change in accounting principles to the extent disclosed separately
on the consolidated statement of income, 
 (e) any unrealized gains or losses of the Company or its consolidated
Subsidiaries on any Hedging Obligations, and 
 (f) any non-cash compensation expense
realized for grants of performance shares, stock options or other rights to officers, directors and employees of the Company or any Restricted Subsidiary, provided, however, that if any such shares, options or other rights are subsequently redeemed
for Property other than Capital Stock of the Company that is not Disqualified Stock then the Fair Market Value of such Property shall be treated as a reduction in Consolidated Net Income during the period of such redemption. 

Notwithstanding the foregoing, for purposes of Section 4.05 only, there shall be excluded from Consolidated Net Income any dividends, repayments of loans
or advances or other transfers of assets from Unrestricted Subsidiaries to the Company or a Restricted Subsidiary to the extent the dividends, repayments or transfers increase the amount of Restricted Payments permitted under that Section pursuant
to clause (c)(4) thereof. 

  
 -7- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Consolidated Net Tangible Assets” means, as of any date of determination, the sum
of the amounts that would appear on a consolidated balance sheet of the Company and its consolidated Restricted Subsidiaries as the total assets (less accumulated depreciation, amortization, allowances for doubtful receivables, other applicable
allowances and other properly deductible items) of the Company and its Restricted Subsidiaries, after giving effect to purchase accounting and after deducting therefrom Consolidated Current Liabilities and, to the extent otherwise included, the
amounts of (without duplication): 
 (a) the excess of cost over fair market value of assets or businesses acquired; 

(b) any revaluation or other write-up in book value of assets subsequent to the last
day of the fiscal quarter of the Company immediately preceding the Issue Date as a result of a change in the method of valuation in accordance with GAAP; 

(c) unamortized debt discount and expenses and other unamortized deferred charges, goodwill, patents, trademarks, service
marks, trade names, copyrights, licenses, organization or developmental expenses and other intangible items; 
 (d)
noncontrolling interests in consolidated Subsidiaries held by Persons other than the Company or any Restricted Subsidiary; 

(e) treasury stock; 

(f) cash or securities set aside and held in a sinking or other analogous fund established for the purpose of redemption or
other retirement of Capital Stock to the extent such obligation is not reflected in Consolidated Current Liabilities; and 

(g) Investments in and assets of Unrestricted Subsidiaries. 

For the avoidance of doubt, any deferred tax assets that would appear on a consolidated balance sheet of the Company and its Restricted
Subsidiaries shall be included in the calculation of Consolidated Net Tangible Assets. 
 “Consolidated Secured Leverage Ratio”
means, as of any date of determination, the ratio of the aggregate amount of all Debt secured by Liens of the Company and its Restricted Subsidiaries at the end of the most recent fiscal period, for which financial information in respect thereof is
available immediately preceding the date of the transaction (the “Transaction Date”) giving rise to the need to calculate the Consolidated Secured Leverage Ratio to the aggregate amount of EBITDA for the Company for the four full fiscal
quarters, treated as one period, for which financial information in respect thereof is available immediately preceding the Transaction Date (such four full fiscal quarter period being referred to herein as the “Four Quarter Period”). In
addition, for purposes of calculating the ratio, the entire commitment of any revolving credit facility of the Company or any Restricted Subsidiary shall be deemed to be fully drawn as of the date such agreement is executed, and thereafter the
amount of such commitment shall be deemed to fully borrowed at all times for purposes of determining the ratio. In addition to and without limitation of the foregoing, for purposes of this definition, this ratio shall be calculated after giving
effect to the following: 

  
 -8- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (a) if since the beginning of that period the Company or any Restricted
Subsidiary shall have made any Asset Sale or an Investment (by merger or otherwise) in any Restricted Subsidiary (or any Person which becomes a Restricted Subsidiary) or an acquisition of Property which constitutes all or substantially all of an
operating unit of a business, 
 (b) if the transaction giving rise to the need to calculate the Consolidated Secured
Leverage Ratio involves an Asset Sale, Investment or acquisition, or 
 (c) since the beginning of the Four Quarter Period
any Person (that subsequently became a Restricted Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of the Four Quarter Period) shall have made such an Asset Sale, Investment or acquisition, 

EBITDA for that period shall be calculated after giving pro forma effect to the Asset Sale, Investment or acquisition as if the Asset Sale,
Investment or acquisition occurred on the first day of the Four Quarter Period. 
 “Consolidated Total Leverage Ratio” means, as
of any date of determination, the ratio of the aggregate amount of all Debt at the end of the most recent fiscal period, for which financial information in respect thereof is available immediately preceding the Transaction Date giving rise to the
need to calculate the Consolidated Total Leverage Ratio to the aggregate amount of EBITDA for the Company for the Four Quarter Period immediately preceding the Transaction Date. In addition, for purposes of calculating the ratio, the amount of any
revolving credit facility of the Company or any Restricted Subsidiary outstanding on the Transaction Date shall be deemed to be the average daily balance outstanding under such revolving credit facility during the immediately preceding Four Quarter
Period. In addition to and without limitation of the foregoing, for purposes of this definition, this ratio shall be calculated after giving effect to the following: 

(a) if since the beginning of that period the Company or any Restricted Subsidiary shall have made any Asset Sale or an
Investment (by merger or otherwise) in any Restricted Subsidiary (or any Person which becomes a Restricted Subsidiary) or an acquisition of Property which constitutes all or substantially all of an operating unit of a business, 

(b) if the transaction giving rise to the need to calculate the Consolidated Total Leverage Ratio involves an Asset Sale,
Investment or acquisition, or 
 (c) since the beginning of the Four Quarter Period any Person (that subsequently became a
Restricted Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of the Four Quarter Period) shall have made such an Asset Sale, Investment or acquisition, 

EBITDA for that period shall be calculated after giving pro forma effect to the Asset Sale, Investment or acquisition as if the Asset Sale,
Investment or acquisition occurred on the first day of the Four Quarter Period. 
 “Credit Facilities” means, with respect to the
Company or any Restricted Subsidiary, one or more debt or commercial paper facilities (including related Guarantees) with banks, investment banks, insurance companies, mutual funds or other institutional lenders (including the Existing Bank Credit
Facility), providing for revolving credit loans, term loans, receivables or inventory financing (including through the sale of receivables or inventory to institutional lenders or to special purpose, bankruptcy remote entities formed to borrow from
institutional lenders against those receivables or inventory) or 

  
 -9- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
trade or standby letters of credit, in each case together with any Refinancing thereof on any basis so long as such Refinancing constitutes Debt; provided that, in the case of a transaction in
which any accounts receivable are sold, conveyed or otherwise transferred by the Company or any of its subsidiaries to another Person other than a Receivables Entity, then that transaction must satisfy the following three conditions: 

(a) if the transaction involves a transfer of accounts receivable with Fair Market Value equal to or greater than
$25.0 million, the Board of Directors shall have determined in good faith that the transaction is economically fair and reasonable to the Company or the Subsidiary that sold, conveyed or transferred the accounts receivable, 

(b) the sale, conveyance or transfer of accounts receivable by the Company or the Subsidiary is made at Fair Market Value, and

 (c) the financing terms, covenants, termination events and other provisions of the transaction shall be market terms (as
determined in good faith by the Board of Directors). 
 “Currency Exchange Protection Agreement” means, in respect of a Person,
any foreign exchange contract, currency swap agreement, currency option or other similar agreement or arrangement designed to protect that Person against fluctuations in currency exchange rates. 

“Debt” means, with respect to any Person on any date of determination (without duplication): 

(a) the principal of and premium (if any) in respect of: 

(1) debt of the Person for money borrowed, and 

(2) debt evidenced by notes, debentures, bonds or other similar instruments for the payment of which the Person is responsible
or liable; 
 (b) all Capital Lease Obligations of the Person and all Attributable Debt in respect of Sale and Leaseback
Transactions entered into by the Person; 
 (c) all obligations of the Person issued or assumed as the deferred purchase
price of Property, all conditional sale obligations of the Person and all obligations of the Person under any title retention agreement (but excluding trade accounts payable arising in the ordinary course of business); 

(d) all obligations of the Person for the reimbursement of any obligor on any letter of credit, banker’s acceptance or
similar credit transaction (other than obligations with respect to letters of credit securing obligations (other than obligations described in clauses (a) through (c) above) entered into in the ordinary course of business of the Person to the
extent those letters of credit are not drawn upon or, if and to the extent drawn upon, the drawing is reimbursed no later than the third Business Day following receipt by the Person of a demand for reimbursement following payment on the letter of
credit); 
 (e) the amount of all obligations of the Person with respect to the Repayment of any Disqualified Stock or, with
respect to any Subsidiary of the Person, any Preferred Stock (but excluding, in each case, any accrued dividends); 

  
 -10- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (f) all obligations of the type referred to in clauses (a) through (e)
of other Persons and all dividends of other Persons for the payment of which, in either case, the Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise, including by means of any Guarantee; 

(g) all obligations of the type referred to in clauses (a) through (f) of other Persons secured by any Lien on any
Property of the Person (whether or not such obligation is assumed by the Person), the amount of such obligation being deemed to be the lesser of the value of that Property or the amount of the obligation so secured; and 

(h) to the extent not otherwise included in this definition, Hedging Obligations of such Person. 

The amount of Debt of any Person at any date shall be the outstanding balance at that date of all unconditional obligations as described above and the maximum
liability, upon the occurrence of the contingency giving rise to the obligation, of any contingent obligations at that date. The amount of Debt represented by a Hedging Obligation shall be equal to: 

(1) zero if the Hedging Obligation has been Incurred pursuant to clause (f), (g) or (h) of the second paragraph of
Section 4.04, or 
 (2) if the Hedging Obligation is not Incurred pursuant to clause (f), (g) or (h) of the second
paragraph of Section 4.04, then 105% of the aggregate net amount, if any, that would then be payable by the Company and any Restricted Subsidiary on a per counter-party basis pursuant to Section 6(e) of the ISDA Master Agreement
(Multicurrency-Cross Border) in the form published by the International Swaps and Derivatives Association in 1992 (the “ISDA Form”), as if the date of determination were a date that constitutes or is substantially equivalent to an Early
Termination Date, as defined in the ISDA Form, with respect to all transactions governed by the ISDA Form, plus the equivalent amount under the terms of any other Hedging Obligations that are not Incurred pursuant to clause (f), (g) or (h) of
the second paragraph of Section 4.04, each such amount to be estimated in good faith by the Company. 
 “Debt Issuances”
means, with respect to the Company or any Restricted Subsidiary, one or more issuances after the Issue Date of Debt evidenced by notes, debentures, bonds or other similar securities or instruments. 

“Default” means any event which is, or after notice or passage of time or both would be, an Event of Default. 

“Disqualified Stock” means, with respect to any Person, any Capital Stock that by its terms (or by the terms of any security into
which it is convertible or for which it is exchangeable, in either case at the option of the holder thereof) or otherwise: 

(a) matures or is mandatorily redeemable pursuant to a sinking fund obligation or otherwise, 

(b) is or may become redeemable or repurchaseable at the option of the holder thereof, in whole or in part, or 

(c) is convertible or exchangeable at the option of the holder thereof for Debt or Disqualified Stock, 

on or prior to, in the case of clause (a), (b) or (c), the first anniversary of the Stated Maturity of the Notes. 

  
 -11- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Disqualified Stock Dividends” means all dividends with respect to Disqualified
Stock of the Company held by Persons other than a Wholly Owned Restricted Subsidiary. The amount of any dividend of this kind shall be equal to the quotient of the dividend divided by the difference between one and the maximum statutory federal
income tax rate (expressed as a decimal number between 1 and 0) then applicable to the Company. 
 “Dollar Equivalent” means, with
respect to any monetary amount in a currency other than U.S. dollars, at any time for the determination thereof, the amount of U.S. dollars obtained by converting such foreign currency involved in such computation into U.S. dollars at the spot rate
for the purchase of U.S. dollars with the applicable foreign currency as published by the Federal Reserve Board on the date of such determination. 

“EBITDA” means, for any period, an amount equal to, for the Company and its consolidated Restricted Subsidiaries: 

(a) the sum of Consolidated Net Income for that period, plus the following to the extent reducing Consolidated Net Income for
that period: 
 (1) the provision for taxes based on income or profits or utilized in computing net loss, 

(2) Consolidated Fixed Charges, 

(3) depreciation, 

(4) amortization of intangibles, 

(5) any non-recurring expenses relating to, or arising from, any closures of
facilities, 
 (6) restructuring costs, facilities relocation costs and acquisition integration costs and fees (including
cash severance payments) made in connection with acquisitions, 
 (7) any non-cash
impairment charge or asset write-off and the amortization of intangibles, 
 (8)
inventory purchase accounting adjustments and amortization and impairment charges resulting from other purchase accounting adjustments in connection with acquisitions, 

(9) any expenses or charges related to any offering of securities, acquisition, incurrence of Debt permitted to be incurred by
this Indenture (whether or not successful), and 
 (10) any other non-cash items
(other than any non-cash item to the extent that it represents an accrual of or reserve for cash expenditures in any future period), minus 

  
 -12- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) all non-cash items increasing
Consolidated Net Income for that period (other than any such non-cash item to the extent that it has resulted or will result in the receipt of cash payments in any period). 

“Equipment Financing Transaction” means any arrangement (together with any Refinancings thereof) with any Person pursuant to which
the Company or any Restricted Subsidiary Incurs Debt secured by a Lien on equipment or equipment related property of the Company or any Restricted Subsidiary. 

“Equity Offering” means (i) an underwritten public equity offering of Qualified Capital Stock of the Company pursuant to an
effective registration statement under the Securities Act, or any direct or indirect parent company of the Company but only to the extent contributed to the Company in the form of Qualified Capital Stock of the Company or (ii) a private equity
offering of Qualified Capital Stock of the Company, or any direct or indirect parent company of the Company but only to the extent contributed to the Company in the form of Qualified Capital Stock of the Company, other than any public offerings
registered on Form S-8. 
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
 “Existing Bank Credit Facility” means, the Amended and Restated Credit Agreement dated as of March 21, 2014,
among the Company, Levi Strauss & Co. (Canada), Inc., JPMorgan Chase Bank, N.A., as administrative agent, and the other agents and lenders from time to time party thereto, as amended as of the Issue Date. 

“Existing Policies” means (1) the Company’s estate tax repurchase policy under which the Company repurchases a portion of
a deceased stockholder’s shares to generate funds for payment of estate taxes and (2) the Company’s valuation policy under which the Company obtains an annual valuation of the Company’s common stock, as both policies exist at the
Issue Date or as they may exist from time to time, provided that if either of these policies is materially amended after the Issue Date in a manner less favorable to the Company than the policy as existing on the Issue Date, then that amended policy
shall be deemed not to be an Existing Policy. 
 “Fair Market Value” means, with respect to any Property, the price that could be
negotiated in an arm’s-length free market transaction, for cash, between a willing seller and a willing buyer, neither of whom is under undue pressure or compulsion to complete the transaction. For
purposes of Section 4.05 and Section 4.07 and the definitions of “Qualified Receivables Transaction” and “Credit Facilities,” Fair Market Value shall be determined, except as otherwise provided, 

(a) if the Property has a Fair Market Value equal to or less than $25.0 million, by any Officer of the Company, or 

(b) if the Property has a Fair Market Value in excess of $25.0 million, by a majority of the Board of Directors and
evidenced by a Board Resolution, dated within 12 months of the relevant transaction, delivered to the Trustee. 
 “Foreign Restricted
Subsidiary” means any Restricted Subsidiary which is not organized under the laws of the United States of America or any State thereof or the District of Columbia. 

“Future Guarantor” means any Subsidiary of the Company that provides a Guarantee of the notes at any time after the Issue Date
pursuant to Section 4.14. 

  
 -13- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “GAAP” means United States generally accepted accounting principles as in effect on
the Issue Date, including those set forth in the Accounting Standards Codification of the Financial Accounting Standards Board and in the rules and regulations of the SEC governing the inclusion of financial statements (including pro forma financial
statements) in periodic reports required to be filed pursuant to Section 13 of the Exchange Act. 
 “Government Obligations”
means direct obligations (or certificates representing an ownership interest in such obligations) of any country that is a member of the European Union on the Issue Date (including any agency or instrumentality thereof) for the payment of which the
full faith and credit of such European Union country is pledged and which are not callable or redeemable at the issuer’s option. 

“Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any Debt of any other
Person and any obligation, direct or indirect, contingent or otherwise, of that Person: 
 (a) to purchase or pay (or advance
or supply funds for the purchase or payment of) the Debt of such other Person (whether arising by virtue of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services, to
take-or-pay or to maintain financial statement conditions or otherwise), or 

(b) entered into for the purpose of assuring in any other manner the obligee against loss in respect thereof (in whole or in
part); 
 provided, however, that the term “Guarantee” shall not include endorsements for collection or deposit in the ordinary
course of business. 
 The term “Guarantee” used as a verb has a corresponding meaning. The term “Guarantor” shall mean any Person
Guaranteeing any obligation. 
 “Hedging Obligation” of any Person means any obligation of that Person pursuant to any Interest
Rate Agreement, Currency Exchange Protection Agreement, Commodity Price Protection Agreement or any other similar agreement or arrangement. 

“Holder” or “Noteholder” means the Person in whose name the Note is registered on the Note register described in
Section 2.04. 
 “Incur” means, with respect to any Debt or other obligation of any Person, to create, issue, incur (by
merger, conversion, exchange or otherwise), extend, assume, Guarantee or become liable in respect of that Debt or other obligation or the recording, as required pursuant to GAAP or otherwise, of any Debt or obligation on the balance sheet of that
Person (and “Incurrence” and “Incurred” shall have meanings correlative to the foregoing); provided, however, that a change in GAAP that results in an obligation of that Person that exists at such time, and is not theretofore
classified as Debt, becoming Debt shall not be deemed an Incurrence of that Debt; provided further, however, that any Debt or other obligations of a Person existing at the time the Person becomes a Subsidiary (whether by merger, consolidation,
acquisition or otherwise) shall be deemed to be Incurred by that Subsidiary at the time it becomes a Subsidiary; and provided further, however, that solely for purposes of determining compliance with Section 4.04, amortization of debt discount
or premium shall not be deemed to be the Incurrence of Debt, provided that in the case of Debt sold at a discount or at a premium, the amount of the Debt Incurred shall at all times be the aggregate principal amount at Stated Maturity. 

“Indenture” means this Indenture as amended or supplemented from time to time. 

  
 -14- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Interest Rate Agreement” means, for any Person, any interest rate swap agreement,
interest rate option agreement or other similar agreement or arrangement designed to protect against fluctuations in interest rates. 

“Investment” by any Person means any direct or indirect loan (other than advances to customers and suppliers in the ordinary course
of business that are recorded as accounts receivable on the balance sheet of that Person), advance or other extension of credit or capital contribution (by means of transfers of cash or other Property to others or payments for Property or services
for the account or use of others, or otherwise) to, or Incurrence of a Guarantee of any obligation of, or purchase or acquisition of Capital Stock, bonds, notes, debentures or other securities or evidence of Debt issued by, any other Person. For
purposes of Section 4.05, Section 4.10 and the definition of “Restricted Payment”, Investment shall include the portion (proportionate to the Company’s equity interest in the Subsidiary) of the Fair Market Value of the net
assets of any Subsidiary of the Company at the time that the Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a redesignation of that Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to
have a permanent “Investment” in an Unrestricted Subsidiary of an amount (if positive) equal to: 
 (a) the
Company’s “Investment” in that Subsidiary at the time of such redesignation, less 
 (b) the portion
(proportionate to the Company’s equity interest in such Subsidiary) of the Fair Market Value of the net assets of that Subsidiary at the time of such redesignation. 

In determining the amount of any Investment made by transfer of any Property other than cash, the Property shall be valued at its Fair Market
Value at the time of the Investment. 
 “Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent)
by Moody’s and BBB- (or the equivalent) by S&P. 
 “Issue Date” means
February 28, 2017. 
 “Lien” means, with respect to any Property of any Person, any mortgage or deed of trust, pledge,
hypothecation, assignment, deposit arrangement, security interest, lien, charge, easement (other than any easement not materially impairing usefulness or marketability), encumbrance, preference, priority or other security agreement or preferential
arrangement of any kind or nature whatsoever on or with respect to that Property (including any Capital Lease Obligation, conditional sale or other title retention agreement having substantially the same economic effect as any of the foregoing or
any Sale and Leaseback Transaction). 
 “Moody’s” means Moody’s Investors Service, Inc. or any successor to the rating
agency business thereof. 
 “Net Available Cash” from any Asset Sale means cash payments received therefrom (including any cash
payments received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise, but only as and when received, but excluding any other consideration received in the form of assumption by the acquiring Person of
Debt or other obligations relating to the Property that is the subject of that Asset Sale or received in any other non-cash form), in each case net of: 

(a) all legal, title and recording tax expenses, commissions and other fees (including, without limitation, brokers’ or
investment bankers’ commissions or fees) and expenses incurred, and all Federal, state, provincial, foreign and local taxes required to be accrued as a liability under GAAP, as a consequence of the Asset Sale, 

  
 -15- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) all payments made on any Debt that is secured by any Property subject to
the Asset Sale, in accordance with the terms of any Lien upon or other security agreement of any kind with respect to that Property, or which must by its terms, or in order to obtain a necessary consent to the Asset Sale, or by applicable law, be
repaid out of the proceeds from the Asset Sale, 
 (c) all distributions and other payments required to be made to
noncontrolling interest holders in Subsidiaries or joint ventures as a result of the Asset Sale, and 
 (d) the deduction of
appropriate amounts provided by the seller as a reserve, in accordance with GAAP, against any liabilities associated with the Property disposed in the Asset Sale and retained by the Company or any Restricted Subsidiary after the Asset Sale. 

“Notes” have the meaning in the second paragraph of the preamble. 

“Officer” means the Chief Executive Officer, the President, the Chief Financial Officer, the Treasurer or the Assistant Treasurer of
the Company. 
 “Officers’ Certificate” means a certificate signed by two Officers of the Company, at least one of whom shall
be the principal executive officer, principal financial officer or the principal accounting officer of the Company, and delivered to the Trustee. 

“Opinion of Counsel” means a written opinion from legal counsel which is acceptable to the Trustee. The counsel may be an employee
of or counsel to the Company. 
 “Permitted Business” means any business that is reasonably similar, ancillary or related to, or a
reasonable extension, development or expansion of, the businesses in which the Company and its Restricted Subsidiaries are engaged in on the Issue Date. 

“Permitted Holders” means the holders of Voting Stock as of the Issue Date, together with any Person who is a “Permitted
Transferee” of the holders, as that term is defined in the Stockholders Agreement dated as of April 15, 1996 between the Company and the stockholders of the Company party thereto, as amended, as that Stockholders Agreement was in effect on
the Issue Date, except that transferees pursuant to Section 2.2(a)(x) of that Stockholders Agreement shall not be deemed to be Permitted Transferees for purposes of this Indenture. 

“Permitted Liens” means: 

(a) Liens (including, without limitation and to the extent constituting a Lien, negative pledges) to secure Debt in an
aggregate principal amount not to exceed the greater of (x) the amount permitted to be Incurred under clause (b) of the second paragraph of Section 4.04, regardless of whether the Company and the Restricted Subsidiaries are actually
subject to the covenant contained in Section 4.04 at the time the Lien is Incurred and (y) an amount that does not cause the Consolidated Secured Leverage Ratio to exceed 3.50 to 1.0; 

(b) Liens for taxes, assessments or governmental charges or levies on the Property of the Company or any Restricted Subsidiary
if the same shall not at the time be delinquent or thereafter can be paid without penalty, or are being contested in good faith and by appropriate proceedings promptly instituted and diligently concluded, provided that any reserve or other
appropriate provision that shall be required in conformity with GAAP shall have been made therefor; 

  
 -16- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Liens imposed by law, such as carriers’, warehousemen’s and
mechanics’ Liens and other similar Liens, on the Property of the Company or any Restricted Subsidiary arising in the ordinary course of business and securing payment of obligations that are not more than 60 days past due or are being contested
in good faith and by appropriate proceedings; 
 (d) Liens on the Property of the Company or any Restricted Subsidiary
Incurred in the ordinary course of business to secure performance of obligations with respect to statutory or regulatory requirements, performance or return-of-money
bonds, surety bonds or other obligations of a like nature and incurred in a manner consistent with industry practice, including banker’s liens and rights of set-off, in each case which are not Incurred in
connection with the borrowing of money, the obtaining of advances or credit or the payment of the deferred purchase price of Property and which do not in the aggregate impair in any material respect the use of Property in the operation of the
business of the Company and the Restricted Subsidiaries taken as a whole; 
 (e) Liens on Property at the time the Company or
any Restricted Subsidiary acquired the Property, including any acquisition by means of a merger or consolidation with or into the Company or any Restricted Subsidiary; provided, however, that any Lien of this kind may not extend to any other
Property of the Company or any Restricted Subsidiary; provided further, however, that the Liens shall not have been Incurred in anticipation of or in connection with the transaction or series of transactions pursuant to which the Property was
acquired by the Company or any Restricted Subsidiary; 
 (f) Liens on the Property of a Person at the time that Person
becomes a Restricted Subsidiary; provided, however, that any Lien of this kind may not extend to any other Property of the Company or any other Restricted Subsidiary that is not a direct Subsidiary of that Person; provided further, however, that the
Lien was not Incurred in anticipation of or in connection with the transaction or series of transactions pursuant to which the Person became a Restricted Subsidiary; 

(g) pledges or deposits by the Company or any Restricted Subsidiary under worker’s compensation laws, unemployment
insurance laws or similar legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Debt) or leases to which the Company or any Restricted Subsidiary is party, or deposits to secure public or
statutory obligations of the Company or any Restricted Subsidiary, or deposits for the payment of rent, in each case Incurred in the ordinary course of business; 

(h) Liens (including, without limitation and to the extent constituting Liens, negative pledges), assignments and pledges of
rights to receive premiums, interest or loss payments or otherwise arising in connection with worker’s compensation loss portfolio transfer insurance transactions or any insurance or reinsurance agreements pertaining to losses covered by
insurance, and Liens (including, without limitation and to the extent constituting Liens, negative pledges) in favor of insurers or reinsurers on pledges or deposits by the Company or any Restricted Subsidiary under workmen’s compensation laws,
unemployment insurance laws or similar legislation; 
 (i) utility easements, building restrictions and such other
encumbrances or charges against real Property as are of a nature generally existing with respect to properties of a similar character; 

  
 -17- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (j) Liens arising out of judgments or awards against the Company or a
Restricted Subsidiary with respect to which the Company or the Restricted Subsidiary shall then be proceeding with an appeal or other proceeding for review; 

(k) Liens in favor of surety bonds or letters of credit issued pursuant to the request of and for the account of the Company or
a Restricted Subsidiary in the ordinary course of its business, provided that these letters of credit do not constitute Debt; 

(l) leases or subleases of real property granted by the Company or a Restricted Subsidiary to any other Person in the ordinary
course of business and not materially impairing the use of the real property in the operation of the business of the Company or the Restricted Subsidiary; 

(m) Liens (including, without limitation and to the extent constituting Liens, negative pledges) on intellectual property
arising from intellectual property licenses entered into in the ordinary course of business; 
 (n) Liens or negative pledges
attaching to or related to joint ventures engaged in a Related Business, restricting Liens on interests in those joint ventures; 

(o) Liens existing on the Issue Date not otherwise described in clauses (a) through (n) above; 

(p) Liens not otherwise described in clauses (a) through (o) above on (x) the Property of any Foreign Subsidiary to
secure any Debt permitted to be Incurred by the Foreign Subsidiary pursuant to Section 4.04 and (y) the Property of the Company or any Restricted Subsidiary to secure any Debt permitted to be incurred under clause (l) of such Section;

 (q) Liens on the Property of the Company or any Restricted Subsidiary to secure any Refinancing, in whole or in part, of
any Debt secured by Liens referred to in clause (d), (e), (f), (j) or (k) above; provided, however, that any Lien of this kind shall be limited to all or part of the same Property that secured the original Lien (together with improvements and
accessions to such Property) and the aggregate principal amount of Debt that is secured by the Lien shall not be increased to an amount greater than the sum of: 

(1) the outstanding principal amount, or, if greater, the committed amount, of the Debt secured by Liens described under clause
(d), (e), (f), (j) or (k) above, as the case may be, at the time the original Lien became a Permitted Lien under this Indenture, and 

(2) an amount necessary to pay any fees and expenses, including premiums and defeasance costs, incurred by the Company or the
Restricted Subsidiary in connection with the Refinancing; 
 (r) Liens not otherwise permitted by clauses (a) through
(q) above that are Liens permitted by the Existing Bank Credit Facility as they exist on the Issue Date; 
 (s) Liens on cash
or Temporary Cash Investments held as proceeds of Permitted Refinancing Debt pending the payment, purchase, defeasance or other retirement of the Debt being Refinanced; and 

  
 -18- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (t) Liens not otherwise permitted by clauses (a) through (s) above
encumbering assets having an aggregate Fair Market Value not in excess of the greater of (i) $250.0 million and (ii) 15% of Consolidated Net Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of
the most recent fiscal quarter ending at least 45 days prior to the date the Lien shall be Incurred. 
 “Permitted Refinancing
Debt” means any Debt that Refinances any other Debt, including any successive Refinancings, so long as: 
 (a) the new
Debt is in an aggregate principal amount (or if Incurred with original issue discount, an aggregate issue price) not in excess of the sum of: 

(1) the aggregate principal amount (or if Incurred with original issue discount, the aggregate accreted value) then outstanding
of the Debt being Refinanced, and 
 (2) an amount necessary to pay any fees and expenses, including premiums and defeasance
costs, related to the Refinancing, 
 (b) the Average Life of the new Debt is equal to or greater than the Average Life of
the Debt being Refinanced, 
 (c) the Stated Maturity of the new Debt is no earlier than the Stated Maturity of the Debt
being Refinanced, and 
 (d) the new Debt shall not be senior in right of payment to the Debt that is being Refinanced; 

provided, however, that Permitted Refinancing Debt shall not include: 

(1) Debt of a Subsidiary that Refinances Debt of the Company, or 

(2) Debt of the Company or a Restricted Subsidiary that Refinances Debt of an Unrestricted Subsidiary. 

“Person” means any individual, corporation, company (including any limited liability company), association, partnership, joint
venture, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

“Preferred Stock” means any Capital Stock of a Person, however designated, which entitles the holder thereof to a preference with
respect to the payment of dividends, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of that Person, over shares of any other class of Capital Stock issued by that Person. 

“Preferred Stock Dividends” means all dividends with respect to Preferred Stock of Restricted Subsidiaries held by Persons other
than the Company or a Wholly Owned Restricted Subsidiary. The amount of any dividend of this kind shall be equal to the quotient of the dividend divided by the difference between one and the maximum statutory federal income rate (expressed as a
decimal number between 1 and 0) then applicable to the issuer of the Preferred Stock. 
 “principal” of any Debt (including the
Notes) means the principal amount of such Debt plus the premium, if any, on such Debt. 

  
 -19- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Productive Assets” means assets (other than securities and inventory) that are
used or usable by the Company and its Restricted Subsidiaries in Permitted Businesses. 
 “pro forma” means, with respect to any
calculation made or required to be made pursuant to the terms hereof, a calculation performed in accordance with Article 11 of Regulation S-X promulgated under the Securities Act, as interpreted in good faith
by the Board of Directors of the Company, or otherwise a calculation made in good faith by the Board of Directors of the Company, as the case may be. 

“Property” means, with respect to any Person, any interest of that Person in any kind of property or asset, whether real, personal
or mixed, or tangible or intangible, including Capital Stock in, and other securities of, any other Person. For purposes of any calculation required pursuant to this Indenture, the value of any Property shall be its Fair Market Value. 

“Purchase Money Debt” means Debt: 

(a) consisting of the deferred purchase price of property, conditional sale obligations, obligations under any title retention
agreement, other purchase money obligations and obligations in respect of industrial revenue bonds, in each case where the maturity of the Debt does not exceed the anticipated useful life of the Property being financed, and 

(b) Incurred to finance the acquisition, construction or lease by the Company or a Restricted Subsidiary of the Property,
including additions and improvements thereto; 
 provided, however, that the Debt is Incurred within 180 days after the acquisition,
construction or lease of the Property by the Company or Restricted Subsidiary. 
 “Qualified Capital Stock” means any Capital
Stock that is not Disqualified Stock. 
 “Qualified Receivables Transaction” means any transaction or series of transactions that
may be entered into by the Company or any of its Subsidiaries pursuant to which the Company or any of its Subsidiaries may sell, convey or otherwise transfer to: 

(a) a Receivables Entity (in the case of a transfer by the Company or any of its Subsidiaries), and 

(b) any other Person (in the case of a transfer by a Receivables Entity), 

or may grant a security interest in, any accounts receivable (whether now existing or arising in the future) of the Company or any of its Subsidiaries, and
any assets related thereto including, without limitation, all collateral securing those accounts receivable, all contracts and all Guarantees or other obligations in respect of those accounts receivable, proceeds of those accounts receivable and
other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable; provided that: 

(1) if the transaction involves a transfer of accounts receivable with Fair Market Value equal to or greater than
$25.0 million, the Board of Directors shall have determined in good faith that the Qualified Receivables Transaction is economically fair and reasonable to the Company and the Receivables Entity, 

(2) all sales of accounts receivable and related assets to or by the Receivables Entity are made at Fair Market Value, and 

  
 -20- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (3) the financing terms, covenants, termination events and other provisions
thereof shall be market terms (as determined in good faith by the Board of Directors). 
 The grant of a security interest in any accounts receivable of the
Company or any of its Restricted Subsidiaries to secure the Credit Facilities shall not be deemed a Qualified Receivables Transaction. 

“Rating Agencies” mean Moody’s and S&P. 

“Real Estate Financing Transaction” means any arrangement with any Person pursuant to which the Company or any Restricted Subsidiary
Incurs Debt secured by a Lien on real property of the Company or any Restricted Subsidiary and related personal property together with any Refinancings thereof. 

“Receivables Entity” means a wholly owned Subsidiary of the Company (or another Person formed for the purposes of engaging in a
Qualified Receivables Transaction with the Company in which the Company or any Subsidiary of the Company makes an Investment and to which the Company or any Subsidiary of the Company transfers accounts receivable and related assets) which engages in
no activities other than in connection with the financing of accounts receivable of the Company and its Subsidiaries, all proceeds thereof and all rights (contractual or other), collateral and other assets relating thereto, and any business or
activities incidental or related to that business, and (with respect to any Receivables Entity formed after the Issue Date) which is designated by the Board of Directors (as provided below) as a Receivables Entity and 

(a) no portion of the Debt or any other obligations (contingent or otherwise) of which 

(1) is Guaranteed by the Company or any Subsidiary of the Company (excluding Guarantees of obligations (other than the
principal of, and interest on, Debt) pursuant to Standard Securitization Undertakings), 
 (2) is recourse to or obligates
the Company or any Subsidiary of the Company in any way other than pursuant to Standard Securitization Undertakings, or 

(3) subjects any property or asset of the Company or any Subsidiary of the Company, directly or indirectly, contingently or
otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings; 
 (b) with which
neither the Company nor any Subsidiary of the Company has any material contract, agreement, arrangement or understanding other than on terms which the Company reasonably believes to be no less favorable to the Company or the Subsidiary than those
that might be obtained at the time from Persons that are not Affiliates of the Company, and 
 (c) to which neither the
Company nor any Subsidiary of the Company has any obligation to maintain or preserve the entity’s financial condition or cause the entity to achieve certain levels of operating results other than pursuant to Standard Securitization
Undertakings. 
 Any designation of this kind by the Board of Directors shall be evidenced to the Trustee by filing with the Trustee a certified copy of the
resolution of the Board of Directors giving effect to the designation and an Officers’ Certificate certifying that the designation complied with the foregoing conditions. 

  
 -21- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Refinance” means, in respect of any Debt, to refinance, extend, renew, refund,
repay, prepay, repurchase, redeem, defease or retire, or to issue other Debt, in exchange or replacement for, that Debt. “Refinanced” and “Refinancing” shall have correlative meanings. 

“Related Business” means any business that is related, ancillary or complementary to the businesses of the Company and the
Restricted Subsidiaries on the Issue Date. 
 “Repay” means, in respect of any Debt, to repay, prepay, repurchase, redeem, legally
defease or otherwise retire that Debt. “Repayment” and “Repaid” shall have correlative meanings. For purposes of Section 4.04 and Section 4.07 and the definition of “Consolidated Fixed Charges Coverage Ratio,”
Debt shall be considered to have been Repaid only to the extent the related loan commitment, if any, shall have been permanently reduced in connection therewith. 

“Restricted Payment” means: 

(a) any dividend or distribution (whether made in cash, securities or other Property) declared or paid on or with respect to
any shares of Capital Stock of the Company or any Restricted Subsidiary (including any payment in connection with any merger or consolidation with or into the Company or any Restricted Subsidiary), except for any dividend or distribution that is
made to the Company or the parent of the Restricted Subsidiary or any dividend or distribution payable solely in shares of Capital Stock (other than Disqualified Stock) of the Company; 

(b) the purchase, repurchase, redemption, acquisition or retirement for value of any Capital Stock of the Company or any
Restricted Subsidiary (other than from the Company or a Restricted Subsidiary) or any securities exchangeable for or convertible into Capital Stock of the Company or any Restricted Subsidiary, including the exercise of any option to exchange any
Capital Stock (other than for or into Capital Stock of the Company that is not Disqualified Stock); 
 (c) the purchase,
repurchase, redemption, acquisition or retirement for value, prior to the date for any scheduled maturity, sinking fund or amortization or other installment payment, of any Subordinated Obligation (other than the purchase, repurchase or other
acquisition of any Subordinated Obligation purchased in anticipation of satisfying a scheduled maturity, sinking fund or amortization or other installment obligation, in each case due within one year of the date of acquisition); or 

(d) d) the issuance, sale or other disposition of Capital Stock of any Restricted Subsidiary to a Person other than the Company
or another Restricted Subsidiary if the result thereof is that the Restricted Subsidiary shall cease to be a Restricted Subsidiary, in which event the amount of the “Restricted Payment” shall be the Fair Market Value of the remaining
interest, if any, in the former Restricted Subsidiary held by the Company and the other Restricted Subsidiaries. 
 “Restricted
Subsidiary” means any Subsidiary of the Company other than an Unrestricted Subsidiary. 
 “S&P” means S&P Global
Ratings (a division of S&P Global Inc.) or any successor to the rating agency business thereof. 
 “Sale and Leaseback
Transaction” means any direct or indirect arrangement relating to Property now owned or hereafter acquired whereby the Company or a Restricted Subsidiary transfers that Property to another Person and the Company or a Restricted Subsidiary
leases it from that other Person together with any Refinancings thereof. 

  
 -22- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “SEC” means the Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Significant Subsidiary” means any Subsidiary that would be a “Significant Subsidiary” of the Company within the meaning
of Rule 1-02 under Regulation S-X promulgated by the SEC. 

“Standard Securitization Undertakings” means representations, warranties, covenants and indemnities entered into by the Company or
any Subsidiary of the Company which are customary in an accounts receivable securitization transaction involving a comparable company. 

“Stated Maturity” means, with respect to any security, the date specified in the security as the fixed date on which the payment of
principal of the security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision providing for the repurchase of the security at the option of the holder thereof upon the happening of any
contingency beyond the control of the issuer unless that contingency has occurred). 
 “Subordinated Obligation” means any Debt of
the Company (whether outstanding on the Issue Date or thereafter Incurred) that is subordinate or junior in right of payment to the Notes pursuant to a written agreement to that effect. 

“Subsidiary” means, in respect of any Person, any corporation, company (including any limited liability company), association,
partnership, joint venture or other business entity of which a majority of the total voting power of the Voting Stock is at the time owned or controlled, directly or indirectly, by: 

(a) that Person, 

(b) that Person and one or more Subsidiaries of that Person, or 

(c) one or more Subsidiaries of that Person. 

“Temporary Cash Investments” means any of the following: 

(a) Investments in U.S. Government Obligations maturing within 365 days of the date of acquisition thereof; 

(b) Investments in time deposit accounts, banker’s acceptances, certificates of deposit and money market deposits maturing
within 180 days of the date of acquisition thereof issued by a bank or trust company organized under the laws of the United States of America or any state thereof having capital, surplus and undivided profits aggregating in excess of
$500.0 million or issued by a commercial bank organized under the laws of any other country that is a member of the Organization for Economic Cooperation and Development having total assets in excess of $500.0 million (or its foreign
currency equivalent at the time), and in any case whose long-term debt is rated “A-3” or “A-” or higher according to Moody’s or S&P (or a
similar equivalent rating by at least one “nationally recognized statistical rating organization” (as defined in Rule 436 under the Securities Act)); 

(c) repurchase obligations with a term of not more than 30 days for underlying securities of the types described in clause
(a) entered into with: 
 (1) a bank meeting the qualifications described in clause (b) above, or 

  
 -23- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (2) any primary government securities dealer reporting to the Market Reports
Division of the Federal Reserve Bank of New York; 
 (d) Investments in commercial paper, maturing not more than 270 days
after the date of acquisition, issued by a corporation (other than an Affiliate of the Company) organized and in existence under the laws of the United States of America or any other country that is a member of the Organization for Economic
Cooperation and Development, and in any case with a rating at the time as of which any Investment therein is made of “P-1” (or higher) according to Moody’s or
“A-1” (or higher) according to S&P (or a similar equivalent rating by at least one “nationally recognized statistical rating organization” (as defined in Rule 436 under the Securities
Act)); and 
 (e) direct obligations (or certificates representing an ownership interest in such obligations) of any state of
the United States of America (including any agency or instrumentality thereof) for the payment of which the full faith and credit of such state is pledged and which are not callable or redeemable at the issuer’s option, provided that: 

(1) the long-term debt of the state is rated “A-3” or “A-” or higher according to Moody’s or S&P (or a similar equivalent rating by at least one “nationally recognized statistical rating organization” (as defined in Rule 436 under the
Securities Act)), and 
 (2) the obligations mature within 180 days of the date of acquisition thereof. 

“TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of this Indenture;
provided, however, that, in the event the TIA is amended after such date, “TIA” means, to the extent required by any such amendments, the Trust Indenture Act of 1939 as so amended. 

“Trust Officer” means, when used with respect to the Trustee, any officer within the corporate trust department of the Trustee,
including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee who customarily performs such functions similar to those performed by the Persons who at the time
shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this
Indenture. 
 “Trustee” means the party named as such in this Indenture until a successor replaces it and, thereafter, means the
successor. 
 “Uniform Commercial Code” means the New York Uniform Commercial Code as in effect from time to time. 

“United States” means the United States of America (including the states and the District of Columbia) and its territories,
possessions and other areas subject to its jurisdiction. 
 “United States Person” means any person who is, for U.S. federal
income tax purposes, an individual who is a citizen or resident of the United States, a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of
Columbia (other than a partnership that is not treated as a United States person under any applicable Treasury regulations), or any estate or trust the income of which is subject to United States federal income taxation regardless of its source.

  
 -24- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Unrestricted Subsidiary” means: 

(a) any Subsidiary of the Company that is designated after the Issue Date as an Unrestricted Subsidiary as permitted or
required pursuant to Section 4.10 and is not thereafter redesignated as a Restricted Subsidiary as permitted pursuant thereto; and 

(b) any Subsidiary of an Unrestricted Subsidiary. 

“U.S. Government Obligations” means direct obligations (or certificates representing an ownership interest in such obligations) of
the United States of America (including any agency or instrumentality thereof) for the payment of which the full faith and credit of the United States of America is pledged and which are not callable or redeemable at the issuer’s option. 

“Voting Stock” of any Person means all classes of Capital Stock or other interests (including partnership interests) of that Person
then outstanding and normally entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof. 

“Wholly Owned Restricted Subsidiary” means, at any time, a Restricted Subsidiary all the Voting Stock of which (except
directors’ qualifying shares) is at that time owned, directly or indirectly, by the Company and its other Wholly Owned Subsidiaries. 

SECTION 1.02 Other Definitions. 
  

			
	 Term
	 	 Defined in Section

	“Affiliate Transaction”	 	4.09
	“Bankruptcy Law”	 	6.01
	“Change of Control Offer”	 	4.12
	“Change of Control Payment Date”	 	4.12
	“Change of Control Purchase Price”	 	4.12
	“covenant defeasance option”	 	8.01
	“Custodian”	 	6.01
	“Event of Default”	 	6.01
	“Exchange Note”	 	Appendix A
	“Global Note”	 	Appendix A
	“legal defeasance option”	 	8.01
	“Legal Holiday”	 	10.09
	“Offer Amount”	 	4.07
	“Offer Period”	 	4.07
	“OID”	 	2.01
	“Original Notes”	 	2.01
	“Paying Agent”	 	2.04
	“Prepayment Offer”	 	4.07
	“Principal Paying Agent”	 	2.04
	“Registered Exchange Offer”	 	Appendix A
	“Registrar”	 	2.04
	“Shelf Registration Statement”	 	Appendix A
	“Surviving Person”	 	5.01
	“Suspended Covenants”	 	4.01

  
 -25- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 1.03 Incorporation by Reference of Trust Indenture Act. This Indenture is
subject to the mandatory provisions of the TIA, which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings: 

“Commission” means the SEC. 

“indenture securities” means the Notes. 

“indenture security holder” means a Noteholder. 

“indenture to be qualified” means this Indenture. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“obligor” on these Indenture securities means the Company and any other obligor on these Indenture securities. 

All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule
have the meanings assigned to them by such definitions. 
 SECTION 1.04 Rules of Construction. Unless the context otherwise requires:

 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) “including” means including without limitation; 

(5) words in the singular include the plural and words in the plural include the singular; 

(6) unsecured Debt shall not be deemed to be subordinate or junior to secured Debt merely by virtue of its nature as unsecured
Debt; 
 (7) the principal amount of any non-interest bearing or other discount
security at any date shall be the principal amount thereof that would be shown on a balance sheet of the issuer dated such date prepared in accordance with GAAP; and 

(8) the principal amount of any Preferred Stock shall be the greater of (i) the maximum liquidation value of such
Preferred Stock or (ii) the maximum mandatory redemption or mandatory repurchase price with respect to such Preferred Stock. 
 ARTICLE
II. 
 The Notes 

SECTION 2.01 Amount of Notes; Issuable in Series. The aggregate principal amount of Notes which may be authenticated and delivered under this
Indenture is unlimited. All Notes shall be substantially identical in all respects other than issue prices, issuance dates and ISIN numbers and/or Common Code. The Notes may be issued in one or more series; provided, however, that any Notes issued
with original issue discount (“OID”) for Federal income tax purposes shall not be issued as part of the same series as any Notes that are issued with a different amount of OID or are not issued with OID. All Notes of any one series shall
be substantially the same except as to denomination, issuance date and in some cases, may have a different first interest payment. 

  
 -26- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Subject to Section 2.03, the Trustee or an Authenticating Agent on its behalf shall
authenticate Notes for original issue on the Issue Date in the aggregate principal amount of €475.0 million (the “Original Notes”). With respect to any Notes issued after the Issue Date (except for Notes authenticated and
delivered upon registration of transfer of, or in exchange for, or in lieu of, Original Notes pursuant to Section 2.07, 2.08, 2.09 or 3.06 or Appendix A), there shall be established in or pursuant to a resolution of the Board of Directors, and
subject to Section 2.03, set forth, or determined in the manner provided in an Officers’ Certificate, or established in one or more indentures supplemental hereto, prior to the issuance of such Notes: 

(1) whether such Notes shall be issued as part of a new or existing series of Notes and the title of such Notes (which shall
distinguish the Notes of the series from Notes of any other series); 
 (2) the aggregate principal amount of such Notes that
may be authenticated and delivered under this Indenture (except for Notes authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Notes of the same series pursuant to Section 2.07, 2.08, 2.09 or
3.06 or Appendix A and except for Notes which, pursuant to Section 2.03, are deemed never to have been authenticated and delivered hereunder); 

(3) the issue price and issuance date of such Notes, including the date from which interest on such Notes shall accrue; 

(4) if applicable, that such Notes shall be issuable in whole or in part in the form of one or more Global Notes and, in such
case, the respective depositories for such Global Notes, the form of any legend or legends that shall be borne by any such Global Note in addition to or in lieu of those set forth in Exhibit A and any circumstances in addition to or in lieu of those
set forth in Section 2.3 of Appendix A in which any such Global Note may be exchanged in whole or in part for Notes registered, and any transfer of such Global Note in whole or in part may be registered, in the name or names of Persons other
than the Common Depositary or a nominee thereof; and 
 (5) if applicable, that such Notes shall not be issued in the form of
Initial Notes subject to Appendix A, but shall be issued in the form of Exchange Notes as set forth in Exhibit A. 
 If any of the terms of
any series are established by action taken pursuant to a resolution of the Board of Directors, a copy of an appropriate record of such action shall be certified by the Secretary or any Assistant Secretary of the Company and delivered to the Trustee
at or prior to the delivery of the Officers’ Certificate or the trust indenture supplemental hereto setting forth the terms of the series. 

SECTION 2.02 Form and Dating. Provisions relating to the Initial Notes of each series and the Exchange Notes are set forth in Appendix
A, which is hereby incorporated in and expressly made part of this Indenture. The Initial Notes of each series and the certificate of authentication included therein shall be substantially in the form of Exhibit A which is hereby incorporated in and
expressly made a part of this Indenture. The Exchange Notes and the certificate of authentication shall be substantially in the form of Exhibit A, which is hereby incorporated in and expressly made a part of this Indenture. The Notes of each series
may have notations, legends or endorsements required by law, stock exchange rule, agreements to which the Company is subject, if any, or usage, provided that any such notation, legend or endorsement is in a form reasonably acceptable to the Company.
Each Note shall be dated the date of its authentication. The terms of the Notes of each series set forth in Exhibit A are part of the terms of this Indenture. The Notes shall be issuable in denominations of €100,000 and integral multiples of
€1,000 in excess thereof. 

  
 -27- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 2.03 Execution and Authentication. Two Officers shall sign the Notes for the
Company by manual signature. The Company’s seal may be impressed, affixed, imprinted or reproduced on the Notes and may be in facsimile form. 

If an Officer whose signature is on a Note no longer holds that office at the time the Trustee or the Authenticating Agent authenticates the
Note, the Note shall be valid nevertheless. 
 At any time and from time to time after the execution and delivery of this Indenture, the
Company may deliver Notes of any series executed by the Company to the Trustee for authentication, together with a written order of the Company in the form of an Officers’ Certificate for the authentication and delivery of such Notes, and the
Authenticating Agent in accordance with such written order of the Company shall authenticate and deliver such Notes. 
 A Note shall not be
valid until an authorized signatory of the Trustee or the Authenticating Agent manually signs the certificate of authentication on the Note. The signature shall be conclusive evidence that the Note has been authenticated under this Indenture. 

The Trustee may appoint an Authenticating Agent reasonably acceptable to the Company to authenticate any series of Notes. Unless limited by
the terms of such appointment, an Authenticating Agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An Authenticating Agent has the
same rights as any Registrar, Paying Agent or agent for service of notices and demands. HSBC Bank plc will act as initial Authenticating Agent. 

SECTION 2.04 Registrar and Paying Agent. 

The Company shall maintain one or more Paying Agents (each, a “Paying Agent”) for the notes, including one Paying Agent in the City
of London (the “Principal Paying Agent”). The initial Principal Paying Agent for the notes will be HSBC Bank plc in the City of London. 

The Company will also maintain one or more registrars (each, a “Registrar”) and one or more transfer agents in the City of London or
a European Union member state. The initial Registrar and transfer agent will be HSBC Bank plc. The Registrar will maintain a register reflecting ownership of book-entry and definitive registered notes outstanding from time to time, if any, and will
facilitate transfers of book-entry and definitive registered notes on behalf of the Company. The transfer agent shall perform the functions of a transfer agent. 

The Company may change any Paying Agent, Registrar or transfer agent for the notes without prior notice to the Holders of the notes. However,
if and for so long as any notes are listed on the Official List of the Luxembourg Stock Exchange and the rules of the Luxembourg Stock Exchange so require, the Company will publish notice of the change in a Paying Agent, Registrar or transfer agent
in a leading newspaper of general circulation in Luxembourg or, to the extent and in the manner permitted by such rules, post such notice on the official website of the Luxembourg Stock Exchange (www.bourse.lu). The Company or any of its
subsidiaries may act as Paying Agent or Registrar in respect of the notes. 
 SECTION 2.05 Money Held by the Paying Agent. On each
due date of the principal and interest on any Note, prior to 10:00 a.m. London Time, the Company shall deposit with the Paying Agent a sum sufficient to pay such principal and interest when so becoming due. The Company at any time may require a
Paying Agent to pay all money held by it to the Trustee and account for any funds disbursed and the Trustee may at any time during the continuance of any payment default under the Notes, upon written request to any Paying Agent, require such Paying
Agent to pay all money held by it to the Trustee and to 

  
 -28- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
account for any funds disbursed. Moneys held by any Paying Agent need not be segregated except as required by law and it shall not be liable to any person for interest thereon. No Agent shall
exercise any right of set-off or lien or similar claim over moneys paid to it or under this Indenture and shall not be liable to account to the Company for any interest or other amounts in respect of such
moneys. All payments to be made by a Paying Agent hereunder shall be made without charging any commission or fee to the Holders or any of them. If the Company or a Wholly Owned Subsidiary acts as Paying Agent, it shall segregate the money held by it
as Paying Agent and hold it as a separate trust fund. Upon complying with this Section, the Paying Agent shall have no further liability for the money delivered to the Trustee. 

SECTION 2.06 Noteholder Lists. The Registrar shall preserve in as current a form as is reasonably practicable the most recent list
available to it of the names and addresses of Noteholders. If the Trustee is not the Registrar, the Company shall furnish to the Trustee, in writing at least five Business Days before each interest payment date and at such other times as the Trustee
may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Noteholders. 

SECTION 2.07 Replacement Notes. If a mutilated Note is surrendered to the Registrar or if the Holder of a Note claims that such Note
has been lost, destroyed or wrongfully taken, the Company shall issue and the Authenticating Agent shall authenticate a replacement Note if the requirements of Section 8-405 of the Uniform Commercial Code
are met and the Holder satisfies any other reasonable requirements of the Trustee and/or the Authenticating Agent, as applicable. If required by the Trustee or the Company, such Holder shall furnish an indemnity bond sufficient in the judgment of
the Company and the Trustee (and the Paying Agent, Registrar and Authenticating Agent, if not the Trustee) to protect the Company, the Trustee, the Paying Agent, the Registrar and any co-registrar from any
loss which any of them may suffer if a Note is replaced. The Company and the Trustee may charge the Holder for their expenses in replacing a Note. 

Every replacement Note is an additional obligation of the Company. 

SECTION 2.08 Outstanding Notes. Notes outstanding at any time are all Notes authenticated by the Authenticating Agent, except for those
canceled by it, those delivered to it for cancellation and those described in this Section as not outstanding. A Note does not cease to be outstanding because the Company or an Affiliate of the Company holds the Note. 

If a Note is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee and the Company receive proof satisfactory
to them that the replaced Note is held by a bona fide purchaser. 
 If the Paying Agent holds, in accordance with this Indenture, on a
redemption date or maturity date, money sufficient to pay all principal and interest payable on that date with respect to the Notes (or portions thereof) to be redeemed or maturing, as the case may be, then on and after that date such Notes (or
portions thereof) cease to be outstanding and interest on them ceases to accrue. 
 SECTION 2.09 Temporary Notes. Until definitive
Notes are ready for delivery, the Company may prepare and the Authenticating Agent shall authenticate temporary Notes. Temporary Notes shall be substantially in the form of definitive Notes but may have variations that the Company considers
appropriate for temporary Notes. Without unreasonable delay, the Company shall prepare and the Trustee or the Authenticating Agent shall authenticate definitive Notes and deliver them in exchange for temporary Notes. 

  
 -29- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 2.10 Cancellation. The Company at any time may deliver Notes to a Paying Agent
for cancellation. Each Paying Agent shall forward to the Registrar any Notes surrendered to them for registration of transfer, exchange or payment. The Paying Agents and no one else shall cancel and dispose of all Notes surrendered for registration
of transfer, exchange, payment or cancellation in its customary manner. The Company may not issue new Notes to replace Notes it has redeemed, paid or delivered to a Paying Agent for cancellation, except pursuant to the terms of this Indenture. 

SECTION 2.11 Defaulted Interest. If the Company defaults in a payment of interest on the Notes, the Company shall pay the defaulted
interest (plus interest on such defaulted interest to the extent lawful) in any lawful manner. The Company may pay the defaulted interest to the persons who are Noteholders on a subsequent special record date. The Company shall fix or cause to be
fixed any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail to each Noteholder a notice that states the special record date, the payment date and the amount of defaulted interest to be
paid. 
 SECTION 2.12 ISIN or Common Code Numbers. The Company in issuing the Notes may use “ISIN” or “Common
Code” numbers (if then generally in use) and, if so, the Trustee shall use “ISIN” or “Common Code” numbers in notices of redemption as a convenience to Holders; provided, however, that neither the Company nor the Trustee
shall have any responsibility for any defect in the “ISIN” or “Common Code” number that appears on any Note, check, advice of payment or redemption notice, and any such notice may state that no representation is made as to the
correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Notes, and any such redemption shall not be affected by
any defect in or omission of such numbers. The Company shall promptly notify the Trustee and the Agents of any change in such numbers. 

ARTICLE III. 
 Redemption

 SECTION 3.01 Notices to Trustee. If the Company elects to redeem Notes pursuant to paragraph 5 of the Notes, it shall notify
the Trustee in writing of the redemption date, the principal amount of Notes to be redeemed and that such redemption is being made pursuant to paragraph 5 of the Notes. 

The Company shall give each notice to the Trustee and the Agents provided for in this Section at least 25 days before the redemption date
unless the Trustee consents to a shorter period; provided that the Trustee shall not agree to a period shorter than 5 Business Days without the consent of the Paying Agent. Such notice shall be accompanied by an Officers’ Certificate and an
Opinion of Counsel from the Company to the effect that such redemption will comply with the conditions herein. 
 SECTION 3.02 Selection
of Notes To Be Redeemed. If fewer than all of the Notes are to be redeemed, the Trustee shall select the Notes to be redeemed pro rata or by lot or another method the Trustee deems to be fair and appropriate in accordance with the applicable
procedures of the depository. Notwithstanding the foregoing, if less than all of the Notes are to be redeemed, no Notes of a principal amount of €100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the
Notes (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such
Notes (or such portion thereof) called for redemption. Provisions of this Indenture that apply to Notes called for redemption also apply to portions of Notes called for redemption. The Trustee shall notify the Company and the Agents promptly of the
Notes or portions of Notes to be redeemed. 

  
 -30- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 3.03 Notice of Redemption. At least 10 days but not more than 60 days before a
date for redemption of Notes, the Company shall mail a notice of redemption by first-class mail, and in the case of Notes held in book entry form, by electronic transmission, to each Holder of Notes to be redeemed. 

The notice shall identify the Notes to be redeemed (including any Common Code or ISIN numbers) and shall state: 

(1) the redemption date; 

(2) the redemption price or the information specified in clause (c) of paragraph 5 of the Notes; 

(3) the name and address of the applicable Paying Agent; 

(4) that Notes called for redemption must be surrendered to the Paying Agent to collect the redemption price; 

(5) if fewer than all the outstanding Notes are to be redeemed, the identification and principal amounts of the particular
Notes to be redeemed; 
 (6) that, unless the Company defaults in making such redemption payment, interest on Notes (or
portion thereof) called for redemption ceases to accrue on and after the redemption date; 
 (7) that no representation is
made as to the correctness or accuracy of the ISIN or Common Code number, if any, listed in such notice or printed on the Notes; and 

(8) whether such notice is conditional and the timeframe for satisfying such conditions. 

At the Company’s written request, the Trustee shall give the notice of redemption in the Company’s name and at the Company’s
expense. In such event, the Company shall provide the Trustee with the information required by this Section at least 25 days before the redemption date unless the Trustee consents to a shorter period. 

If the Company elects to provide, in lieu of the redemption price, the information specified in clause (c) of paragraph 5 of the Notes in
the notice of redemption, the Trustee shall give the notice of the redemption price, in the Company’s name and the Company’s expense, one business day prior to the redemption date. 

SECTION 3.04 Effect of Notice of Redemption. Once notice of redemption is mailed, Notes called for redemption become due and payable on
the redemption date and at the redemption price stated in the notice. Upon surrender to the applicable Paying Agent, such Notes shall be paid at the redemption price stated in the notice, plus accrued interest to the redemption date (subject to the
right of Holders of record on the relevant record date to receive interest due on the related interest payment date that is on or prior to the date of redemption). Failure to give notice or any defect in the notice to any Holder shall not affect the
validity of the notice to any other Holder. 
 SECTION 3.05 Deposit of Redemption Price. On the redemption date prior to 10:00 a.m.
London time, the Company shall deposit with the applicable Paying Agent (or, if the Company or a Wholly Owned Subsidiary is the Paying Agent, shall segregate and hold in trust) money in euros sufficient to pay the redemption price of and accrued
interest (subject to the right of Holders of record on the relevant record date to receive interest due on the related interest payment date that is on or prior to the date of redemption) on all Notes to be redeemed on that date other than Notes or
portions of Notes called for redemption that have been delivered by the Company to that Paying Agent for cancellation. 

  
 -31- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 3.06 Notes Redeemed in Part. Upon surrender of a Note that is redeemed in
part, the Company shall execute and the Authenticating Agent shall authenticate for the Holder (at the Company’s expense) a new Note equal in principal amount to the unredeemed portion of the Note surrendered. 

ARTICLE IV. 
 Covenants

 SECTION 4.01 Covenant Suspension. During any period of time that: 

(a) the Notes have Investment Grade Ratings from both Rating Agencies, and 

(b) no Default or Event of Default has occurred and is continuing under this Indenture, 

the Company and the Restricted Subsidiaries will not be subject to the following Sections of this Indenture: Section 4.04, Section 4.05,
Section 4.07, Section 4.08, clause (x) of the third paragraph (and as referred to in the first paragraph) of Section 4.10, and clause (d) of Section 5.01 (collectively, the “Suspended Covenants”). In the event
that the Company and the Restricted Subsidiaries are not subject to the Suspended Covenants for any period of time as a result of the preceding sentence and, subsequently, one or both of the Rating Agencies withdraws its ratings or downgrades the
ratings assigned to the Notes below the required Investment Grade Rating or a Default or Event of Default occurs and is continuing, then the Company and the Restricted Subsidiaries will thereafter again be subject to the Suspended Covenants for all
periods after that withdrawal, downgrade, Default or Event of Default and, furthermore, compliance with the provisions of Section 4.05 with respect to Restricted Payments made after the time of the withdrawal, downgrade, Default or Event of
Default will be calculated in accordance with the terms of that covenant as though that covenant had been in effect during the entire period of time from the Issue Date, provided that there will not be deemed to have occurred a Default or Event of
Default with respect to that covenant during the time that the Company and the Restricted Subsidiaries were not subject to the Suspended Covenants (or after that time based solely on events that occurred during that time). 

SECTION 4.02 Payment of Notes. The Company shall promptly pay the principal of and interest on the Notes on the dates and in the manner
provided in the Notes and in this Indenture. Principal and interest shall be considered paid on the date due if on such date the Trustee or the applicable Paying Agent holds in accordance with this Indenture money sufficient to pay all principal and
interest then due. 
 The Company shall pay interest on overdue principal at the rate specified therefor in the Notes, and it shall pay
interest on overdue installments of interest at the rate borne by the Notes to the extent lawful. 
 SECTION 4.03 SEC Reports.
Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company shall file with the SEC and provide the Trustee and Holders of Notes with annual reports and information,
documents and other reports as are specified in Sections 13 and 15(d) of the Exchange Act and applicable to a U.S. corporation subject to those Sections, and the information, documents and reports to be so filed and provided at the times specified
for the filing of the information, documents and reports under those Sections; provided, however, that (i) the Company shall not be so obligated to file the information, documents and reports with the SEC if the SEC does not permit those
filings and (ii) the electronic filing with the SEC through the 

  
 -32- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
SEC’s Electronic Data Gathering, Analysis, and Retrieval System (or any successor system providing for free public access to such filings) shall satisfy the Company’s obligation to
provide such reports, information and documents to the Trustee and the Holders of Notes, it being understood that the Trustee shall have no responsibility to determine whether or not such information has been filed. Delivery of such reports,
information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein,
including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to conclusively rely exclusively on Officers’ Certificates). 

If and so long as the Notes are listed on the Official List of the Luxembourg Stock Exchange and admitted for trading on the Euro MTF Market
and the rules of the Luxembourg Stock Exchange so require, copies of the reports, information and documents required under the paragraph above shall be made available at the offices of the Paying Agent or, to the extent and in the manner permitted
by such rules, or such reports, information and documents shall be posted on the official website of the Luxembourg Stock Exchange (www.bourse.lu). 

SECTION 4.04 Limitation on Debt. The Company shall not, and shall not permit any Restricted Subsidiary to, Incur, directly or
indirectly, any Debt unless, after giving effect to the application of the proceeds thereof, no Default or Event of Default would occur as a consequence of the Incurrence or be continuing following the Incurrence and either: 

(1) Debt is Debt of the Company or a Restricted Subsidiary and after giving effect to the Incurrence of the Debt and the application of the
proceeds thereof, the Consolidated Fixed Charges Coverage Ratio would be greater than 2.00 to 1.00; provided, that the aggregate amount of Debt that may be Incurred pursuant to the foregoing by a Restricted Subsidiary that is not a Future Guarantor
shall not at any one time be outstanding in an amount exceeding the greater of (i) $200.0 million and (ii) 12% of Consolidated Net Tangible Assets, or 

(2) the Debt is Permitted Debt. 

“Permitted Debt” means: 

(a) Debt of the Company evidenced by the Original Notes; 

(b) Debt of the Company or a Restricted Subsidiary Incurred under any Credit Facilities, Incurred by the Company or a
Restricted Subsidiary pursuant to a Real Estate Financing Transaction, a Sale and Leaseback Transaction, an Equipment Financing Transaction or Debt Issuances, Debt Incurred by the Company or a Restricted Subsidiary in respect of Capital Lease
Obligations and Purchase Money Debt, or Incurred by a Receivables Entity in a Qualified Receivables Transaction that is not recourse to the Company or any other Restricted Subsidiary of the Company (except for Standard Securitization Undertakings),
provided that the aggregate principal amount of all Debt of this kind at any one time outstanding shall not exceed the greater of: 

(1) $1.9 billion, which amount shall be permanently reduced by the amount of Net Available Cash from an Asset Sale used to
Repay Debt Incurred pursuant to this clause (b) pursuant to Section 4.07, and 
 (2) the sum of the amounts equal
to: 

  
 -33- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (A) 60% of the book value of the inventory of the Company and the Restricted
Subsidiaries, and 
 (B) 85% of the book value of the accounts receivable of the Company and the Restricted Subsidiaries, in
the case of each of clauses (A) and (B) as of the most recently ended quarter of the Company for which financial statements of the Company have been provided to the Holders of Notes; 

(c) Debt of the Company owing to and held by any Restricted Subsidiary and Debt of a Restricted Subsidiary owing to and held by
the Company or any Restricted Subsidiary; provided, however, that (1) any subsequent issue or transfer of Capital Stock or other event that results in any Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of
that Debt (except to the Company or a Restricted Subsidiary) shall be deemed, in each case, to constitute the Incurrence of that Debt by the issuer thereof, and (2) if the Company is the obligor on that Debt, the Debt is expressly subordinated
to the prior payment in full in cash of all obligations with respect to the Notes; 
 (d) Debt of a Restricted Subsidiary
outstanding on the date on which that Restricted Subsidiary was acquired by the Company or otherwise became a Restricted Subsidiary (other than Debt Incurred as consideration in, or to provide all or any portion of the funds or credit support
utilized to consummate, a transaction or series of transactions pursuant to which the Restricted Subsidiary became a Restricted Subsidiary of the Company or was otherwise acquired by the Company), provided that at the time that Person was acquired
by the Company or otherwise became a Restricted Subsidiary and after giving effect to the Incurrence of that Debt, (i) the Company would have been able to Incur $1.00 of additional Debt pursuant to clause (1) of the first paragraph of this
Section 4.04 or (ii) the Consolidated Fixed Charges Coverage Ratio would have been greater than such ratio immediately prior to such transaction; 

(e) Debt Incurred as consideration in, or to provide all or any portion of the funds or credit support utilized to consummate,
a transaction or series of transactions pursuant to which a Person became a Restricted Subsidiary of the Company or was otherwise acquired by the Company; provided at the time that Person was acquired by the Company or otherwise became a Restricted
Subsidiary and after giving effect to the Incurrence of that Debt, (i) the Company would have been able to Incur $1.00 of additional Debt pursuant to clause (1) of the first paragraph of this covenant or (ii) the Consolidated Fixed
Charges Coverage Ratio would have been greater than such ratio immediately prior to such transaction and would be at least 1.75 to 1.0; 

(f) Debt under Interest Rate Agreements entered into by the Company or a Restricted Subsidiary for the purpose of limiting
interest rate risk in the ordinary course of the financial management of the Company or that Restricted Subsidiary and not for speculative purposes, provided that the obligations under those agreements are related to payment obligations on Debt
otherwise permitted by the terms of this Section 4.04; 
 (g) Debt under Currency Exchange Protection Agreements entered
into by the Company or a Restricted Subsidiary for the purpose of limiting currency exchange rate risks directly related to transactions entered into by the Company or that Restricted Subsidiary in the ordinary course of business and not for
speculative purposes; 
 (h) Debt under Commodity Price Protection Agreements entered into by the Company or a Restricted
Subsidiary in the ordinary course of the financial management of the Company or that Restricted Subsidiary and not for speculative purposes; 

  
 -34- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) Debt in connection with one or more standby letters of credit or
performance bonds issued by the Company or a Restricted Subsidiary in the ordinary course of business or pursuant to self-insurance obligations and not in connection with the borrowing of money or the obtaining of advances or credit; 

(j) Debt arising from agreements of the Company or a Restricted Subsidiary providing for indemnification, adjustment of
purchase price or similar obligations, in each case, incurred in connection with the disposition of any business, assets or Capital Stock of a Subsidiary, other than Guarantees of Debt Incurred by any Person acquiring all or any portion of such
business, assets or Capital Stock; provided, however, that the maximum aggregate liability in respect of all such Debt shall at no time exceed the gross proceeds actually received by the Company or such Restricted Subsidiary in connection with such
disposition; 
 (k) Debt outstanding on the Issue Date not otherwise described in clauses (a) through (j) above; 

(l) Debt of the Company or a Restricted Subsidiary in an aggregate principal amount outstanding at any one time not to exceed
the greater of $200.0 million and 12% of the Company’s Consolidated Net Tangible Assets (as calculated at the time of incurrence); 

(m) Debt of one or more Foreign Restricted Subsidiaries in an aggregate principal amount outstanding at any one time not to
exceed the greater of $200.0 million and 12% of the Company’s Consolidated Net Tangible Assets (as calculated at the time of incurrence); 

(n) Guarantees of Debt otherwise permitted herein by a Future Guarantor; and 

(o) Permitted Refinancing Debt Incurred in respect of Debt Incurred pursuant to clause (1) of the first paragraph of this
Section 4.04 and clauses (a), (d), (e) and (k) above. 
 For purposes of determining compliance with any restriction on the
incurrence of Debt in dollars where Debt is denominated in a different currency, the amount of such Debt will be the Dollar Equivalent determined on the date of such determination, provided that if any such Debt denominated in a different currency
is subject to a Currency Exchange Protection Agreement (with respect to dollars) covering principal amounts payable on such Debt, the amount of such Debt expressed in euros will be adjusted to take into account the effect of such agreement. The
principal amount of any Permitted Refinancing Debt Incurred in the same currency as the Debt being Refinanced will be the Dollar Equivalent of the Debt Refinanced determined on the date such Debt being Refinanced was initially Incurred.
Notwithstanding any other provision of this covenant, for purposes of determining compliance with this Section 4.04, increases in Debt solely due to fluctuations in the exchange rates of currencies will not be deemed to exceed the maximum
amount that the Company or any Restricted Subsidiary may Incur under any of clauses (a) through (o) of this Section 4.04. 
 For
purposes of determining compliance with this Section 4.04: 
 (A) in the event that an item of Debt meets the criteria
of more than one of the types of Debt described above, the Company, in its sole discretion, will classify such item of Debt at the time of Incurrence and only be required to include the amount and type of such Debt in one of the above clauses; and

 (B) the Company will be entitled to divide and classify and reclassify an item of Debt in more than one of the types of
Debt described above. 

  
 -35- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 4.05 Limitation on Restricted Payments. The Company shall not make, and shall
not permit any Restricted Subsidiary to make, directly or indirectly, any Restricted Payment if at the time of, and after giving effect to, the proposed Restricted Payment, 

(a) a Default or Event of Default shall have occurred and be continuing, 

(b) the Company could not Incur at least $1.00 of additional Debt pursuant to clause (1) of the first paragraph of
Section 4.04, or 
 (c) the aggregate amount of that Restricted Payment and all other Restricted Payments declared or
made after the Issue Date (the amount of any Restricted Payment, if made other than in cash, to be based upon Fair Market Value) would exceed an amount equal to the sum of: 

(1) 50% of the aggregate amount of Consolidated Net Income accrued during the period (treated as one accounting period) from
November 28, 2016, to the end of the most recent fiscal quarter ending at least 45 days prior to the date of the Restricted Payment (or if the aggregate amount of Consolidated Net Income for such period shall be a deficit, minus 100% of such
deficit), plus 
 (2) Capital Stock Sale Proceeds received after the Issue Date, plus 

(3) the sum of: 

(A) the aggregate net cash proceeds received by the Company or any Restricted Subsidiary from the issuance or sale after the
Issue Date of convertible or exchangeable Debt that has been converted into or exchanged for Capital Stock (other than Disqualified Stock) of the Company, and 

(B) the aggregate amount by which Debt of the Company or any Restricted Subsidiary is reduced on the Company’s
consolidated balance sheet on or after the Issue Date upon the conversion or exchange of any Debt issued or sold on or prior to the Issue Date that is convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company, 

excluding, in the case of clause (A) or (B): 

(x) any Debt issued or sold to the Company or a Subsidiary of the Company or an employee stock ownership plan or trust
established by the Company or any Subsidiary for the benefit of their employees, and 
 (y) the aggregate amount of any cash
or other Property distributed by the Company or any Restricted Subsidiary upon any such conversion or exchange, plus 
 (4)
an amount equal to the sum of: 
 (A) the net reduction in Investments in any Person other than the Company or a Restricted
Subsidiary resulting from dividends, repayments of loans or advances or other transfers of Property made after the Issue Date, in each case to the Company or any Restricted Subsidiary from that Person, less the cost of the disposition of those
Investments, and 

  
 -36- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (B) the lesser of the net book value or the Fair Market Value of the
Company’s equity interest in an Unrestricted Subsidiary at the time the Unrestricted Subsidiary is designated a Restricted Subsidiary (provided that such designation occurs after the Issue Date); 

provided, however, that the foregoing sum shall not exceed, in the case of any Person, the amount of Investments previously made
(and treated as a Restricted Payment) by the Company or any Restricted Subsidiary in that Person; plus 
 (5) an amount equal
to the restricted payment availability as of the Issue Date under the provisions corresponding to the foregoing in the indenture governing the Company’s 5.00% Senior Notes due 2025, which approximated $993.0 million as of November 27,
2016. 
 Notwithstanding the foregoing limitation, the Company may: 

(a) pay dividends on its Capital Stock within 60 days of the declaration thereof if, on said declaration date, the dividends
could have been paid in compliance with this Indenture; provided, however, that the dividend shall be included in the calculation of the amount of Restricted Payments; 

(b) purchase, repurchase, redeem, legally defease, acquire or retire for value Capital Stock of the Company or Subordinated
Obligations in exchange for, or out of the proceeds of the substantially concurrent sale of, Capital Stock of the Company (other than Disqualified Stock and other than Capital Stock issued or sold to a Subsidiary of the Company or an employee stock
ownership plan or trust established by the Company or any Subsidiary for the benefit of their employees); provided, however, that 

(1) the purchase, repurchase, redemption, legal defeasance, acquisition or retirement shall be excluded in the calculation of
the amount of Restricted Payments, and 
 (2) the Capital Stock Sale Proceeds from the exchange or sale shall be excluded
from the calculation pursuant to clause (c)(2) above; 
 (c) purchase, repurchase, redeem, legally defease, acquire or retire
for value any Subordinated Obligations in exchange for, or out of the proceeds of the substantially concurrent sale of, Permitted Refinancing Debt; provided, however, that the purchase, repurchase, redemption, legal defeasance, acquisition or
retirement shall be excluded in the calculation of the amount of Restricted Payments; 
 (d) pay scheduled dividends (not
constituting a return on capital) on Disqualified Stock of the Company issued pursuant to and in compliance with Section 4.04; 

(e) permit a Restricted Subsidiary that is not a Wholly Owned Subsidiary to pay dividends to shareholders of that Restricted
Subsidiary that are not the parent of that Restricted Subsidiary, so long as the Company or a Restricted Subsidiary that is the parent of that Restricted Subsidiary receives dividends on a pro rata basis or on a basis that results in the receipt by
the Company or a Restricted Subsidiary that is the parent of that Restricted Subsidiary of dividends or distributions of greater value than it would receive on a pro rata basis; 

(f) make cash payments in lieu of fractional shares in connection with the exercise of warrants, options or other securities
convertible into Capital Stock of the Company; provided, however, that such repurchases shall be excluded in the calculation of the amount of Restricted Payments; 

  
 -37- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (g) make repurchases of shares of common stock of the Company deemed to occur
upon the exercise of options to purchase shares of common stock of the Company if such shares of common stock of the Company represent a portion of the exercise price of such options; provided, however, that such repurchases shall be excluded in the
calculation of the amount of Restricted Payments; 
 (h) pay dividends on the common stock of the Company following the first
Equity Offering of the Company after the Issue Date in an annual amount not to exceed 6% of the net cash proceeds received by the Company in such Equity Offering; provided, however, that such dividends shall be included in the calculation of the
amount of Restricted Payments; 
 (i) repurchase shares of, or options to purchase shares of, common stock of the Company
from current or former officers, directors or employees of the Company or any of its Subsidiaries (or permitted transferees of such current or former officers, directors or employees), pursuant to the terms of agreements (including employment
agreements) or plans approved by the Board of Directors under which such individuals acquire shares of such common stock; provided, however, that the aggregate amount of such repurchases shall not exceed $30.0 million in any calendar year (with
unused amounts in any calendar year carried over to succeeding calendar years subject to a maximum of $60.0 million in any calendar year); and provided further, however, that such repurchases shall be excluded in the calculation of the amount
of Restricted Payments; 
 (j) purchase, defease or otherwise acquire or retire for value any Subordinated Obligations upon a
Change of Control of the Company or an Asset Sale by the Company, to the extent required by any agreement pursuant to which such Subordinated Obligations were issued, but only if the Company has previously made the offer to purchase notes required
under Section 4.12 or Section 4.07; provided, however, that such payments shall be included in the calculation of the amount of Restricted Payments; 

(k) make other Restricted Payments not to exceed $150.0 million in the aggregate; provided, however, that such other
payments shall be included in the calculation of the amount of Restricted Payments; and 
 (l) make other Restricted
Payments, provided that after giving pro forma effect to such Restricted Payment the Consolidated Total Leverage Ratio will be less than or equal to 2.50 to 1.00; provided, however, that such other payments shall be included in the calculation of
the amount of Restricted Payments. 
 SECTION 4.06 Limitation on Liens. The Company shall not, and shall not permit any Restricted
Subsidiary to, directly or indirectly, Incur or suffer to exist, any Lien (other than Permitted Liens) upon any of its Property (including Capital Stock of a Restricted Subsidiary), whether owned at the Issue Date or thereafter acquired, or any
interest therein or any income or profits therefrom, unless it has made or will make effective provision whereby the Notes will be secured by that Lien equally and ratably with (or prior to) all other Debt of the Company or any Restricted Subsidiary
secured by that Lien. 
 SECTION 4.07 Limitation on Asset Sales. 

(a) The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, consummate any Asset Sale
unless: 

  
 -38- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) the Company or the Restricted Subsidiary receives consideration at the
time of the Asset Sale at least equal to the Fair Market Value of the Property subject to such Asset Sale; 
 (ii) at least
75% of the consideration paid to the Company or the Restricted Subsidiary in connection with such Asset Sale is in the form of cash or cash equivalents or the assumption by the purchaser of liabilities of the Company or any Restricted Subsidiary
(other than liabilities that are by their terms subordinated to the Notes) as a result of which the Company and the Restricted Subsidiaries are no longer obligated with respect to such liabilities; and 

(iii) the Company delivers an Officers’ Certificate to the Trustee certifying that such Asset Sale complies with the
foregoing clauses (i) and (ii). 
 For the purposes of this Section 4.07: 

(1) in the case of a transaction involving a sale of any distribution center by the Company or a Restricted Subsidiary and the
establishment of an outsourcing arrangement in which the purchaser assumes distribution responsibilities on behalf of the Company or the Restricted Subsidiary, any credits or other consideration the purchaser grants to the Company or the Restricted
Subsidiary as part of the purchase price of the distribution center, which credits or other consideration effectively offset future payments due from the Company or the Restricted Subsidiary to the purchaser as part of the outsourcing arrangement,
will be considered to be cash equivalents; 
 (2) securities or other assets received by the Company or any Restricted
Subsidiary from the transferee that are converted by the Company or such Restricted Subsidiary into cash within 180 days shall be considered to be cash to the extent of the cash received in that conversion; 

(3) any cash consideration paid to the Company or the Restricted Subsidiary in connection with the Asset Sale that is held in
escrow or on deposit to support indemnification, adjustment of purchase price or similar obligations in respect of such Asset Sale shall be considered to be cash; 

(4) Productive Assets received by the Company or any Restricted Subsidiary in connection with the Asset Sale shall be
considered to be cash; and 
 (5) the requirement that at least 75% of the consideration paid to the Company or the
Restricted Subsidiary in connection with the Asset Sale be in the form of cash or cash equivalents shall also be considered satisfied if the cash received constitutes at least 75% of the consideration received by the Company or the Restricted
Subsidiary in connection with such Asset Sale, determined on an after-tax basis. 

(b) The Net Available Cash (or any portion thereof) from Asset Sales may be applied by the Company or a Restricted Subsidiary,
to the extent the Company or such Restricted Subsidiary elects (or is required by the terms of any Debt): 
 (i) to Repay
Debt of the Company (excluding, in any such case, any Debt that (A) constitutes a Subordinated Obligation or (B) is owed to the Company or an Affiliate of the Company); or 

  
 -39- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (ii) to reinvest in Additional Assets (including by means of an Investment in
Additional Assets by a Restricted Subsidiary with Net Available Cash received by the Company or another Restricted Subsidiary), provided, however, that the Net Available Cash (or any portion thereof) from Asset Sales from the Company to any
Subsidiary must be reinvested in Additional Assets of the Company. 
 (c) Any Net Available Cash from an Asset Sale not
applied in accordance with the preceding paragraph within 360 days from the date of the receipt of such Net Available Cash or that the Company earlier elects to so designate shall constitute “Excess Proceeds.” 

When the aggregate amount of Excess Proceeds not previously subject to a Prepayment Offer (as defined below) exceeds $100.0 million
(taking into account income earned on those Excess Proceeds, if any), the Company will be required to make an offer to purchase (the “Prepayment Offer”) the Notes, which offer shall be in the amount of the Allocable Excess Proceeds, on a
pro rata basis according to principal amount, at a purchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the purchase date (subject to the right of Holders of record on the relevant record date to
receive interest due on the relevant interest payment date), in accordance with the procedures (including prorating in the event of oversubscription) set forth in this Indenture. To the extent that any portion of the amount of Net Available Cash
remains after compliance with the preceding sentence and provided that all Holders of Notes have been given the opportunity to tender their Notes for purchase in accordance with this Indenture, the Company or such Restricted Subsidiary may use the
remaining amount for any purpose permitted by this Indenture and the amount of Excess Proceeds will be reset to zero. 
 The term
“Allocable Excess Proceeds” will mean the product of: 
 (a) the Excess Proceeds, and 

(b) a fraction, 

(1) the numerator of which is the aggregate principal amount of the Notes outstanding on the date of the Prepayment Offer, and

 (2) the denominator of which is the sum of the aggregate principal amount of the Notes outstanding on the date of the
Prepayment Offer and the aggregate principal amount of other Debt of the Company outstanding on the date of the Prepayment Offer that is pari passu in right of payment with the Notes and subject to terms and conditions in respect of Asset Sales
similar in all material respects to the covenant described hereunder and requiring the Company to make an offer to purchase such Debt at substantially the same time as the Prepayment Offer. 

(d) (1) Not later than five Business Days after the Company is obligated to make a Prepayment Offer as described in the
preceding paragraph, the Company shall send a written notice, by first-class mail (or electronic transmission in the case of Notes held in book entry form), to the Holders of Notes, accompanied by information regarding the Company and its
Subsidiaries as the Company in good faith believes will enable the Holders to make an informed decision with respect to that Prepayment Offer. The notice shall state, among other things, the purchase price and the purchase date, which shall be,
subject to any contrary requirements of applicable law, a Business Day no earlier than 30 days nor later than 60 days from the date the notice is mailed. 

  
 -40- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (2) Not later than the date upon which written notice of a Prepayment Offer
is delivered to the Trustee as provided above, the Company shall deliver to the Trustee an Officers’ Certificate as to (i) the amount of the Prepayment Offer (the “Offer Amount”), (ii) the allocation of the Net Available Cash
from the Asset Sales pursuant to which such Prepayment Offer is being made and (iii) the compliance of such allocation with the provisions of clause (c) of this section 4.07. On or before the purchase date, the Company shall also
irrevocably deposit with the Trustee or with the Paying Agent (or, if the Company or a Wholly Owned Subsidiary is the Paying Agent, shall segregate and hold in trust) in Temporary Cash Investments (other than in those enumerated in clause
(b) of the definition of Temporary Cash Investments), maturing on the last day prior to the purchase date or on the purchase date if funds are immediately available by open of business, an amount equal to the Offer Amount to be held for payment
in accordance with the provisions of this Section. Upon the expiration of the period for which the Prepayment Offer remains open (the “Offer Period”), the Company shall deliver to the Trustee for cancellation the Notes or portions thereof
that have been properly tendered to and are to be accepted by the Company. The Trustee or the Paying Agent shall, on the purchase date, mail or deliver payment to each tendering Holder in the amount of the purchase price. In the event that the
aggregate purchase price of the Notes delivered by the Company to the Trustee is less than the Offer Amount, the Trustee or the Paying Agent shall deliver the excess to the Company immediately after the expiration of the Offer Period for application
in accordance with this Section. 
 (3) Holders electing to have a Note purchased shall be required to surrender the Note,
with an appropriate form duly completed, to the Company or its agent at the address specified in the notice at least three Business Days prior to the purchase date. Holders shall be entitled to withdraw their election if the Trustee or the Company
receives not later than one Business Day prior to the purchase date, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Note that was delivered for purchase by the Holder and a
statement that such Holder is withdrawing its election to have such Note purchased. If at the expiration of the Offer Period the aggregate principal amount of Notes surrendered by Holders exceeds the Offer Amount, the Company shall select the Notes
to be purchased on a pro rata basis for all Notes, (with such adjustments as may be deemed appropriate by the Company so that only Notes in denominations of €100,000, or integral multiples of €1,000 thereafter, shall be purchased). Holders
whose Notes are purchased only in part shall be issued new Notes equal in principal amount to the unpurchased portion of the Notes surrendered. 

(4) At the time the Company delivers Notes to the Trustee that are to be accepted for purchase, the Company shall also deliver
an Officers’ Certificate stating that such Notes are to be accepted by the Company pursuant to and in accordance with the terms of this Section. A Note shall be deemed to have been accepted for purchase at the time the Trustee or the applicable
Paying Agent mails or delivers payment therefor to the surrendering Holder. 
 (e) The Company will comply, to the extent
applicable, with the requirements of Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Notes pursuant to this Section. To the extent that the provisions of any securities laws or
regulations conflict with provisions of this Section, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under this Section by virtue thereof. 

  
 -41- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 4.08 Limitation on Restrictions on Distributions from Restricted Subsidiaries.
The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create or otherwise cause or suffer to exist any consensual restriction on the right of any Restricted Subsidiary to: 

(a) pay dividends, in cash or otherwise, or make any other distributions on or in respect of its Capital Stock, or pay any Debt
or other obligation owed, to the Company or any other Restricted Subsidiary, 
 (b) make any loans or advances to the Company
or any other Restricted Subsidiary, or 
 (c) transfer any of its Property to the Company or any other Restricted Subsidiary.

 The foregoing limitations will not apply: 

(1) with respect to clauses (a), (b) and (c), to restrictions: 

(A) in effect on the Issue Date, 

(B) relating to Debt of a Restricted Subsidiary and existing at the time it became a Restricted Subsidiary if such restriction
was not created in connection with or in anticipation of the transaction or series of transactions pursuant to which that Restricted Subsidiary became a Restricted Subsidiary or was acquired by the Company, 

(C) that result from the Refinancing of Debt Incurred pursuant to an agreement referred to in clause (1)(A) or (B) above
or in clause (2)(A) or (B) below, provided that restriction is no less favorable to the Holders of Notes than those under the agreement evidencing the Debt so Refinanced, 

(D) resulting from the Incurrence of any Permitted Debt described in clause (b) of the second paragraph of
Section 4.04, provided that the restriction is no less favorable to the Holders of Notes than the restrictions of the same type contained in this Indenture, or 

(E) constituting Standard Securitization Undertakings relating solely to, and restricting only the rights of, a Receivables
Entity in connection with a Qualified Receivables Transaction, and 
 (2) with respect to clause (c) only, to
restrictions: 
 (A) relating to Debt that is permitted to be Incurred and secured without also securing the Notes pursuant
to Section 4.04 and Section 4.06 that limit the right of the debtor to dispose of the Property securing that Debt, 

(B) encumbering Property at the time the Property was acquired by the Company or any Restricted Subsidiary, so long as the
restriction relates solely to the Property so acquired and was not created in connection with or in anticipation of the acquisition, 

(C) resulting from customary provisions restricting subletting or assignment of leases or customary provisions in other
agreements (including, without limitation, intellectual property licenses entered into in the ordinary course of business) that restrict assignment of the agreements or rights thereunder, or 

  
 -42- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (D) which are customary restrictions contained in asset sale agreements
limiting the transfer of Property pending the closing of the sale. 
 SECTION 4.09 Limitation on Transactions with Affiliates. The
Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, conduct any business or enter into or suffer to exist any transaction or series of transactions (including the purchase, sale, transfer, assignment, lease,
conveyance or exchange of any Property or the rendering of any service) with, or for the benefit of, any Affiliate of the Company (an “Affiliate Transaction”), unless: 

(a) the terms of such Affiliate Transaction are: 

(1) set forth in writing, and 

(2) no less favorable to the Company or that Restricted Subsidiary, as the case may be, than those that could be obtained in a
comparable arm’s-length transaction with a Person that is not an Affiliate of the Company, and 

(b) if the Affiliate Transaction involves aggregate payments or value in excess of $25.0 million, the Board of Directors
(including a majority of the disinterested members of the Board of Directors) approves the Affiliate Transaction and, in its good faith judgment, believes that the Affiliate Transaction complies with clauses (a)(1) and (2) of this paragraph as
evidenced by a Board Resolution promptly delivered to the Trustee. 
 Notwithstanding the foregoing limitation, the Company or any
Restricted Subsidiary may enter into or suffer to exist the following: 
 (a) any transaction or series of transactions
between the Company and one or more Restricted Subsidiaries or between two or more Restricted Subsidiaries in the ordinary course of business, provided that no more than 5% of the total voting power of the Voting Stock (on a fully diluted basis) of
any such Restricted Subsidiary is owned by an Affiliate of the Company (other than a Restricted Subsidiary); 
 (b) any
Restricted Payment permitted to be made pursuant to Section 4.05; 
 (c) the payment of compensation (including amounts
paid pursuant to employee benefit plans) for the personal services of officers, directors and employees of the Company or any of the Restricted Subsidiaries, so long as, in the case of executive officers and directors, the Board of Directors in good
faith shall have approved the terms thereof and deemed the services theretofore or thereafter to be performed for the compensation to be fair consideration therefor; 

(d) loans and advances to employees made in the ordinary course of business in compliance with applicable laws and consistent
with the past practices of the Company or that Restricted Subsidiary, as the case may be, provided that those loans and advances do not exceed $20.0 million in the aggregate at any one time outstanding; 

(e) any transaction effected as part of a Qualified Receivables Transaction or any transaction involving the transfer of
accounts receivable of the type specified in the definition of “Credit Facility” and permitted under clause (b) of the second paragraph of Section 4.04; 

  
 -43- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (f) the Existing Policies or any transaction contemplated thereby; and 

(g) any sale of shares of Capital Stock (other than Disqualified Stock) of the Company. 

SECTION 4.10 Designation of Restricted and Unrestricted Subsidiaries. The Board of Directors may designate any Subsidiary of the
Company to be an Unrestricted Subsidiary if: 
 (a) the Subsidiary to be so designated does not own any Capital Stock or Debt
of, or own or hold any Lien on any Property of, the Company or any other Restricted Subsidiary, and 
 (b) any of the
following: 
 (1) the Subsidiary to be so designated has total assets of $1,000 or less, 

(2) if the Subsidiary has consolidated assets greater than $1,000, then the designation would be permitted under
Section 4.05, or 
 (3) the designation is effective immediately upon the entity becoming a Subsidiary of the Company.

 Unless so designated as an Unrestricted Subsidiary, any Person that becomes a Subsidiary of the Company will be classified as a Restricted Subsidiary;
provided, however, that the Subsidiary shall not be designated a Restricted Subsidiary and shall be automatically classified as an Unrestricted Subsidiary if either of the requirements set forth in clauses (x) and (y) of the second immediately
following paragraph will not be satisfied after giving pro forma effect to the classification or if the Person is a Subsidiary of an Unrestricted Subsidiary. 

Except as provided in the first sentence of the preceding paragraph, no Restricted Subsidiary may be redesignated as an Unrestricted
Subsidiary. In addition, neither the Company nor any Restricted Subsidiary shall at any time be directly or indirectly liable for any Debt that provides that the holder thereof may (with the passage of time or notice or both) declare a default
thereon or cause the payment thereof to be accelerated or payable prior to its Stated Maturity upon the occurrence of a default with respect to any Debt, Lien or other obligation of any Unrestricted Subsidiary in existence and classified as an
Unrestricted Subsidiary at the time the Company or the Restricted Subsidiary is liable for that Debt (including any right to take enforcement action against that Unrestricted Subsidiary). 

The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary if, immediately after giving pro forma effect
to the designation, 
 (x) the Company could Incur at least $1.00 of additional Debt pursuant to clause (1) of the first
paragraph of Section 4.04, and 
 (y) no Default or Event of Default shall have occurred and be continuing or would
result therefrom. 
 Any designation or redesignation of this kind by the Board of Directors will be evidenced to the Trustee by filing with
the Trustee a Board Resolution giving effect to the designation or redesignation and an Officers’ Certificate that: 

(a) certifies that the designation or redesignation complies with the foregoing provisions, and 

  
 -44- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) gives the effective date of the designation or redesignation, and the
filing with the Trustee to occur within 45 days after the end of the fiscal quarter of the Company in which the designation or redesignation is made (or, in the case of a designation or redesignation made during the last fiscal quarter of the
Company’s fiscal year, within 90 days after the end of that fiscal year). 
 SECTION 4.11 [Reserved]. 

SECTION 4.12 Change of Control. 

(a) Upon the occurrence of a Change of Control, unless the Company has exercised its right, if any, to redeem the Notes in
full, each Holder of Notes shall have the right to require the Company to repurchase all or any part of such Holder’s Notes pursuant to the offer described below (the “Change of Control Offer”) at a purchase price (the “Change of
Control Purchase Price”) equal to 101.0% of the principal amount thereof, plus accrued and unpaid interest, if any, to the purchase date (subject to the right of Holders of record on the relevant record date to receive interest due on the
relevant interest payment date). 
 (b) Within 30 days following any Change of Control, the Company shall (i) cause a
notice of the Change of Control Offer to be sent at least once to the Dow Jones News Service or similar business news service in the United States and (ii) send, by first-class mail (or electronic transmission in the case of Notes held in book
entry form), with a copy to the Trustee, to each Holder of Notes, at such Holder’s address appearing in the Note Register, a notice stating: (A) that a Change of Control has occurred and a Change of Control Offer is being made pursuant to
this Section 4.12 and that all Notes timely tendered will be accepted for purchase; (B) the Change of Control Purchase Price and the purchase date, which shall be, subject to any contrary requirements of applicable law, a Business Day no
earlier than 30 days nor later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”); (C) the circumstances and relevant facts regarding the Change of Control (including information with respect to pro
forma historical income, cash flow and capitalization after giving effect to the Change of Control); and (D) the procedures that Holders of Notes must follow in order to tender their Notes (or portions thereof) for payment and the procedures
that Holders of Notes must follow in order to withdraw an election to tender Notes (or portions thereof) for payment. 
 (c)
Holders electing to have a Note purchased shall be required to surrender the Note (for Notes held in book-entry form, in accordance with the applicable procedures of the Clearing Systems), with an appropriate form duly completed, to the Company or
its agent at the address specified in the notice at least three Business Days prior to the Change of Control Payment Date. Holders shall be entitled to withdraw their election if the Trustee or the Company receives not later than one Business Day
prior to the Change of Control Payment Date, a facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Note that was delivered for purchase by the Holder and a statement that such Holder is withdrawing its
election to have such Note purchased (for Notes held in book-entry form, in accordance with the applicable procedures of the Clearing Systems). 

(d) Prior to the Change of Control Payment Date, the Company shall irrevocably deposit with the Paying Agent (or, if the
Company or any of its Wholly Owned Subsidiaries is acting as the Paying Agent, segregate and hold in trust) in cash an amount equal to the Change of Control Purchase Price payable to the Holders entitled thereto, to be held for payment in accordance
with the provisions of this Section. On the Change of Control Payment Date, the Company shall deliver to the Trustee the Notes or portions thereof that have been properly tendered to and are to be accepted by the Company for payment. The Paying
Agent shall, on the Change of Control 

  
 -45- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
Payment Date, mail or deliver payment to each tendering Holder of the Change of Control Purchase Price. In the event that the aggregate Change of Control Purchase Price is less than the amount
delivered by the Company to the Paying Agent, the Paying Agent shall deliver the excess to the Company immediately after the Change of Control Payment Date. 

(e) The Company will not be required to make a Change of Control Offer following a Change of Control if a third party makes the
Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of Control Offer made by the Company and purchases all Notes validly tendered and not withdrawn
under such Change of Control Offer. 
 (f) The Company will comply, to the extent applicable, with the requirements of
Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the purchase of Notes pursuant to this Section. To the extent that the provisions of any securities laws or regulations conflict with the
provisions of this Section, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under this Section by virtue thereof. 

(g) If and for so long as the Notes are listed on the Official List of the Luxembourg Stock Exchange and the rules of the
Luxembourg Stock Exchange so require, the Company will publish a notice of any merger, consolidation or amalgamation described above, or any sale, transfer, assignment, lease, conveyance or other disposition of all or substantially all of the
Property of the Company described above, in a leading newspaper of general circulation in Luxembourg or, to the extent and in the manner permitted by such rules, post such notice on the official website of the Luxembourg Stock Exchange
(www.bourse.lu) and, for so long as the rules of the Luxembourg Stock Exchange so require, notify the Luxembourg Stock Exchange of any such transaction. 

SECTION 4.13 Further Instruments and Acts. Upon request of the Trustee, the Company shall execute and deliver such further instruments
and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 
 SECTION
4.14 Future Subsidiary Guarantors. The Company may, at any time after the Issue Date, cause one or more of its Restricted Subsidiaries to Guarantee the Notes. Upon any Guarantee of the Notes by a Future Guarantor, such Future Guarantor will
execute and deliver to the Trustee a supplemental indenture pursuant to which such Future Guarantor shall Guarantee payment of the Notes. 

SECTION 4.15 Payment of Additional Amounts. 

The Company will, subject to the exceptions and limitations set forth below, pay additional amounts on the Notes as are necessary in order that
each payment made by the Company or a Paying Agent to a beneficial owner of the Notes who is not a United States person (as defined below), after deduction by any applicable withholding agent of any present or future tax, assessment or other
governmental charge (including any interest, penalties, or other additions to tax) of the United States or a political subdivision or taxing authority of or in the United States, imposed by withholding with respect to the payment, will not be less
than the amount provided in the Notes to be then due and payable; provided, however, that the foregoing obligation to pay additional amounts shall not apply: 

(a) to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the Holder, or a
fiduciary, settlor, beneficiary, member or shareholder of the Holder if the Holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as: 

  
 -46- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (1) being or having been engaged in a trade or business in the United States
or having or having had a permanent establishment in the United States; 
 (2) having another current or former connection
with the United States, including being or having been a citizen or resident of the United States, but excluding a connection resulting solely from acquiring, owning or disposing of the notes, receiving payment thereunder or enforcing its rights
thereunder; 
 (3) being or having been a “10-percent shareholder” of the
Company as defined in section 871(h)(3) of the Code or any successor provision or a controlled foreign corporation described in section 881(c)(3)(C) of the Code (or any successor provision); or 

(4) being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into the ordinary
course of its trade or business; 
 (b) to any Holder that is not the sole beneficial owner of the Notes, or a portion of the
Notes, or that is a fiduciary or partnership, but only to the extent that a beneficiary or settlor with respect to the fiduciary, a beneficial owner or member of the partnership would not have been entitled to the payment of an additional amount had
the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment; 

(c) to any tax, assessment or other governmental charge that would not have been imposed but for the failure of the Holder or
any other Person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the Holder or beneficial owner of the Notes, if compliance is
required by statute, by regulation of the United States Treasury Department or by an applicable income tax treaty to which the United States is a party as a precondition to any exemption from, or reduction in, such tax, assessment or other
governmental charge to which the holder is legally entitled; 
 (d) to any tax, assessment or other governmental charge that
is imposed otherwise than by withholding from the payment; 
 (e) to any estate, inheritance, gift, sales, excise, transfer,
wealth or personal property tax or similar tax, assessment or other governmental charge; 
 (f) to any tax, assessment or
other governmental charge required to be withheld by any Paying Agent from any payment of principal of or interest on any Note, if such payment can be made without such withholding by at least one other Paying Agent; 

(g) to any tax, assessment or other governmental charge that would not have been imposed but for the presentation by the Holder
of any Note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later; 

(h) to any U.S. federal back-up withholding tax under Section 3406 of the Code;

 (i) to any U.S. federal withholding tax imposed on a foreign organization that is a private foundation pursuant to
Section 1443(b) of the Code; 

  
 -47- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (j) to any tax imposed under Sections 1471- 1474 of the Code as of the date
hereof (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future United States Treasury Regulations promulgated thereunder or official governmental interpretations
thereof, any agreements entered into pursuant to current Section 1471(b)(1) of the Code (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), and any applicable intergovernmental
agreements (and related laws) and official administrative guidance implementing the foregoing; or 
 (k) in the case of any
combination of items (a) through (j). 
 SECTION 4.16 Maintenance of Listing 

The Company will (i) use its commercially reasonable efforts to cause the Notes to be listed, subject to notice of issuance, on the
Official List of the Luxembourg Stock Exchange and admitted to trading on the Euro MTF Market as promptly as practicable after the Issue Date, and (ii) use its commercially reasonable efforts to maintain such listing for as long as any of the
Notes are outstanding. If the Notes fail to be, or at any time cease to be, listed on the Official List of the Luxembourg Stock Exchange and admitted to trading on the Euro MTF Market, the Company will use its commercially reasonable efforts to list
the Notes on another recognized stock exchange in western Europe as promptly as practicable after the date on which the Notes are not so listed or admitted. 

ARTICLE V. 
 Successor Company

 SECTION 5.01 When Company May Merge or Transfer Assets. The Company shall not merge, consolidate or amalgamate with or into
(other than a merger of a Wholly Owned Restricted Subsidiary into the Company), or sell, transfer, assign, lease, convey or otherwise dispose of all or substantially all its Property in any one transaction or series of transactions to, any Person
unless: 
 (a) the Company shall be the surviving Person (the “Surviving Person”) or the Surviving Person (if other
than the Company) formed by that merger, consolidation or amalgamation or to which that sale, transfer, assignment, lease, conveyance or disposition is made shall be a corporation organized and existing under the laws of the United States of
America, any State thereof or the District of Columbia; 
 (b) the Surviving Person (if other than the Company) expressly
assumes, by supplemental indenture in form satisfactory to the Trustee, executed and delivered to the Trustee by that Surviving Person, the due and punctual payment of the principal of, and premium, if any, and interest on, all the Notes, according
to their tenor, and the due and punctual performance and observance of all the covenants and conditions of this Indenture to be performed by the Company; 

(c) immediately after giving effect to such transaction or series of transactions on a pro forma basis, no Default or Event of
Default shall have occurred and be continuing; 
 (d) immediately after giving effect to that transaction or series of
transactions on a pro forma basis, the Company or the Surviving Person, as the case may be, (i) would be able to Incur at least $1.00 of additional Debt under clause (1) of the first paragraph of Section 4.04, or (ii) the
Consolidated Fixed Charges Coverage Ratio would be greater than such ratio immediately prior to such transaction, provided, however, that this clause (d) shall not be applicable to the Company 

  
 -48- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
merging, consolidating or amalgamating with or into an Affiliate incorporated solely for the purpose of reincorporating the Company in another State of the United States so long as the amount of
Debt of the Company and the Restricted Subsidiaries is not increased thereby; and 
 (e) the Company shall deliver, or cause
to be delivered, to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of Counsel, each stating that the transaction and the supplemental indenture, if any, in respect thereto
comply with this Section and that all conditions precedent herein provided for relating to the transaction and the execution and delivery of a supplemental indenture, as applicable, have been satisfied. 

The Surviving Person shall succeed to, and be substituted for, and may exercise every right and power of the Company under this Indenture, but
the predecessor Company in the case of: 
 (a) a sale, transfer, assignment, conveyance or other disposition (unless that
sale, transfer, assignment, conveyance or other disposition is of all the assets of the Company as an entirety or virtually as an entirety), or 

(b) a lease, 
 shall not be
released from any obligation to pay the principal of, premium, if any, and interest on, the Notes. 
 If and for so long as any notes are
listed on the Official List of the Luxembourg Stock Exchange and the rules of the Luxembourg Stock Exchange so require, the Company will publish a notice of any merger, consolidation or amalgamation described above, or any sale, transfer,
assignment, lease, conveyance or other disposition of all or substantially all of the Property of the Company described above, in a leading newspaper of general circulation in Luxembourg or, to the extent and in the manner permitted by such rules,
post such notice on the official website of the Luxembourg Stock Exchange (www.bourse.lu) and, for so long as the rules of the Luxembourg Stock Exchange so require, notify the Luxembourg Stock Exchange of any such transaction. 

ARTICLE VI. 
 Defaults and
Remedies 
 SECTION 6.01 Events of Default. The following events shall be “Events of Default”: 

(1) the Company defaults in any payment of interest on any Note when the same becomes due and payable, and such default
continues for a period of 30 days; 
 (2) the Company defaults in the payment of the principal of, or premium, if any, on any
Note when the same becomes due and payable at its Stated Maturity, upon acceleration, redemption, optional redemption, required repurchase or otherwise; 

(3) the Company fails to comply with Article V; 

(4) the Company fails to comply with any other covenant or agreement in the Notes or in this Indenture (other than a failure
that is the subject of the foregoing clause (1), (2) or (3)) and such failure continues for 60 days after written notice is given to the Company as specified below; 

  
 -49- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (5) a default under any Debt by the Company or any Restricted Subsidiary that
results in acceleration of the maturity of that Debt, or failure to pay any Debt at maturity, in an aggregate amount greater than $50.0 million or its foreign currency equivalent at the time; 

(6) the Company or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 

(A) commences a voluntary case; 

(B) consents to the entry of an order for relief against it in an involuntary case; 

(C) consents to the appointment of a Custodian of it or for any substantial part of its property; or 

(D) makes a general assignment for the benefit of its creditors; 

or takes any comparable action under any foreign laws relating to insolvency; 

(7) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A) is for relief against the Company or any Significant Subsidiary in an involuntary case; 

(B) appoints a Custodian of the Company or any Significant Subsidiary or for any substantial part of its property; 

(C) orders the winding up or liquidation of the Company or any Significant Subsidiary; or 

(D) grants any similar relief under any foreign laws; and in each such case the order or decree remains unstayed and in effect
for 30 days; or 
 (8) any judgment or judgments for the payment of money in an aggregate amount in excess of
$50.0 million (or its foreign currency equivalent at the time) that shall be rendered against the Company or any Restricted Subsidiary and that shall remain unsatisfied, undischarged, unvacated, unbonded or unstayed for a period of 60
consecutive days or more after such judgment becomes final. 
 The foregoing will constitute Events of Default whatever the reason for any
such Event of Default and whether it is voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. 

The term “Bankruptcy Law” means Title 11, United States Code, or any similar Federal or state law for the relief of debtors. The
term “Custodian” means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. 
 A
Default under clause (4) is not an Event of Default until the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding notify the Company (and in the case of such notice by Holders, the Trustee) of the
Default and the Company does not cure that Default within the time specified after receipt of such notice. The notice must specify the Default, demand that it be remedied and state that such notice is a “Notice of Default”. 

  
 -50- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 The Company shall deliver to the Trustee, within 30 days after the occurrence thereof,
written notice in the form of an Officers’ Certificate of any Event of Default and any event that with the giving of notice and the lapse of time would become an Event of Default, its status and what action the Company is taking or proposes to
take with respect thereto. 
 SECTION 6.02 Acceleration. If an Event of Default with respect to the Notes (other than an Event of
Default specified in Section 6.01(6) or (7) with respect to the Company) shall have occurred and be continuing, the Trustee or the registered Holders of not less than 25% in aggregate principal amount of Notes then outstanding may by
notice to the Company and the Trustee declare to be immediately due and payable the principal amount of all the applicable Notes then outstanding, plus accrued but unpaid interest to the date of acceleration. Upon such a declaration, such principal
and interest shall be due and payable immediately. If an Event of Default specified in Section 6.01(6) or (7) with respect to the Company occurs, the principal of and accrued and unpaid interest on all the Notes shall be due and payable
immediately without any declaration or other act by the Trustee or the Holder of the Notes. After any such acceleration but before a judgment or decree based on acceleration is obtained by the Trustee, the Holders of a majority in aggregate
principal amount of the outstanding Notes by notice to the Trustee and the Company may rescind any declaration of acceleration if the rescission would not conflict with any judgment or decree and if all existing Events of Default have been cured or
waived except nonpayment of principal, premium, or interest that has become due solely because of the acceleration. No such rescission shall affect any subsequent Default or impair any right consequent thereto. 

SECTION 6.03 Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to collect
the payment of principal of, or premium, if any, or interest on, the Notes or to enforce the performance of any provision of the Notes or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of them in the proceeding. A delay
or omission by the Trustee or any Noteholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any
other remedy. All available remedies are cumulative. 
 SECTION 6.04 Waiver of Past Defaults. The Holders of a majority in aggregate
principal amount of the Notes then outstanding by notice to the Trustee may waive an existing Default and its consequences except (i) a Default in the payment of the principal of or interest on a Note or (ii) a Default in respect of a
provision that under Section 9.02 cannot be amended without the consent of each Noteholder affected. When a Default is waived, it is deemed cured, but no such waiver shall extend to any subsequent or other Default or impair any consequent
right. 
 SECTION 6.05 Control by Majority. The Holders of a majority in aggregate principal amount of the Notes then outstanding may
direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee with respect to the Notes. However, the Trustee may refuse to follow any direction
that conflicts with law or this Indenture or that the Trustee determines is unduly prejudicial to the rights of other Noteholders or would involve the Trustee in personal liability; provided, however, that the Trustee may take any other action
deemed proper by the Trustee that is not inconsistent with such direction. Subject to Section 7.01, in case an Event of Default shall occur and be continuing, the Trustee shall be under no obligation to exercise any of its rights or powers
hereunder at the request or direction of any of the Holders, unless the Holders shall have offered to the Trustee indemnity reasonably satisfactory to it against loss, liability or expense. 

  
 -51- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 6.06 Limitation on Suits. No Holder will have any right to institute any
proceeding with respect to this Indenture, or for the appointment of a receiver or trustee, or for any remedy hereunder, unless: 

(1) such Holder shall have previously given to the Trustee written notice of a continuing Event of Default; 

(2) the Holders of at least 25% in aggregate principal amount of the Notes then outstanding shall have made a written request,
and such Holder or Holders shall have offered indemnity, to the Trustee reasonably satisfactory to it against loss, liability or expense to institute such proceeding as trustee; and 

(3) the Trustee shall not have received from the Holders of at least a majority in aggregate principal amount of the Notes
outstanding a direction inconsistent with such request, and shall have failed to institute the proceeding within 60 days after such notice, request and offer. 

The foregoing limitations on the pursuit of remedies by a Noteholder shall not apply to a suit instituted by a Holder of Notes for the
enforcement of payment of the principal of, premium, if any, or interest on such Note on or after the applicable due date specified in such Note. A Noteholder may not use this Indenture to prejudice the rights of another Noteholder or to obtain a
preference or priority over another Noteholder (it being understood that the Trustee does not have an affirmative duty to ascertain whether or not such actions or forbearances are unduly prejudicial to such Holders). 

SECTION 6.07 Rights of Holders to Receive Payment. Notwithstanding any other provision of this Indenture, the right of any Holder to
receive payment of principal of and interest on the Notes held by such Holder, on or after the respective due dates expressed in the Notes, or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be
impaired or affected without the consent of such Holder. 
 SECTION 6.08 Collection Suit by Trustee. If an Event of Default specified
in Section 6.01(1) or (2) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount then due and owing (together with interest on any unpaid
interest to the extent lawful) and the amounts provided for in this Indenture. 
 SECTION 6.09 Trustee May File Proofs of Claim. The
Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee and the Noteholders allowed in any judicial proceedings relative to the Company, its creditors or its
property and, unless prohibited by law or applicable regulations, may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial proceeding is hereby
authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for such compensation as agreed upon in
writing by the parties hereto, expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due the Trustee under this Indenture, or in connection with the transactions contemplated hereunder. To the extent
that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under this Indenture out of the estate, in any such proceeding, shall be denied for any
reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the holders may be entitled to receive in such proceeding whether in liquidation
or under any plan of reorganization or arrangement or otherwise. 

  
 -52- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 6.10 Priorities. If the Trustee collects any money or property pursuant to
this Article 6, it shall pay out the money or property in the following order: 
 FIRST: to the Trustee, including its agents
and counsel, for amounts due under this Indenture; 
 SECOND: to Noteholders for amounts due and unpaid on the Notes for
principal and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Notes for principal and interest, respectively; and 

THIRD: to the Company. 

The Trustee may fix a record date and payment date for any payment to Noteholders pursuant to this Section. At least 15 days before such
record date, the Company shall mail to each Noteholder and the Trustee a notice that states the record date, the payment date and amount to be paid. 

SECTION 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against
the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable
costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section does not apply to a suit by the
Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in aggregate principal amount of the Notes. 

SECTION 6.12 Waiver of Stay or Extension Laws. The Company (to the extent it may lawfully do so) shall not at any time insist upon, or
plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the performance of this Indenture; and the Company (to
the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein granted to the Trustee, but shall suffer and permit the execution of
every such power as though no such law had been enacted. 
 ARTICLE VII. 

Trustee 
 SECTION 7.01
Duties of Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights
and powers vested in it by this Indenture and use the same degree of care and skill in its exercise as a prudent Person would exercise or use under the circumstances in the conduct of such Person’s own affairs. 

(b) Except during the continuance of an Event of Default: 

(1) the Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture and no
implied duties, covenants or obligations shall be read into this Indenture against the Trustee; and 

  
 -53- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (2) in the absence of willful misconduct on its part, the Trustee may
conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, the Trustee shall
examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture but need not confirm or investigate the accuracy of any mathematical calculations or other facts stated therein. 

(c) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful
misconduct, except that: 
 (1) this paragraph does not limit the effect of paragraph (b) of this Section; 

(2) the Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer unless it is proved that
the Trustee was negligent in ascertaining the pertinent facts; and 
 (3) the Trustee shall not be liable with respect to any
action it takes or omits to take in good faith in accordance with a direction received by it pursuant to the terms of this Indenture. 
 (d)
Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of this Section. 

(e) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. 

(f) Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

(g) No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the
performance of any of its duties hereunder or in the exercise of any of its rights or powers. 
 (h) Every provision of this Indenture
relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section and to the provisions of the TIA and the provisions of this Article VII shall apply to the Agents and to
the Trustee (to the extent it shall act in the capacity of Registrar or Paying Agent). 
 SECTION 7.02 Rights of Trustee. 

(a) The Trustee may conclusively rely on any document (whether in its original or facsimile form) believed by it to be genuine
and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the document. The Trustee may, however, in its discretion make such further inquiry or investigation into such facts or matters
as it may see fit and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the expense of the Company and
shall incur no liability or additional liability of any kind by reason of such inquiry or investigation. 

  
 -54- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Before the Trustee acts or refrains from acting, it shall be entitled to
receive an Officers’ Certificate and an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. 

(c) The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed
with due care. 
 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes
to be authorized or within its rights or powers; provided, however, that the Trustee’s conduct does not constitute willful misconduct or negligence. 

(e) The Trustee may consult with counsel of its selection, and the advice or opinion of counsel with respect to legal matters
relating to this Indenture and the Notes shall be full and complete authorization and protection from liability in respect to any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such
counsel. 
 (f) The permissive rights of the Trustee to do things enumerated in this Indenture shall not be construed as a
duty unless so specified herein. 
 (g) The Trustee shall be under no obligation to exercise any of the rights or powers
vested in it by this Indenture at the request or direction of any of the Holders pursuant to this Indenture, unless such Holders shall have offered to the Trustee security or indemnity reasonably satisfactory to the Trustee against the costs,
expenses and liabilities which might be incurred by the Trustee in compliance with such request or direction. 
 (h) The
Trustee may employ or retain accountants, appraisers or other experts or advisers as it may reasonably require for the purpose of determining and discharging its rights and duties hereunder and shall not be responsible for any misconduct on the part
of any of them. 
 (i) In no event shall the Trustee be responsible or liable for special, indirect, punitive or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. 

(j) The Trustee shall not be deemed to have notice of any Default or Event of Default unless (i) a Trust Officer has
actual knowledge thereof or (ii) unless written notice of any event which is in fact such a default is received by the Trustee from the Company or any Holder of at least 25% in aggregate principal amount of the Notes (in accordance with the
notice provisions of this Indenture) and such notice references the Notes and this Indenture. 
 (k) The rights, privileges,
protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other
Person employed to act hereunder. 
 (l) The Trustee shall not be required to give any bond or surety in respect of the
performance of its powers and duties hereunder. 
 (m) The Trustee may request that the Company deliver a certificate setting
forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture. 

  
 -55- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (n) Under no circumstances shall the Trustee be liable in its individual
capacity for the obligations evidenced by the Notes. 
 (o) o) The Trustee shall have no obligation to pursue any action that
is not in accordance with applicable law. 
 The provisions of this Section 7.02 shall survive satisfaction and discharge or the
termination, for any reason, of this Indenture and the resignation and/or removal of the Trustee. 
 SECTION 7.03 Individual Rights of
Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any Agent may do the same
with like rights. However, the Trustee must comply with Sections 7.10 and 7.11. 
 SECTION 7.04 Trustee’s Disclaimer. The
Trustee shall not be responsible for and makes no representation as to the validity, priority or adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s use of the proceeds from the Notes, and it shall not be
responsible for any statement of the Company in this Indenture or in any other document other than the certificate of authentication executed by the Trustee. 

SECTION 7.05 Notice of Defaults. If a Default or Event of Default occurs and is continuing and if it is known to the Trustee, the
Trustee shall mail to each Noteholder notice of the Default or Event of Default within 90 days after it is known to a Trust Officer or written notice of it is received by the Trustee. Except in the case of a Default or Event of Default in payment of
principal of or interest on any Note, the Trustee may withhold the notice if and so long as the Trustee in good faith determines that withholding the notice is in the interests of Noteholders. 

SECTION 7.06 Reports by Trustee to Holders. As promptly as practicable after each December 31 beginning with December 31,
2017, and in any event prior to February 28 in each year, the Trustee shall mail to each Noteholder a brief report dated as of December 31 each year that complies with TIA § 313(a), if and to the extent required by such subsection.
The Trustee shall also comply with TIA § 313(b). 
 A copy of each report at the time of its mailing to Noteholders shall be filed with
the SEC and each stock exchange (if any) on which the Notes are listed. The Company agrees to notify promptly the Trustee whenever the Notes become listed on any stock exchange and of any delisting thereof. 

SECTION 7.07 Compensation and Indemnity. The Company shall pay to the Trustee from time to time such compensation for its services as
agreed upon in writing by the parties hereto. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred or made by it, including costs of collection, in addition to the compensation for its services. Such expenses shall include the reasonable
compensation and expenses, disbursements and advances of the Trustee’s agents, counsel, accountants and experts. The Company shall indemnify, defend, protect and hold the Trustee harmless from and against any and all loss, liability, damages,
cost or expense (including reasonable attorneys’ fees) incurred by it in connection with the performance of its duties hereunder and/or the transactions contemplated under this Indenture and the Trustee shall have no liability or responsibility
for any action or inaction on the part of any Agent or any successor trustee. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company
of its obligations hereunder except to the extent that the Company shall have been actually prejudiced as a result of such failure. The Company shall defend the claim and the Trustee may 

  
 -56- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
have separate counsel and the Company shall pay the fees and expenses of such counsel. The Company need not reimburse any expense or indemnify against any loss, liability or expense incurred by
the Trustee through the Trustee’s own willful misconduct or negligence, as finally adjudicated by a court of competent jurisdiction. The Company need not pay for any settlement made by the Trustee without the Company’s consent, such
consent not to be unreasonably withheld. All indemnifications and releases from liability granted hereunder to the Trustee shall extend to its officers, directors, employees, agents, successors and assigns. 

To secure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Notes on all money or property
held or collected by the Trustee other than money or property held in trust to pay principal of and interest on particular Notes. 
 The
Company’s payment obligations pursuant to this Section shall survive the resignation or removal of the Trustee and the discharge of this Indenture. When the Trustee incurs expenses after the occurrence of a Default specified in
Section 6.01(6) or (7) with respect to the Company, the expenses are intended to constitute expenses of administration under the Bankruptcy Law. 

SECTION 7.08 Replacement of Trustee. The Trustee may resign at any time by so notifying the Company. The Holders of a majority in
aggregate principal amount of the Notes then outstanding may remove the Trustee by so notifying the Trustee and may appoint a successor Trustee. No resignation or removal shall be effective until a successor Trustee has been appointed and has
accepted its appointment. The Company shall remove the Trustee if: 
 (1) the Trustee fails to comply with Section 7.10;

 (2) the Trustee is adjudged bankrupt or insolvent; 

(3) a receiver or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

If the Trustee resigns, is removed by the Company or by the Holders of a majority in aggregate principal amount of the Notes then outstanding
and such Holders do not reasonably promptly appoint a successor Trustee, or if a vacancy exists in the office of Trustee for any reason (the Trustee in such event being referred to herein as the retiring Trustee), the Company shall promptly appoint
a successor Trustee. 
 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the
Company. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of
its succession to Noteholders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07. 

If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, at the
expense of the Company, or the Holders of 10% in aggregate principal amount of the Notes then outstanding may petition any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee fails to comply with Section 7.10, any Noteholder who has been a bona fide Holder of a Note for at least six months may
petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

  
 -57- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Notwithstanding the replacement or resignation of the Trustee pursuant to this Section, the
Company’s obligations under Section 7.07 shall continue for the benefit of the Trustee and survive the termination of this Indenture. 

SECTION 7.09 Successor Trustee by Merger. If the Trustee consolidates with, merges or converts into, or transfers all or substantially
all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation or banking association without any further act shall be the successor Trustee. 

In case at the time such successor or successors by merger, conversion or consolidation to the Trustee shall succeed to the trusts created by
this Indenture any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver such Notes so authenticated; and in case at that
time any of the Notes shall not have been authenticated, any such successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such
certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have. 

SECTION 7.10 Eligibility; Disqualification. The Trustee shall at all times satisfy the requirements of TIA § 310(a). The Trustee
shall have (or, in the case of a corporation included in a bank holding company system, the related bank holding company shall have) a combined capital and surplus of at least $50,000,000 as set forth in its (or its related bank holding
company’s) most recent published annual report of condition. The Trustee shall comply with TIA § 310(b), subject to the penultimate paragraph thereof; provided, however, that there shall be excluded from the operation of TIA §
310(b)(1) any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such exclusion set forth in TIA § 310(b)(1) are met. 

SECTION 7.11 Preferential Collection of Claims Against Company. The Trustee shall comply with TIA § 311(a), excluding any creditor
relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent indicated. 

ARTICLE VIII. 
 Discharge of
Indenture; Defeasance 
 SECTION 8.01 Discharge of Liability on Notes; Defeasance. 

(a) When (i) the Company delivers to the Paying Agent all outstanding Notes (other than Notes replaced pursuant to
Section 2.07) for cancellation or (ii) all outstanding Notes have become due and payable, whether at maturity or as a result of the mailing of a notice of redemption pursuant to Article III and the Company irrevocably deposits with the
Trustee funds sufficient to pay at maturity or upon redemption all outstanding Notes, including interest thereon to maturity or such redemption date (other than Notes replaced pursuant to Section 2.07), and if in either case the Company pays
all other sums payable hereunder by the Company, then this Indenture shall, subject to Section 8.01(c), cease to be of further effect. The Trustee shall acknowledge satisfaction and discharge of this Indenture on written demand of the Company
accompanied by an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions to the satisfaction and discharge have been complied with, and at the cost and expense of the Company. 

  
 -58- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Subject to Sections 8.01(c) and 8.02, the Company at any time may
terminate (i) all of its obligations under the Notes and this Indenture (“legal defeasance option”) or (ii) its obligations under Sections 4.04, 4.05, 4.06, 4.07, 4.08, 4.09, 4.10 and 4.12 and the operation of Sections 6.01(5),
6.01(6), 6.01(7) and 6.01(8) (but, in the case of Sections 6.01(6) and (7), with respect only to Significant Subsidiaries) and the limitations contained in clause (d) of Section 5.01 (“covenant defeasance option”). The Company
may exercise its legal defeasance option notwithstanding its prior exercise of its covenant defeasance option. 
 If the Company exercises
its legal defeasance option, payment of the Notes may not be accelerated because of an Event of Default. If the Company exercises its covenant defeasance option, payment of the Notes may not be accelerated because of an Event of Default specified in
Sections 6.01(4) (with respect to the covenants of Article IV identified in the immediately preceding paragraph), 6.01(5), 6.01(6), 6.01(7) or 6.01(8) (with respect only to Significant Subsidiaries in the case of Sections 6.01(6) and 6.01(7)) or
because of the failure of the Company to comply with the limitations contained in clause (d) of Section 5.01. 
 Upon satisfaction
of the conditions set forth herein and upon request of the Company, accompanied by an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent specified herein relating to the defeasance contemplated have been
complied with, the Trustee shall acknowledge in writing the discharge of those obligations that the Company terminates. 

(c) Notwithstanding clauses (a) and (b) above, the Company’s obligations in Sections 2.04, 2.05, 2.06, 2.07, 7.07,
7.08, 8.05 and 8.06 shall survive until the Notes have been paid in full. Thereafter, the Company’s obligations in Sections 7.07 and 8.05 shall survive such satisfaction or discharge. 

SECTION 8.02 Conditions to Defeasance. The Company may exercise its legal defeasance option or its covenant defeasance option only if:

 (1) the Company irrevocably deposits with the Paying Agent money in euros or euro-denominated Government Obligations for
the payment of principal of and interest (including premium, if any) on the Notes to maturity or redemption; 
 (2) the
Company delivers to the Trustee a certificate from a nationally recognized accounting firm expressing their opinion that the payments of principal and interest when due and without reinvestment on the deposited Government Obligations plus any
deposited money without investment will provide cash at such times and in such amounts as will be sufficient to pay principal and interest (including premium, if any) when due on all the Notes to maturity or redemption, as the case may be; 

(3) 123 days pass after the deposit is made and during the 123-day period no Default
specified in Section 6.01(6) or (7) occurs with respect to the Company or any other Person making the deposit that is continuing at the end of the period; 

(4) no Default or Event of Default has occurred and is continuing on the date of the deposit and after giving effect thereto;

 (5) the deposit does not constitute a default under any other agreement or instrument binding on the Company; 

(6) the Company delivers to the Trustee an Opinion of Counsel to the effect that the trust resulting from the deposit does not
constitute, or is qualified as, a regulated investment company under the Investment Company Act of 1940; 

  
 -59- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (7) in the case of the legal defeasance option, the Company shall have
delivered to the Trustee an Opinion of Counsel stating that (i) the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of this Indenture there has been a change in the
applicable Federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Noteholders will not recognize income, gain or loss for Federal income tax purposes as a result of such
defeasance and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance had not occurred; 

(8) in the case of the covenant defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel to the
effect that the Noteholders will not recognize income, gain or loss for Federal income tax purposes as a result of such covenant defeasance and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as
would have been the case if such covenant defeasance had not occurred; and 
 (9) the Company delivers to the Trustee an
Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance and discharge of the Notes as contemplated by this Article VIII have been complied with. 

Before or after a deposit, the Company may make arrangements satisfactory to the Trustee for the redemption of Notes at a future date in
accordance with Article III. 
 SECTION 8.03 Application of Trust Money. The Trustee shall hold money or Government Obligations
deposited with it pursuant to this Article VIII. It shall apply the deposited money and the money from Government Obligations through the Paying Agent and in accordance with this Indenture to the payment of principal of and interest on the Notes.

 SECTION 8.04 Repayment to Company. The Trustee and the Paying Agent shall promptly turn over to the Company upon written request
any excess money or securities held by them upon satisfaction of the conditions and occurrence of the events set forth in this Article VIII. 

Subject to any applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon request any money held by
them for the payment of principal or interest that remains unclaimed for two years, and, thereafter, Noteholders entitled to the money must look to the Company for payment as general creditors. 

SECTION 8.05 Indemnity for Government Obligations. The Company shall pay and shall indemnify the Trustee against any tax, fee or other
charge imposed on or assessed against deposited Government Obligations or the principal and interest received on such Government Obligations. 

SECTION 8.06 Reinstatement. If the Trustee or Paying Agent is unable to apply any money or Government Obligations in accordance with
this Article VIII by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture
and the Notes shall be revived and reinstated as though no deposit had occurred pursuant to this Article VIII until such time as the Trustee or Paying Agent is permitted to apply all such money or Government Obligations in accordance with this
Article VIII; provided, however, that, if the Company has made any payment of interest on or principal of any Notes because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Notes to
receive such payment from the money or Government Obligations held by the Trustee or Paying Agent. 

  
 -60- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 ARTICLE IX. 

Amendments 
 SECTION 9.01
Without Consent of Holders. The Company and the Trustee may amend this Indenture or the Notes without notice to or consent of any Noteholder: 

(1) to cure any ambiguity, omission, defect or inconsistency, as evidenced in an Officers’ Certificate; 

(2) to comply with Article V; 

(3) to provide for uncertificated Notes in addition to or in place of certificated Notes; provided, however, that the
uncertificated Notes are issued in registered form for purposes of Section 163(f) of the Code or in a manner such that the uncertificated Notes are described in Section 163(f)(2)(B) of the Code; 

(4) to add Guarantees with respect to the Notes; 

(5) to secure the Notes, to add to the covenants of the Company for the benefit of the Holders or to surrender any right or
power herein conferred upon the Company; 
 (6) to comply with any requirements of the SEC in connection with qualifying, or
maintaining the qualification of, this Indenture under the TIA; 
 (7) to make any change that does not adversely affect the
rights of any Noteholder in any material respect; or 
 (8) to provide for the issuance of additional Notes in accordance
with this Indenture. 
 After an amendment under this Section becomes effective, the Company shall mail to Noteholders a notice briefly
describing such amendment. The failure to give such notice to all Noteholders, or any defect therein, shall not impair or affect the validity of an amendment under this Section. 

SECTION 9.02 With Consent of Holders. The Company and the Trustee may amend this Indenture or the Notes without notice to any
Noteholder but with the written consent of the Holders of at least a majority in aggregate principal amount of the Notes then outstanding (including consents obtained in connection with a tender offer or exchange offer for the Notes). However,
without the consent of each Noteholder affected thereby, an amendment may not: 
 (1) reduce the amount of Notes whose
Holders must consent to an amendment or waiver; 
 (2) reduce the rate of or extend the time for payment of interest on any
Note; 
 (3) reduce the principal of or extend the Stated Maturity of any Note 

(4) make any Note payable in money other than euros; 

(5) reduce the amount payable upon the redemption or repurchase of any Note under Article III or Section 4.07 or 4.12,
change the time at which any Note may be redeemed in accordance with Article III, or, at any time after a Change of Control or Asset Sale has occurred, change the time at which the Change of Control Offer relating thereto or Prepayment Offer must be
made or at which the Notes must be repurchased pursuant to such Change of Control Offer or Prepayment Offer; 

  
 -61- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (6) subordinate the Notes to any other obligations of the Company; 

(7) release any security interest that may have been granted in favor of the Holders other than pursuant to the terms of the
agreement granting that security interest; 
 (8) make any change in Section 6.04 or 6.07 or the second sentence of this
Section; or 
 (9) subordinate the Notes to any other obligation of the Company. 

It shall not be necessary for the consent of the Holders under this Section to approve the particular form of any proposed amendment, but it
shall be sufficient if such consent approves the substance thereof. 
 After an amendment under this Section becomes effective, the Company
shall mail to each Noteholder at such Noteholder’s address appearing in the security register (with a copy to the Trustee) a notice briefly describing such amendment. The failure to give such notice to all Noteholders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section. 
 If and for so long as any notes are listed on the Official
List of the Luxembourg Stock Exchange and the rules of the Luxembourg Stock Exchange so require, the Company will publish notice of any amendment, supplement and waiver in a leading newspaper of general circulation in Luxembourg or, to the extent
and in the manner permitted by such rules, post such notice on the official website of the Luxembourg Stock Exchange (www.bourse.lu). 

SECTION 9.03 Compliance with Trust Indenture Act. Every amendment to this Indenture or the Notes shall comply with the TIA as then in
effect. 
 SECTION 9.04 Revocation and Effect of Consents and Waivers. A consent to an amendment or a waiver by a Holder of a Note
shall bind the Holder and every subsequent Holder of that Note or portion of the Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent or waiver is not made on the Note. However, any such Holder or
subsequent Holder may revoke the consent or waiver as to such Holder’s Note or portion of the Note if the Trustee receives the notice of revocation before the date the amendment or waiver becomes effective. After an amendment or waiver becomes
effective, it shall bind every Noteholder. An amendment or waiver becomes effective upon the execution of such amendment or waiver by the Trustee. 

The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Noteholders entitled to give their
consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Noteholders at such record
date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record date.
No such consent shall be valid or effective for more than 120 days after such record date. 

  
 -62- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 9.05 Notation on or Exchange of Notes. If an amendment changes the terms of a
Note, the Trustee may require the Holder of the Note to deliver such Note to the Trustee. The Trustee may place an appropriate notation on the Note regarding the changed terms and return such Note to the Holder. Alternatively, if the Company or the
Trustee so determines, the Company in exchange for the Note shall issue and the Trustee shall authenticate a new Note that reflects the changed terms. Failure to make the appropriate notation or to issue a new Note shall not affect the validity of
such amendment. 
 SECTION 9.06 Trustee To Sign Amendments. The Trustee shall sign any amendment authorized pursuant to this Article
IX if the amendment does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may but need not sign it. In signing such amendment the Trustee shall receive indemnity reasonably satisfactory to it
and to receive, and (subject to Section 7.01) shall be fully protected in conclusively relying upon, an Officers’ Certificate and an Opinion of Counsel stating that such amendment is authorized or permitted by this Indenture and is the
legal, valid and binding obligation of the Company, enforceable in accordance with its terms. 
 SECTION 9.07 Payment for Consent.
Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of
any of the terms or provisions of this Indenture or the Notes unless such consideration is offered to be paid to all Holders that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent,
waiver or agreement. 
 ARTICLE X. 

Miscellaneous 
 SECTION
10.01 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with another provision that is required to be included in this Indenture by the TIA, the required provision shall control. 

SECTION 10.02 Notices. Any notice or communication shall be in writing and delivered in person or mailed by first-class mail or sent by
facsimile (with a hard copy delivered in person or by mail promptly thereafter) and addressed as follows: 
 if to the Company: 

Levi Strauss & Co. 

Levi’s Plaza 
 1155 Battery
Street 
 San Francisco, CA 94111 

Attention of: Legal Department 

Facsimile: (415) 501-1342 

with a copy to: 
 Levi
Strauss & Co. 
 1155 Battery Street 

San Francisco, CA 94111 

Attention: Assistant Treasurer 

Facsimile No: (415) 501-1342 

and 

  
 -63- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Levi Strauss & Co. 

1155 Battery Street 
 San
Francisco, CA 94111 
 Attention: Manager of Treasury Operations 

Facsimile No: (415) 501-1342 

and 
 Levi Strauss & Co.

 1155 Battery Street 
 San
Francisco, CA 94111 
 Attention: Office of the General Counsel 

Facsimile No: (415) 501-7650 

if to the Trustee: 
 Wells Fargo
Bank, National Association 
 333 S. Grand Ave., 5th Floor, Suite 5A 

Los Angeles, CA 90071 
 Facsimile:
(213) 253-7598 
 Attention of: Corporate, Municipal and Escrow Services 

The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.

 Any notice or communication mailed to a Noteholder shall be mailed to the Noteholder at the Noteholder’s address as it appears on
the registration books of the Registrar and shall be sufficiently given if so mailed within the time prescribed. 
 Notices regarding the
Notes will be (a) if and so long as Notes are listed on the Luxembourg Stock Exchange and the rules of such exchange shall so require, published by the Company in a newspaper having a general circulation in Luxembourg or, to the extent and in
the manner permitted by such rules, posted on the website at the Luxembourg Stock Exchange (www.bourse.lu)) and (b) sent to the Trustee. If and so long as such Notes are listed on any other securities exchange, notices will also be given in
accordance with any applicable requirements of such securities exchange. 
 Failure to mail a notice or communication to a Noteholder or any
defect in it shall not affect its sufficiency with respect to other Noteholders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 

SECTION 10.03 Communication by Holders with Other Holders. Noteholders may communicate pursuant to TIA § 312(b) with other
Noteholders with respect to their rights under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA § 312(c). 

SECTION 10.04 Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to take
or refrain from taking any action under this Indenture, the Company shall furnish to the Trustee: 

  
 -64- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (1) an Officers’ Certificate in form and substance reasonably
satisfactory to the Trustee stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 

(2) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee stating that, in the opinion of such
counsel, all such conditions precedent have been complied with. 
 SECTION 10.05 Statements Required in Certificate or Opinion. Each
certificate or opinion with respect to compliance with a covenant or condition provided for in this Indenture shall include: 

(1) a statement that the individual making such certificate or opinion has read such covenant or condition; 

(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based; 
 (3) a statement that, in the opinion of such individual, he has made
such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been fully complied
with. 
 SECTION 10.06 Annual Officer’s Certificate as to Compliance. Not later than June 1 every year, beginning with
June 1, 2017, the Company shall deliver to the Trustee a certificate (which need not comply with Section 10.05 of this Indenture) executed by the principal executive officer, principal financial officer or principal accounting officer of
the Company as to such officer’s knowledge of the Company’s compliance with all conditions and covenants under this Indenture, such compliance to be determined without regard to any period of grace or requirement of notice provided under
this Indenture. 
 SECTION 10.07 When Notes Disregarded. In determining whether the Holders of the required principal amount
of Notes have concurred in any direction, waiver or consent, Notes owned by the Company or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company shall be disregarded and deemed
not to be outstanding, except that, for the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Notes that the Trustee knows are so owned shall be so disregarded. Also, subject to
the foregoing, only Notes outstanding at the time shall be considered in any such determination. 
 SECTION 10.08 Rules by Trustee,
Paying Agents and Registrar. The Trustee may make reasonable rules for action by or a meeting of Noteholders. The Agents may make reasonable rules for their functions. 

SECTION 10.09 Legal Holidays. A “Legal Holiday” is a Saturday, a Sunday or a day on which banking institutions are not
required to be open in the State of New York. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period. If a regular record date is a
Legal Holiday, the record date shall not be affected. 

  
 -65- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 10.10 Governing Law; Jury Trial Waiver; Submission to Jurisdiction. THIS
INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE COMPANY, THE HOLDERS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK
STATE COURT SITTING IN THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK OR ANY FEDERAL COURT SITTING IN THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE AND
THE NOTES, AND IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, JURISDICTION OF THE AFORESAID COURTS. 

SECTION 10.11 No Recourse Against Others. A director, officer, employee or stockholder, as such, of the Company shall not have any
liability for any obligations of the Company under the Notes or this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Note, each Noteholder shall waive and release all such
liability. The waiver and release shall be part of the consideration for the issue of the Notes. 
 SECTION 10.12 Successors. All
agreements of the Company in this Indenture and the Notes shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 

SECTION 10.13 Multiple Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original,
but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. Delivery of an executed signature page by facsimile or electronic transmission (e.g. “pdf” or “tif”) shall be effective as
delivery of a manually executed counterpart hereof. 
 SECTION 10.14 Table of Contents; Headings. The table of contents,
cross-reference sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions
hereof. 
 SECTION 10.15 Force Majeure. In no event shall the Trustee be responsible or liable for any failure or delay in the
performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances,
nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent
with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 
 SECTION 10.16
U.S.A. Patriot Act. The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is
required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such
information within the Company’s custody or control or as the Company may reasonably obtain that the Trustee may request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act. 

  
 -66- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 10.17 Judgment Currency. 

Any payment on account of an amount that is payable in euro which is made to or for the account of any Holder of Notes or the Trustee or
Paying Agent in lawful currency of any other jurisdiction (the “Judgment Currency”), whether as a result of any judgment or order or the enforcement thereof or the liquidation of the Company or a Future Guarantor, shall constitute a
discharge of the Company’s or the Future Guarantor’s obligation under this Indenture and the notes or the Guarantee of the Notes, as the case may be, only to the extent of the amount of euros which such Holder or the Trustee, as the case
may be, could purchase in the London foreign exchange markets with the amount of the Judgment Currency in accordance with normal banking procedures at the rate of exchange prevailing on the first business day following receipt of the payment in the
Judgment Currency. If the amount of euros that could be so purchased is less than the amount of euros originally due to such Holder or the Trustee, as the case may be, the Company and any Future Guarantors shall indemnify and hold harmless the
Holder or the Trustee, as the case may be, from and against all loss or damage arising out of, or as a result of, such deficiency. This indemnity shall constitute an obligation separate and independent from the other obligations contained in this
Indenture or the Notes, shall give rise to a separate and independent cause of action, shall apply irrespective of any indulgence granted by any holder or the Trustee from time to time and shall continue in full force and effect notwithstanding any
judgment or order for a liquidated sum in respect of an amount due hereunder or under any judgment or order. 
 [Signature Pages Follow]

  
 -67- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date
first written above. 
  

					
	LEVI STRAUSS & CO.
		
	    By:	 	 /s/ Chris Ogle

		 	Name:	 	Chris Ogle
		 	Title:	 	Vice President and Treasurer

 [Signature Page to the Indenture] 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	 /s/ Maddy Hughes

		 	Name: Maddy Hughes
		 	Title: Vice President

 [Signature Page to the Indenture] 

 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 APPENDIX A 

PROVISIONS RELATING TO INITIAL NOTES 

AND EXCHANGE NOTES 
  

	1.	 Definitions  

  

	1.1	 Definitions  

For the purposes of this Appendix A the following terms shall have the meanings indicated below: 

“Clearing Systems” means Euroclear and Clearstream. 

“Clearstream” means Clearstream Banking, société anonyme or any successor securities clearing agency. 

“Common Depositary” means with respect to the Notes, HSBC Bank plc, its nominees and their respective successors, acting in the
capacity of common depository for Euroclear and Clearstream or, as applicable, such other nominee of or custodian for Euroclear and/or Clearstream, as applicable, as may be acceptable to the Company and named or otherwise appointed in accordance
with the customary practice or policies of Euroclear or Clearstream, 
 “Definitive Note” means a certificated Initial Note or
Exchange Note or Private Exchange Note bearing, if required, the restricted securities legend set forth in Section 2.3(c). 

“Distribution Compliance Period” means, with respect to any Notes, the period of 40 consecutive days beginning on the later of
(i) the day on which such Notes are first offered to Persons other than distributors (as defined in Regulation S under the Securities Act) in reliance on Regulation S and (ii) the issue date with respect to such Notes. 

“Euroclear” means Euroclear Bank S.A./N.V., as operator of the Euroclear Clearance System or any successor securities clearing
agency. 
 “Exchange Notes” means the 3.375% Senior Notes due 2027 to be issued pursuant to this Indenture in connection with a
Registered Exchange Offer pursuant to the Registration Rights Agreement. 
 “Initial Notes” means 3.375% Senior Notes due 2027, to
be issued from time to time, in one or more series as provided for in this Indenture. 
 “Initial Purchasers” means Merrill Lynch
International, Goldman, Sachs & Co., J.P. Morgan Securities plc, Deutsche Bank AG, London Branch, HSBC Securities (USA) Inc., SunTrust Robinson Humphrey, Inc., Scotiabank Europe plc and Wells Fargo Securities International Limited. 

“Original Notes” means Notes issued on February 28, 2017. 

“Private Exchange” means the offer by the Company, pursuant to Section 2 of the Registration Rights Agreement or pursuant to
any similar provision of any other Registration Rights Agreement, to issue and deliver to certain purchasers, in exchange for the Initial Notes held by such purchasers as part of their initial distribution, a like aggregate principal amount of
Private Exchange Notes. 
 “Private Exchange Notes” means the Notes to be issued pursuant to this Indenture in connection with a
Private Exchange pursuant to a Registration Rights Agreement. 

  
 Appendix A-1 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Purchase Agreement” means the Purchase Agreement dated February 23, 2017,
between the Company and Merrill Lynch International, as representative of the Initial Purchasers, relating to the Original Notes, or any similar agreement relating to any future sale of Initial Notes by the Company. 

“QIB” means a “qualified institutional buyer” as defined in Rule 144A. 

“Registered Exchange Offer” means the offer by the Company, pursuant to a Registration Rights Agreement, to certain Holders of
Initial Notes, to issue and deliver to such Holders, in exchange for the Initial Notes, a like aggregate principal amount of Exchange Notes registered under the Securities Act. 

“Registration Rights Agreement” means (i) the Registration Rights Agreement dated as of February 28, 2017, between the
Company and Merrill Lynch International on behalf of itself and the other Initial Purchasers relating to the Original Notes, or (ii) any similar agreement relating to any additional Initial Notes. 

“Shelf Registration Statement” means a registration statement issued by the Company in connection with the offer and sale of Initial
Notes or Private Exchange Notes pursuant to the Registration Rights Agreement. 
 “Transfer Restricted Notes” means Definitive
Notes and any other Notes that bear or are required to bear the legend set forth in Section 2.3(c) hereto. 
  

	1.2	 Other Definitions  

 

					
	 Term
	  	Defined in Section:	 
	 “Agent Members”
	  	 	2.1	(b) 
	 “Global Note”
	  	 	2.1	(a) 
	 “Permanent Regulation S Global Note”
	  	 	2.1	(a) 
	 “Regulation S”
	  	 	2.1	 
	 “Regulation S Global Note”
	  	 	2.1	(a) 
	 “Rule 144A”
	  	 	2.1	 
	 “Rule 144A Global Note”
	  	 	2.1	(a) 
	 Temporary Regulation S Global Note”
	  	 	2.1	(a) 

  

	2.	 The Notes  

  

	2.1	 Form and Dating  

The Initial Notes will be offered and sold by the Company, from time to time, pursuant to one or more Purchase Agreements. The Initial Notes
will be resold initially only to QIBs in reliance on Rule 144A under the Securities Act (“Rule 144A”) and in reliance on Regulation S under the Securities Act (“Regulation S”). Initial Notes may thereafter be transferred to,
among others, QIBs, purchasers in reliance on Regulation S under Rule 501(a)(1), (2), (3) or (7) under the Securities Act, subject to the restrictions on transfer set forth herein. 

(a) Global Notes. Initial Notes initially resold pursuant to Rule 144A shall be issued initially in the form of one or more permanent
global Notes in definitive, fully registered form (collectively, the “Rule 144A Global Note”) with the restricted securities legend set forth in Exhibit A to this Indenture, and Initial Notes initially resold pursuant to Regulation S shall
be issued initially in the form of one or more global securities in registered form with the global securities legend and the applicable restricted securities legend set forth in Exhibit A to this Indenture (the “Temporary Regulation S Global
Note”) or with such other 

  
 Appendix A-2 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
legends as may be appropriate. Except as set forth in this Section 2.1(a) and Section 2.3(b), beneficial ownership interest in a Temporary Regulation S Global Note will be exchangeable
for interests in a Rule 144A Global Note or a permanent global note (the “Permanent Regulation S Global Note” and, together with the Temporary Regulation S Global Note, the “the “Regulation S Global Note”) or a Definitive
Note in registered certificated form only after the expiration of the Distribution Compliance Period and then only upon certification in form reasonably satisfactory to the Trustee that beneficial ownership interests in such Temporary Regulation S
Global Note are owned either by non-U.S. persons or U.S. persons who purchased such interests in a transaction that did not require registration under the Securities Act without interest coupons and with the
global securities legend and restricted securities legend set forth in Exhibit A to this Indenture, which shall be deposited on behalf of the purchasers of the Initial Notes represented thereby with the Common Depositary, and registered in the name
of the Common Depositary or its nominee, duly executed by the Company and authenticated by the Trustee or the Authenticating Agent as provided in this Indenture. The Rule 144A Global Note and Regulation S Global Note are collectively referred to
herein as “Global Notes.” The aggregate principal amount of the Global Notes may from time to time be increased or decreased by adjustments made on the records of the Trustee and the Registrar as hereinafter provided. 

(b) Book-Entry Provisions. This Section 2.1(b) shall apply only to a Global Note deposited with the Common Depositary. 

The Company shall execute and the Authenticating Agent shall, in accordance with this Section 2.1(b) and pursuant to an order of the
Company, authenticate and deliver initially one or more Global Notes that (a) shall be registered in the name of the Common Depositary or its nominee and (b) shall be delivered by the Trustee to the Common Depositary. 

Members of, or participants, in Euroclear or Clearstream (“Agent Members”) shall have no rights under this Indenture with respect to
any Global Note held on their behalf by the Common Depositary or under such Global Note, and the Common Depositary or its nominee as registered holder of such Global Note may be treated by the Company, the Trustee and any agent of the Company or the
Trustee as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written
certification, proxy or other authorization furnished by the Common Depositary or impair, as between Euroclear and Clearstream and their Agent Members, the operation of customary practices of the Clearing Systems governing the exercise of the rights
of a holder of a beneficial interest in any Global Note. 
 (c) Definitive Notes. Except as provided in Section 2.3 or 2.4,
owners of beneficial interests in Global Notes will not be entitled to receive physical delivery of Definitive Notes. 
 2.2 Authentication. The
Authenticating Agent shall authenticate and deliver: (1) Original Notes for original issue in an aggregate principal amount of €475 million, (2) additional Initial Notes, if and when issued, in an aggregate principal amount as
established in or pursuant to a resolution of the Board of Directors of the Company and (3) the Exchange Notes or Private Exchange Notes for issue only in a Registered Exchange Offer or a Private Exchange, respectively, pursuant to the
Registration Rights Agreement, for a like principal amount of Initial Notes or Private Exchange Notes, as applicable, upon a written order of the Company signed by two Officers or by an Officer and either an Assistant Treasurer or an Assistant
Secretary of the Company. Such order shall specify the amount of the Notes to be authenticated and the date on which the original issue of Notes is to be authenticated and whether the Notes are to be Initial Notes or Exchange Notes. The aggregate
principal amount of Notes outstanding at any time may not exceed the aggregate principal amount established in or pursuant to a resolution of the Board of Directors of the Company, except as provided in Section 2.08 of this Indenture. 

  
 Appendix A-3 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

	2.3	 Transfer and Exchange.  

(a) Transfer and Exchange of Definitive Notes. When Definitive Notes are presented to the Registrar or a
co-registrar with a request: 
 (x) to register the transfer of such Definitive
Notes; or 
 (y) to exchange such Definitive Notes for an equal principal amount of Definitive Notes of other authorized
denominations, 
 the Registrar or co-registrar shall register the transfer or make the exchange as
requested if its reasonable requirements for such transaction are met; provided, however, that the Definitive Notes surrendered for transfer or exchange: 

(i) shall be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company
and the Registrar or co-registrar, duly executed by the Holder thereof or his attorney duly authorized in writing; and 

(ii) if such Definitive Notes bear a restricted securities legend, they are being transferred or exchanged pursuant to an
effective registration statement under the Securities Act or pursuant to clause (A), (B) or (C) below, and are accompanied by the following additional information and documents, as applicable: 

(A) if such Definitive Notes are being delivered to the Registrar by a Holder for registration in the name of such Holder,
without transfer, a certification from such Holder to that effect; or 
 (B) if such Definitive Notes are being transferred
to the Company, a certification to that effect; or 
 (C) if such Definitive Notes are being transferred pursuant to an
exemption from registration in accordance with Rule 144 under the Securities Act, (i) a certification to that effect and (ii) if the Company or the Trustee so requests, an opinion of counsel or other evidence reasonably satisfactory to it
as to the compliance with the restrictions set forth in the legend set forth in Section 2.3(c)(i). 
 (b) Transfer and Exchange of
Global Notes. 
 (i) The transfer and exchange of Global Notes or beneficial interests therein shall be effected through
the Common Depositary, in accordance with this Indenture (including applicable restrictions on transfer set forth herein, if any) and the procedures of Euroclear and Clearstream therefor. A transferor of a beneficial interest in a Global Note shall
deliver a written order given in accordance with Euroclear’s and Clearstream’s procedures containing information regarding the participant account of Euroclear or Clearstream to be credited with a beneficial interest in the Global Note and
such account shall be credited in accordance with such instructions with a beneficial interest in the Global Note and the account of the Person making the transfer shall be debited by an amount equal to the beneficial interest in the Global Note
being transferred. 
 (ii) If the proposed transfer is a transfer of a beneficial interest in one Global Note to a beneficial
interest in another Global Note, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global Note to which such interest is being transferred in an amount equal to the principal amount of the
interest to be so transferred, and the Registrar shall reflect on its books and records the date and a corresponding decrease in the principal amount of the Global Note from which such interest is being transferred. 

  
 Appendix A-4 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (iii) Notwithstanding any other provisions of this Appendix A (other than the
provisions set forth in Section 2.4), a Global Note may not be transferred as a whole except by the Common Depositary to a nominee of the Common Depositary or by a nominee of the Common Depositary to the Common Depositary or another nominee of
the Common Depositary or by the Common Depositary or any such nominee to a successor Common Depositary or a nominee of such successor Common Depositary. 

(iv) In the event that a Global Note is exchanged for Definitive Notes pursuant to Section 2.4 prior to the consummation
of a Registered Exchange Offer or the effectiveness of a Shelf Registration Statement with respect to such Notes, such Notes may be exchanged only in accordance with such procedures as are substantially consistent with the provisions of this
Section 2.3 (including the certification requirements set forth on the reverse of the Initial Notes intended to ensure that such transfers comply with Rule 144A, Regulation S or such other applicable exemption from registration under the
Securities Act, as the case may be) and such other procedures as may from time to time be adopted by the Company. 
 (v)
Restrictions on Transfer of Temporary Regulation S Global Notes. 
 (A) During the Distribution Compliance Period,
beneficial ownership interests in Temporary Regulation S Global Notes may only be sold, pledged or transferred (i) to Company, (ii) in an offshore transaction in accordance with Rule 904 of Regulation S (other than a transaction resulting
in an exchange for an interest in a Permanent Regulation S Global Note) or (iii) pursuant to an effective registration statement under the Securities Act, in each case in accordance with any applicable securities laws of any State of the United
States; and 
 (B) Beneficial interests in a Rule 144A Global Note may be transferred to a Person who takes delivery in the
form of an interest in a Regulation S Global Note, whether before or after the expiration of the Distribution Compliance Period, only if the transferor first delivers to the Trustee a written certificate (in form reasonably satisfactory to the
Trustee) to the effect that such transfer is being made in accordance with Rule 903 or 904 of Regulation S or Rule 144 (if applicable). 

(c) Legend.  

(i) Except as permitted by the following paragraphs (ii), (iii) and (iv), each certificate evidencing the Global Notes and the
Definitive Notes (and all Notes issued in exchange therefor or in substitution thereof) shall bear a legend in substantially the following form: 

“THE SECURITY (OR ITS PREDECESSOR) EVIDENCED HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE
UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH
PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM 

  
 Appendix A-5 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. THE
HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE COMPANY THAT: 
 (A) SUCH SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR
OTHERWISE TRANSFERRED, ONLY: 
 (i)(a) TO A PERSON WHO THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE
144A UNDER THE SECURITIES ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (b) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE THE UNITED STATES TO A
NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 903 OR 904 UNDER THE SECURITIES ACT, OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
(AND BASED UPON AN OPINION OF COUNSEL AND OTHER CERTIFICATIONS AND DOCUMENTS IF THE COMPANY SO REQUESTS), 
 (ii) TO THE COMPANY, OR 

(iii) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT 

AND, IN EACH CASE, IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND
IN EACH CASE SUBJECT TO ANY REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN ITS OR THEIR CONTROL; AND 

(B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER FROM IT OF THE SECURITY EVIDENCED HEREBY OF THE RESALE
RESTRICTIONS SET FORTH IN (A) ABOVE. 
 THIS SECURITY MAY NOT BE ACQUIRED OR HELD WITH THE ASSETS OF (I) AN “EMPLOYEE BENEFIT
PLAN” (AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”)) THAT IS SUBJECT TO ERISA, (II) A “PLAN” WHICH IS SUBJECT TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF
1986, AS AMENDED (THE “CODE”), (III) ANY ENTITY DEEMED UNDER ERISA TO HOLD “PLAN ASSETS” OF ANY OF THE FOREGOING BY REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY, OR (IV) A GOVERNMENTAL
PLAN, CHURCH PLAN OR NON-U.S. PLAN SUBJECT TO APPLICABLE LAW THAT IS SIMILAR IN PURPOSE OR EFFECT TO THE FIDUCIARY RESPONSIBILITY OR PROHIBITED TRANSACTION PROVISIONS OF ERISA OR SECTION 4975 OF THE CODE
(“SIMILAR LAW”), UNLESS THE ACQUISITION AND HOLDING OF THIS SECURITY (AND ANY EXCHANGE OF THE NOTE FOR AN EXCHANGE NOTE) BY THE PURCHASER OR TRANSFEREE WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED
TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE OR A SIMILAR VIOLATION UNDER ANY APPLICABLE SIMILAR LAW. BY ITS ACQUISITION OR HOLDING OF THIS SECURITY, EACH PURCHASER AND TRANSFEREE WILL BE DEEMED TO HAVE REPRESENTED AND
WARRANTED THAT THE FOREGOING REQUIREMENTS HAVE BEEN SATISFIED.” 

  
 Appendix A-6 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Each Definitive Note will also bear the following additional legend: 

“IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS
SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.” 

(ii) Upon any sale or transfer of a Transfer Restricted Note (including any Transfer Restricted Note represented by a Global
Note) pursuant to Rule 144 under the Securities Act: 
 (A) in the case of any Transfer Restricted Note that is a Definitive
Note, the Registrar shall permit the Holder thereof to exchange such Transfer Restricted Note for a Note that does not bear the legends set forth above and rescind any restriction on the transfer of such Transfer Restricted Note; and 

(B) in the case of any Transfer Restricted Note that is represented by a Global Note, the Registrar shall permit the Holder
thereof to exchange such Transfer Restricted Note for a Note that does not bear the legends set forth above and rescind any restriction on the transfer of such Transfer Restricted Note, 

in either case, if the Holder certifies in writing to the Registrar that its request for such exchange was made in reliance on Rule 144 (such
certification to be in the form set forth on the reverse of the Initial Note). 
 (iii) After a transfer of any Initial Notes
or Private Exchange Notes, as the case may be, during the period of the effectiveness of a Shelf Registration Statement with respect to such Initial Notes or Private Exchange Notes, all requirements pertaining to restricted legends on such Initial
Note or such Private Exchange Note will cease to apply and an Initial Note or Private Exchange Note, as the case may be, in global form without restricted legends will be available to the transferee of the beneficial interests of such Initial Notes
or Private Exchange Notes. Upon the occurrence of any of the circumstances described in this paragraph, the Company will deliver an Officers’ Certificate to the Trustee instructing the Trustee to issue Notes without restricted legends. 

(iv) Upon the consummation of a Registered Exchange Offer with respect to the Initial Notes pursuant to which certain Holders
of such Initial Notes are offered Exchange Notes in exchange for their Initial Notes, Exchange Notes in global form without the restricted legends will be available to Holders or beneficial owners that exchange such Initial Notes (or beneficial
interests therein) in such Registered Exchange Offer. Upon the occurrence of any of the circumstances described in this paragraph, the Company will deliver the Exchange Notes accompanied by an Officers’ Certificate to the Trustee instructing
the Trustee to authenticate the Exchange Notes without restricted legends. 
 (d) Cancellation or Adjustment of Global Note. At such
time as all beneficial interests in a Global Note have either been exchanged for Definitive Notes, redeemed, repurchased or canceled, such Global Note shall be returned by the Common Depositary to the Registrar for cancellation pursuant to its
customary practice. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for Definitive Notes, redeemed, repurchased or canceled, the principal amount of Notes represented by such Global Note shall be
reduced and an adjustment shall be made on the books and records of the Common Depositary with respect to such Global Note, and by the Common Depositary, to reflect such reduction. 

  
 Appendix A-7 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Obligations with Respect to Transfers and Exchanges of Notes.  

(i) To permit registrations of transfers and exchanges, the Company shall execute and the Authenticating Agent shall
authenticate Definitive Notes and Global Notes at the Registrar’s or co-registrar’s request. 

(ii) No service charge shall be made for any registration of transfer or exchange, but the Company may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections
3.06, 4.08 and 9.05 of this Indenture). 
 (iii) The Registrar or co-registrar shall
not be required to register the transfer of or exchange of any Note selected for redemption (except, in the case of a Note to be redeemed in part, the portion of a Note not to be redeemed) or to transfer or exchange any Notes for a period beginning
15 days before the selection of Notes to be redeemed or 15 days before the mailing of a notice of redemption or an offer to repurchase Notes or 15 days before an interest payment date. 

(iv) Prior to the due presentation for registration of transfer of any Note, the Company, the Trustee, the Paying Agent, the
Registrar or any co-registrar may deem and treat the person in whose name a Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal of and interest on such Note
and for all other purposes whatsoever, whether or not such Note is overdue, and none of the Company, the Trustee, the Paying Agent, the Registrar or any co-registrar shall be affected by notice to the
contrary. 
 (v) All Notes issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the
same debt and shall be entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange. 
 (f)
No Obligation of the Trustee.  
 (i) The Trustee shall have no responsibility or obligation to any beneficial owner
of a Global Note, a member of, or a participant in Euroclear or Clearstream or any other Person with respect to the accuracy of the records of the Common Depositary or its nominee or of any participant or member thereof, with respect to any
ownership interest in the Notes or with respect to the delivery to any participant, member, beneficial owner or other Person (other than the Common Depositary) of any notice (including any notice of redemption or repurchase) or the payment of any
amount, under or with respect to such Notes. All notices and communications to be given to the Holders and all payments to be made to Holders under the Notes shall be given or made only to the registered Holders (which shall be the Common Depositary
or its nominee in the case of a Global Note). The rights of beneficial owners in any Global Note shall be exercised only through the Common Depositary subject to the applicable rules and procedures of Euroclear or Clearstream. The Trustee may rely
and shall be fully protected in relying upon information furnished by the Clearing Systems with respect to their members, participants and any beneficial owners. 

  
 Appendix A-8 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (ii) The Trustee shall have no obligation or duty to monitor, determine or
inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers between or among Clearing Systems participants, members
or beneficial owners in any Global Note) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to
examine the same to determine substantial compliance as to form with the express requirements hereof. 
  

	2.4	 Definitive Notes  

(a) A Global Note deposited with the Common Depositary pursuant to Section 2.1 shall be transferred to the beneficial owners thereof in
the form of Definitive Notes in an aggregate principal amount equal to the principal amount of such Global Note, in exchange for such Global Note, only if such transfer complies with Section 2.3 and (i) the Common Depositary notifies the
Company that it is unwilling or unable to continue as a Common Depositary for such Global Note or if at any time the relevant Clearing System ceases to be a “clearing agency” registered under the Exchange Act, and a successor Common
Depositary or Clearing System is not appointed by the Company within 90 days of such notice, or (ii) a Default or an Event of Default has occurred and is continuing or (iii) the Company, in its sole discretion, notifies the Registrar in
writing that it elects to cause the issuance of Definitive Notes under this Indenture. 
 (b) Any Global Note that is transferable to the
beneficial owners thereof pursuant to this Section 2.4 shall be surrendered by the Common Depositary to the Registrar, to be so transferred, in whole or from time to time in part, without charge, and the Authenticating Agent shall authenticate
and deliver, upon such transfer of each portion of such Global Note, an equal aggregate principal amount of Definitive Notes of authorized denominations. Definitive Notes issued in exchange for any portion of a Global Note transferred pursuant to
this Section shall be executed, authenticated and delivered only in denominations of €100,000 and any integral multiples of €1,000 in excess thereof and registered in such names as the Common Depositary shall direct. Any Definitive Note
delivered in exchange for an interest in the Global Note shall, except as otherwise provided by Section 2.3(d), bear the restricted securities legend set forth in Exhibit 1 hereto. 

(c) The registered Holder of a Global Note may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may
hold interests through Agent Members, to take any action that a Holder is entitled to take under this Indenture or the Notes. 
 (d) In the
event of the occurrence of any of the events specified in Section 2.4(a)(i), (ii) or (iii), the Company will promptly make available to the Registrar a reasonable supply of Definitive Notes in definitive, fully registered form without interest
coupons. 

  
 Appendix A-9 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT A 

[FORM OF FACE OF INITIAL NOTE] 

[Global Euro Notes Legend] 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF HSBC BANK PLC, AS COMMON DEPOSITARY (THE “COMMON
DEPOSITARY”) FOR EUROCLEAR BANK S.A./N.V. AND CLEARSTREAM BANKING SOCIÉTÉ ANONYME, OR ITS NOMINEE, HSBC ISSUER SERVICES COMMON DEPOSITARY NOMINEE (UK) LIMITED, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR
PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF ITS AUTHORIZED NOMINEE OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY OR ITS NOMINEE (AND ANY PAYMENT IS MADE TO ITS AUTHORIZED NOMINEE, OR
TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY OR ITS NOMINEE) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
ITS AUTHORIZED NOMINEE, HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN
PART, TO THE COMMON DEPOSITARY OR ITS NOMINEES OR TO SUCCESSORS THEREOF OR SUCH SUCCESSOR’S NOMINEES AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE
INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 [Restricted Notes Legend] 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE
SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT
OF THE COMPANY THAT: 
  

	 	(A)	 SUCH SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY: 

(i)(a) TO A PERSON WHO THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN
A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (b) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE THE UNITED STATES TO A NON-U.S. PERSON IN A
TRANSACTION MEETING THE REQUIREMENTS OF RULE 903 OR 904 UNDER THE SECURITIES ACT, OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND OTHER
CERTIFICATIONS AND DOCUMENTS IF THE COMPANY SO REQUESTS), 

  
 A-1 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (ii) TO THE COMPANY, OR 

(iii) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT 

AND, IN EACH CASE, IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE
SUBJECT TO ANY REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN ITS OR THEIR CONTROL; AND 
  

	 	(B)	 THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER FROM IT OF THE SECURITY
EVIDENCED HEREBY OF THE RESALE RESTRICTIONS SET FORTH IN (A) ABOVE. 

 THIS SECURITY MAY NOT BE ACQUIRED OR HELD WITH
THE ASSETS OF (I) AN “EMPLOYEE BENEFIT PLAN” (AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”)) THAT IS SUBJECT TO ERISA, (II) A “PLAN” WHICH IS SUBJECT
TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), (III) ANY ENTITY DEEMED UNDER ERISA TO HOLD “PLAN ASSETS” OF ANY OF THE FOREGOING BY REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S
INVESTMENT IN SUCH ENTITY, OR (IV) A GOVERNMENTAL PLAN, CHURCH PLAN OR NON-U.S. PLAN SUBJECT TO APPLICABLE LAW THAT IS SIMILAR IN PURPOSE OR EFFECT TO THE FIDUCIARY RESPONSIBILITY OR PROHIBITED
TRANSACTION PROVISIONS OF ERISA OR SECTION 4975 OF THE CODE (“SIMILAR LAW”), UNLESS THE ACQUISITION AND HOLDING OF THIS SECURITY (AND ANY EXCHANGE OF THE NOTE FOR AN EXCHANGE NOTE) BY THE PURCHASER OR TRANSFEREE WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE OR A SIMILAR VIOLATION UNDER ANY APPLICABLE SIMILAR LAW. BY ITS ACQUISITION OR HOLDING OF THIS SECURITY, EACH PURCHASER AND
TRANSFEREE WILL BE DEEMED TO HAVE REPRESENTED AND WARRANTED THAT THE FOREGOING REQUIREMENTS HAVE BEEN SATISFIED. 
 [Definitive Notes Legend]

 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS
SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 
 [Temporary Regulation S
Legend] 
 THE RIGHTS ATTACHING TO THIS REGULATION S TEMPORARY GLOBAL NOTE, AND THE CONDITIONS AND PROCEDURES GOVERNING ITS EXCHANGE FOR
DEFINITIVE NOTES, ARE AS SPECIFIED IN THE INDENTURE (AS DEFINED HEREIN). 

  
 A-2 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 [FORM OF FACE OF INITIAL NOTE] 

No.                          
                                         
                                         
                                         
                                        € 

3.375% Senior Notes due 2027 
  

			
		  	Common Code No. [             ]
		  	ISIN No. [                 ]

 LEVI STRAUSS & CO., a Delaware corporation, promises to pay to HSBC Issuer Services Common Depositary
Nominee (UK) Limited, or registered assigns, the principal sum of [                 ] euros (€        ) on March 15,
2027. 
 Interest Payment Dates: March 15 and September 15. 

Record Dates: March 1 and September 1. 

  
 A-1-2 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have caused this instrument to be duly executed. 

 

					
	LEVI STRAUSS & CO.
		
	By:	 	  

		 	Name:	 	Harmit Singh
		 	Title:	 	Executive Vice President and Chief Financial Officer

  

					
	By:	 	  

		 	Name:	 	Chris Ogle
		 	Title:	 	Vice President and Treasurer

  
 A-1-3 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 AUTHENTICATING AGENT’S 

CERTIFICATE OF AUTHENTICATION 
 Dated:
____________________________ 
 HSBC BANK PLC, 
 not in its
personal capacity, but as 
 Authenticating Agent appointed by 

the Trustee, Wells Fargo Bank, 
 N.A., certifies that this is one
of the 
 Notes referred to in the Indenture. 
 By:
                                        
                         

      Authorized Signatory 

  
 A-1-4 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 [FORM OF REVERSE SIDE OF NOTE] 

3.375% Senior Notes due 2027 
 Interest

 (a) LEVI STRAUSS & CO., a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the “Company”), promises to pay interest on the principal amount of this 3.375% Senior Note due 2027 (this “Note” and, together with any other 3.375% Senior Notes due 2027, the
“Notes”) at the rate per annum shown above. The Company will pay interest semiannually on March 15 and September 15 of each year, commencing September 15, 2017. Interest on the Notes will accrue from the most recent date to
which interest has been paid or, if no interest has been paid, from February 28, 2017. Interest shall be computed on the basis of a 360-day year of twelve 30-day
months. The Company shall pay interest on overdue principal at the rate borne by the Notes plus 1% per annum, and it shall pay interest on overdue installments of interest at the rate borne by the Notes to the extent lawful. 

(b) Special Interest. The holder of this Note is entitled to the benefits under the terms of a Registration Rights Agreement, dated as
of February 28, 2017, among the Company and the Initial Purchasers named therein (the “Registration Rights Agreement”). 
 2. Method of
Payment  
 The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders of Notes at
the close of business on the March 1 or September 1 next preceding the interest payment date even if Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to
collect principal payments. The Company will pay principal and interest in euros or such other lawful currency of the participating Member States in the Third Stage of European Economic and Monetary Union of the Treaty Establishing the European
Community that at the time of payment is legal tender for payment of public and private debts. Payments in respect of the Notes represented by a Global Note (including principal, premium and interest) will be made by wire transfer of immediately
available funds to the accounts specified by Euroclear or Clearstream. The Company will make all payments in respect of a Definitive Note (including principal, premium and interest), by mailing a check to the registered address of each Holder
thereof; provided, however, that payments on a definitive Note will be made by wire transfer if such Holder elects payment by wire transfer by giving written notice to the Paying Agent (with a copy to the Trustee) to such effect designating such
account no later than 30 days immediately preceding the relevant due date for payment (or such other date as the Paying Agent may accept in its discretion). 

3. Paying Agent and Registrar  
 Initially,
HSBC Bank plc in the City of London will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or co-registrar without notice. The Company or any of its domestically
incorporated Wholly Owned Subsidiaries may act as Paying Agent, Registrar or co-registrar. 
 4. Indenture 

 The Company issued the Notes under an Indenture dated as of February 28, 2017 (the “Indenture”), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of the Indenture (the
“TIA”). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Noteholders are referred to the Indenture and the TIA for a statement of those
terms. 

  
 A-1-5 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 The Indenture imposes certain limitations on the ability of the Company and its Restricted
Subsidiaries to, among other things, make certain Investments and other Restricted Payments, pay dividends and other distributions, incur Debt, enter into consensual restrictions upon the payment of certain dividends and distributions by such
Restricted Subsidiaries, issue or sell shares of capital stock of such Restricted Subsidiaries, enter into or permit certain transactions with Affiliates, create or incur Liens and make Asset Sales. The Indenture also imposes limitations on the
ability of the Company to consolidate or merge with or into any other Person or sell, transfer, assign, lease, convey or otherwise dispose of all or substantially all of the Property of the Company. 

5. Optional Redemption  
 (a) Except as set
forth below, the Notes may not be redeemed prior to March 15, 2022. On and after that date, the Company may redeem the Notes in whole at any time or in part from time to time at the following redemption prices (expressed in percentages of
principal amount), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date that is on or prior to the date
of redemption), if redeemed during the 12-month period beginning on or after March 15 of the years set forth below: 
  

					
	 Period
	  	Redemption
Price	 
	 2022
	  	 	101.688	% 
	 2023
	  	 	101.125	% 
	 2024
	  	 	100.563	% 
	 2025 and thereafter
	  	 	100.000	% 

 (b) Notwithstanding the foregoing, prior to March 15, 2020 the Company may redeem up to 40% of the
original aggregate principal amount of the Notes issued (including additional Initial Notes, if any) with the proceeds from one or more Equity Offerings by the Company, at a redemption price equal to 103.375% of the principal amount thereof, plus
accrued and unpaid interest thereon, if any, to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date that is on or prior to the date of redemption);
provided, however, that after giving effect to any such redemption, at least 60% of the original aggregate principal amount of the Notes (including additional Initial Notes, if any) remains outstanding. Any such redemption shall be made within 90
days of such Equity Offering. 
 (c) Notwithstanding the foregoing, the Company may redeem all or any portion of the Notes, at once or over
time, prior to March 15, 2022, at a redemption price equal to the sum of: 
 (a) 100% of the principal amount of the
Notes to be redeemed, plus 
 (b) the Applicable Premium, 

plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest
due on the relevant interest payment date). 
 In connection with any redemption of Notes described above, such redemption may, at the
Company’s discretion, be subject to one or more conditions precedent, including any related Equity Offering, issuance of Debt or other transaction. If such redemption or notice is subject to satisfaction of one or more conditions precedent,
such notice shall state that, in the Company’s discretion, such redemption 

  
 A-1-6 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
may not occur and such notice may be rescinded in the event that any or all of such conditions shall not have been satisfied by the redemption date. If less than all of the notes are to be
redeemed, the notes to be redeemed will be selected by the trustee on a pro rata basis, by lot or another method the Trustee deems to be fair and appropriate in accordance with the applicable procedures of the depository. Notwithstanding the
foregoing, if less than all of the notes are to be redeemed, no notes of a principal amount of €100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the notes (or portions thereof) to be redeemed on the
redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such notes (or such portion thereof) called for
redemption. 
 “Applicable Premium” means with respect to any Note on any redemption date, the excess of (i) the present
value on such redemption date of (A) the redemption price of such Note on March 15, 2022 (such redemption price being described in the table appearing in clause (a) of this paragraph 5 exclusive of any accrued interest), plus
(B) all required remaining scheduled interest payments due on such Note through March 15, 2022 (including any accrued and unpaid interest) computed using a discount rate equal to the Bund Rate plus 50 basis points, over (ii) the
principal amount of such Note. 
 “Bund Rate” means, as of any redemption date, the rate per annum equal to the equivalent yield
to maturity as of such redemption date of the Comparable German Bund Issue, assuming a price for the Comparable German Bund Issue (expressed as a percentage of its principal amount) equal to the Comparable German Bund Price for such relevant date,
where: 
  

	 	(1)	 “Comparable German Bund Issue” means the German Bundesanleihe security selected by any Reference
German Bund Dealer as having a fixed maturity most nearly equal to the period from such redemption date to March 15, 2022, and that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new
issues of euro denominated corporate debt securities in a principal amount approximately equal to the then outstanding principal amount of the Notes and of a maturity most nearly equal to March 15, 2022; provided, however, that, if the period
from such redemption date to March 15, 2022 is less than one year, a fixed maturity of one year shall be used; 

  

	 	(2)	 “Comparable German Bund Price” means, with respect to any relevant date, the average of all Reference
German Bund Dealer Quotations for such date (which, in any event, must include at least two such quotations), after excluding the highest and lowest such Reference German Bund Dealer Quotations, or if the Company obtains fewer than four such
Reference German Bund Dealer Quotations, the average of all such quotations; 

  

	 	(3)	 “Reference German Bund Dealer” means any dealer of German Bundesanleihe securities appointed by the
Company in good faith; and 

  

	 	(4)	 “Reference German Bund Dealer Quotations” means, with respect to each Reference German Bund Dealer
and any relevant date, the average as determined by the Company of the bid and offered prices for the Comparable German Bund Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Company by such Reference
German Bund Dealer at 3:30 p.m. Frankfurt, Germany time on the third business day preceding the relevant date. 

 (d) If,
as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated under the laws) of the United States (or any political subdivision or taxing authority of or in the United States), or any change in, or amendments
to, an official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment is announced and becomes 

  
 A-1-7 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
effective after February 23, 2017, the Company becomes or, based upon a written opinion of independent counsel selected by the Company, will become obligated to pay additional amounts as
described in Section 4.15 of the Indenture with respect to the Notes, then the Company may at any time at its option redeem, in whole, but not in part, the Notes on not less than 10 nor more than 60 days prior notice, at a redemption price
equal to 100% of their principal amount, together with interest accrued but unpaid on those Notes to the date fixed for redemption. Any such redemption may not take place more than 60 days prior to the date on which we would first be required to pay
any additional amounts. 
 6. Notice of Optional Redemption  

Notice of redemption will be mailed by first-class mail and in the case of Notes held in book entry form, by electronic transmission at least
10 days but not more than 60 days before the redemption date to each Holder of Notes to be redeemed at his or her registered address. Any notice to Holders of Notes of such redemption pursuant to clause (c) in paragraph 5 needs to include the
appropriate calculation of the redemption price, but does not need to include the redemption price itself. The actual redemption price, calculated as described in such clause (c), must be set forth in an Officers’ Certificate delivered to the
Trustee no later than two Business Days prior to the redemption date. Notes in denominations larger than €100,000 may be redeemed in part but only in whole multiples of €1,000. If money sufficient to pay the redemption price of and accrued
interest on all Notes (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on
such Notes (or such portions thereof) called for redemption. 
 If the Company effects an optional redemption of the notes, it will, if and
for so long as any notes are listed on the Official List of the Luxembourg Stock Exchange and the rules of the Luxembourg Stock Exchange so require, inform the Luxembourg Stock Exchange of such optional redemption and confirm the aggregate principal
amount of the notes that will remain outstanding immediately after such redemption. 
 7. Sinking Fund  

The Notes are not subject to any sinking fund. 

8. Repurchase of Notes at the Option of Holders upon Change of Control  

Upon a Change of Control, unless the Company has exercised its right, if any, to redeem the Notes in full, any Holder of Notes will have the
right, subject to certain conditions specified in the Indenture, to cause the Company to repurchase all or any part of the Notes of such Holder at a purchase price equal to 101% of the principal amount of the Notes to be repurchased plus accrued and
unpaid interest, if any, to the date of purchase (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date that is on or prior to the date of purchase) as provided in, and
subject to the terms of, the Indenture. 
 If and for so long as the notes are listed on the Official List of the Luxembourg Stock Exchange
and admitted for trading on the Euro MTF Market, the Company will publish notices relating to the Change of Control Offer (including with respect to the results thereof) in a leading newspaper of general circulation in Luxembourg or, to the extent
and in the manner permitted by such rules, post such notices on the official website of the Luxembourg Stock Exchange (www.bourse.lu). 

  
 A-1-8 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 9. Denominations; Transfer; Exchange  

The Notes are in registered form without coupons, in minimum denomination of €100,000 and integral multiples of €1,000 in excess
thereof. A Holder may transfer or exchange Notes in accordance with the Indenture. Upon any transfer or exchange, the Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and
to pay any taxes required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be
redeemed) or to transfer or exchange any Notes for a period beginning 15 days prior to a selection of Notes to be redeemed or 15 days before the mailing of a notice of redemption or an offer to repurchase Notes or 15 days before an interest payment
date. 
 10. Persons Deemed Owners  
 The
registered Holder of this Note may be treated as the owner of it for all purposes. 
 11. Unclaimed Money  

If money for the payment of principal or interest remains unclaimed for two years, or prior to the applicable escheat date, the Trustee or
Paying Agent shall pay the money back to the Company at its written request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee for
payment. 
 12. Discharge and Defeasance  

Subject to certain conditions, the Company at any time may terminate some of or all its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money in euros or euro-dominated Government Obligations for the payment of principal and interest Notes (including premium, if any) on the Notes, in each case to redemption or maturity. 

13. Amendment, Waiver  
 Subject to certain
exceptions set forth in the Indenture, (i) the Indenture or the Notes may be amended without prior notice to any Noteholder but with the written consent of the Holders of at least a majority in aggregate principal amount of the outstanding
Notes and (ii) any default or noncompliance with any provision may be waived with the written consent of the Holders of at least a majority in principal amount of the outstanding Notes. Subject to certain exceptions set forth in the Indenture,
without the consent of any Holder of Notes, the Company and the Trustee may amend the Indenture or the Notes (i) to cure any ambiguity, omission, defect or inconsistency, as evidenced in an Officers’ Certificate; (ii) to comply with
Article V of the Indenture; (iii) to provide for uncertificated Notes in addition to or in place of certificated Notes; (iv) to add Guarantees with respect to the Notes; (v) to secure the Notes, to add additional covenants or to
surrender rights and powers conferred on the Company; (vi) to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under the TIA; (vii) to make any change that does not adversely affect
the rights of any Noteholder in any material respect; or (viii) to provide for the issuance of additional Notes in accordance with the Indenture. 
 14.
Defaults and Remedies  
 If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate
principal amount of Notes then outstanding, subject to certain limitations, may declare all the Notes to be immediately due and payable. Certain events of bankruptcy or insolvency are Events of Default and shall result in the Notes being immediately
due and payable upon the occurrence of such Events of Default without any further act of the Trustee or any Holder. 

  
 A-1-9 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Holders of Notes may not enforce the Indenture or the Notes except as provided in the
Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security reasonably satisfactory to it. Subject to certain limitations, Holders of a majority in aggregate principal amount of the Notes then
outstanding may direct the Trustee in its exercise of any trust or power under the Indenture. The Holders of a majority in aggregate principal amount of the Notes then outstanding, by written notice to the Company and the Trustee, may rescind any
declaration of acceleration and its consequences if the rescission would not conflict with any judgment or decree, and if all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely
because of the acceleration. 
 15. Trustee Dealings with the Company  

Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. 

16. No Recourse Against Others  
 A
director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations or their
creation. By accepting a Note, each Noteholder waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Notes. 

17. Authentication  
 This Note shall not
be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of authentication on the other side of this Note. 

18. Abbreviations  
 Customary
abbreviations may be used in the name of a Noteholder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian),
and U/G/M/A (=Uniform Gift to Minors Act). 
 19. Governing Law  

THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK BUT WITHOUT GIVING EFFECT TO APPLICABLE
PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 
 20. Identification
Numbers  
 The Company has caused ISIN and Common Code numbers to be printed on the Notes and has directed the Trustee to use such
numbers in notices of redemption as a convenience to Noteholders. No representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other
identification numbers placed thereon. 

  
 A-1-10 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 The Company will furnish to any Holder of Notes upon written request and without charge to
the Holder a copy of the Indenture which has in it the text of this Note. 

  
 A-1-11 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 LEVI STRAUSS & CO. 3.375% SENIOR NOTES DUE 2027 

ASSIGNMENT FORM 
 To assign this Note, fill in the
form below: 
 I or we assign and transfer this Note to 
  

 
 (Print or type assignee’s name,
address and zip code) 
  
  

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 

 

									
	Date:	 	  
	  		  	Your Signature:	 	  

		 		  		  		 	Sign exactly as your name appears on the other side of this Note.

 In connection with any transfer of any of the Notes evidenced by this certificate occurring while this Note is a Transfer
Restricted Note, the undersigned confirms that such Notes are being transferred in accordance with its terms: 
 CHECK ONE BOX BELOW 

 

					
	(1)	  	☐	  	To the Company; or
			
	(2)	  	☐	  	Pursuant to an effective registration statement under the Securities Act of 1933; or
			
	(3)	  	☐	  	Inside the United States to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933) that purchases for its own account or for the account of a qualified institutional buyer to whom
notice is given that such transfer is being made in reliance on Rule 144A, in each case pursuant to and in compliance with Rule 144A under the Securities Act of 1933; or
			
	(4)	  	☐	  	Outside the United States in an offshore transaction within the meaning of Regulation S under the Securities Act in compliance with Rule 904 under the Securities Act of 1933; or
			
	(5)	  	☐	  	Pursuant to another available exemption from registration provided by Rule 144 under the Securities Act of 1933

  
 A-1-11 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this
certificate in the name of any person other than the registered holder thereof; provided, however, that if box (4), (5) or (6) is checked, the Trustee may require, prior to registering any such transfer of the Notes, such legal opinions,
certifications and other information as the Company has reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933.

  

	
	  

	Your Signature

 Signature Guarantee: 
  

                       
                                         
                                     

Signature must be guaranteed by a participant in a recognized signature guaranty medallion program or other signature guarantor acceptable to
the Trustee     
  

							
	Date:	 	  
	  		 	  

		 		  		 	Signature of Signature Guarantee

  
 A-1-12 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 TO BE COMPLETED BY PURCHASER IF (3) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises
sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, and is aware that the sale to it is being made in reliance on Rule 144A and
acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon the
undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

							
	Date:	  	  
	  		  	  

		  		  		  	NOTICE: To be executed by an executive officer

  

  
 A-1-13 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 [TO BE ATTACHED TO GLOBAL NOTES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTE 

The initial principal amount of this Global Note is € [         ]. The following increases
or decreases in this Global Note have been made: 
  

									
	 Date of Exchange
	  	 Amount of decrease in
Principal Amount of
this
Global Note
	  	 Amount of increase

in Principal Amount

of this Global Note
	  	
Principal amount of this
Global Note following
such decrease or increase
	  	
Signature of authorized
signatory of Trustee or
Registrar

  
 A-1-14 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 LEVI STRAUSS & CO. 3.375% SENIOR NOTES DUE 2027 

OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to Section 4.07 (Asset Sale) or 4.12 (Change of Control) of the
Indenture, check the box: 
  
 ☐ 

If you want to elect to have only part of this Note purchased by the Company pursuant to Section 4.07 or 4.12 of the Indenture, state the
amount: 
 $                 

 

									
	Date:	 	  
	  		  	Your Signature:	 	  

		 		  		  		 	(Sign exactly as your name appears on the other side of the Note)

 Signature Guarantee: 
  

                       
                                         
                                         
    
 Signature must be guaranteed by a participant in a recognized signature guaranty medallion program or other
signature guarantor acceptable to the Trustee     

  
 A-1-15 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT B 

Form of 
 Transferee Letter of
Representation 
 Levi Strauss & Co. 
 In care of

 Wells Fargo Bank, National Association, as Trustee 
 608 2nd
Avenue South, 12th Floor 
 Minneapolis, MN 55402 
 Facsimile:
(866) 969-1290 
 Attention of: Bondholder Communications 

Ladies and Gentlemen: 
 This certificate is
delivered to request a transfer of € [    ] principal amount of the 3.375% Senior Notes due 2027 [Common Code Number] (the “Notes”) of LEVI STRAUSS & CO. (the “Company”). 

Upon transfer, the Notes would be registered in the name of the new beneficial owner as follows: 

Name:
                                         
                        
 Address
                                         
                     
 Taxpayer ID Number:
                                       

The undersigned represents and warrants to you that: 

1. We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act of
1933, as amended (the “Securities Act”)), purchasing for our own account or for the account of such an institutional “accredited investor,” and we are acquiring the Notes not with a view to, or for offer or sale in connection
with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of our investment in the Notes, and we invest in or purchase notes
similar to the Notes in the normal course of our business. We, and any accounts for which we are acting, are each able to bear the economic risk of our or its investment. 

2. We understand that the Notes have not been registered under the Securities Act and, unless so registered, may not be sold except as
permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for which we are purchasing Notes to offer, sell or otherwise transfer such Notes prior to the date that is two years after the later of the date
of original issue and the last date on which the Company or any affiliate of the Company was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”) only (a) to the Company, (b) pursuant
to a registration statement that has been declared effective under the Securities Act, (c) in a transaction complying with the requirements of Rule 144A under the Securities Act (“Rule 144A”), to a person we reasonably believe is a
qualified institutional buyer under Rule 144A (a “QIB”) that is purchasing for its own account or for the account of a QIB and to whom notice is given that the transfer is being made in reliance on Rule 144A, (d) pursuant to offers
and sales that occur outside the United States within the meaning of Regulation S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities
Act that is purchasing for its own account or for the account of such an institutional “accredited investor,” or (f) pursuant to any other available exemption from the registration requirements of the Securities Act, subject in each
of the foregoing cases to any requirement of law that the 

  
 B-1 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
disposition of our property or the property of such investor account or accounts be at all times within our or their control and in compliance with any applicable state securities laws. The
foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale or other transfer of the Notes is proposed to be made pursuant to clause (e) above prior to the Resale Restriction Termination
Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the Trustee, which shall provide, among other things, that the transferee is an institutional “accredited investor”
within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act and that it is acquiring such Notes for investment purposes and not for distribution in violation of the Securities Act. Each purchaser acknowledges that the Company
and the Trustee reserve the right prior to the offer, sale or other transfer prior to the Resale Restriction Termination Date of the Notes pursuant to clause (d), (e) or (f) above to require the delivery of an opinion of counsel, certifications
or other information satisfactory to the Company and the Trustee. 
  

	
	TRANSFEREE:
                                         
                ,
	By:
                                         
                                     
	

  

  
 B-2EX-4.5

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Exhibit 4.5 

U.S. SECURITY AGREEMENT 

THIS SECURITY AGREEMENT (as it may be amended or modified from time to time, the “Security Agreement”) is entered into as of
September 30, 2011, by and between Levi Strauss & Co., a Delaware corporation (the “U.S. Borrower”) and Levi’s Only Stores, Inc., a Delaware corporation, Levi Strauss International, Inc., a Delaware corporation,
LVC, LLC, a Delaware limited liability company, Levi’s Only Stores Georgetown, LLC, a Delaware limited liability company, Levi Strauss, U.S.A., LLC, a Delaware limited liability company, Levi Strauss-Argentina, LLC, a Delaware limited liability
company and Levi Strauss International, a California corporation (each a “Grantor,” and together with the U.S. Borrower and any Domestic Subsidiary that executes a U.S. Joinder Agreement following the date hereof, the
“Grantors”), and JPMorgan Chase Bank, N.A., in its capacity as administrative agent (the “Administrative Agent”) for the lenders party to the Credit Agreement referred to below. 

PRELIMINARY STATEMENT 
 The
Grantors, the Administrative Agent, the other Loan Parties and the Lenders are entering into a Credit Agreement dated as of September 30, 2011 (as it may be amended or modified from time to time, the “Credit Agreement”). Each
Grantor is entering into this Security Agreement in order to induce the Lenders to enter into and extend credit to the U.S. Borrower and Levi Strauss & Co. (Canada) Inc., an Ontario corporation under the Credit Agreement and to secure the
Secured Obligations. 
 ACCORDINGLY, the Grantors and the Administrative Agent, on behalf of the Lender Parties, hereby agree as follows:

 ARTICLE I 

DEFINITIONS 
 1.1. Terms
Defined in Credit Agreement. All initially capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Credit Agreement. 

1.2. Terms Defined in UCC. Terms defined in the UCC which are not otherwise defined in this Security Agreement are used herein as
defined in the UCC. 
 1.3. Definitions of Certain Terms Used Herein. As used in this Security Agreement, in addition to the terms
defined in the first paragraph hereof and in the Preliminary Statement, the following terms shall have the following meanings: 

“Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Amendment” shall have the meaning set forth in Section 4.4. 

“Article” means a numbered article of this Security Agreement, unless another document is specifically referenced. 

“Bankruptcy Code” means Title 11 of the United States Code (11 U.S.C. § 101 et seq.). 

“Chattel Paper” shall have the meaning set forth in Article 9 of the UCC. 

“Collateral” shall have the meaning set forth in Article II. 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Collateral Access Agreement” means any landlord waiver or other agreement,
in form and substance reasonably satisfactory to the Administrative Agent, between the Administrative Agent and any third party (including any bailee, consignee, customs broker, or other similar Person) in possession of any Collateral or any
landlord of any real property where any Collateral is located, as such landlord waiver or other agreement may be amended, restated, or otherwise modified from time to time. 

“Collateral Deposit Account” shall have the meaning set forth in Section 7.1(a). 

“Collateral Report” means any certificate (including any Borrowing Base Certificate), report or other document delivered by
any Grantor to the Administrative Agent or any Lender with respect to the Collateral pursuant to any Loan Document. 
 “Commercial
Tort Claims” shall have the meaning set forth in Article 9 of the UCC. 
 “Commodity Accounts” shall have the
meaning set forth in Article 9 of the UCC. 
 “Control” shall have the meaning set forth in Article 8 or, if applicable, in
Section 9-104, 9-105, 9-106 or 9-107 of Article 9 of the UCC. 

“Copyrights” means, with respect to any Person, all of such Person’s right, title, and interest in and to the following:
(a) all copyrights, copyrightable works and rights in designs, including without any limitation copyright registrations, and copyright applications; (b) all renewals of any of the foregoing; (c) all income, royalties, damages, and
payments now or hereafter due and/or payable under any of the foregoing, including, without limitation, damages or payments for past or future infringements for any of the foregoing; and (d) the right to sue for past, present, and future
infringements of any of the foregoing. 
 “Default” means any event or condition which constitutes an Event of Default or
which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 
 “Deposit Account Control
Agreement” means an agreement, in form and substance reasonably satisfactory to the Administrative Agent, among any Loan Party, a banking institution holding such Loan Party’s funds, and the Administrative Agent with respect to
collection and control of all deposits and balances held in a deposit account maintained by such Loan Party with such banking institution. 

“Deposit Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Documents” shall have the meaning set forth in Article 9 of the UCC. 

“Event of Default” means an event described in Section 5.1. 

“Exhibit” refers to a specific exhibit to this Security Agreement, unless another document is specifically referenced. 

“General Intangibles” shall have the meaning set forth in Article 9 of the UCC. 

“Goods” shall have the meaning set forth in Article 9 of the UCC. 

“Instruments” shall have the meaning set forth in Article 9 of the UCC. 

“Inventory” shall have the meaning set forth in Article 9 of the UCC. 

  
 -2- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Investment Property” shall have the meaning set forth in Article 9 of the
UCC. 
 “Licenses” means, with respect to any Person, all of such Person’s right, title, and interest in and to
(a) any and all licensing agreements or similar arrangements in and to the U.S. Levi’s Patents, U.S. Levi’s Trademarks and U.S. Levi’s Copyrights or otherwise related to or used in conjunction with the Levi’s brand product
lines, (b) all income, royalties, damages, claims, and payments now or hereafter due or payable under and with respect thereto, including, without limitation, damages and payments for past and future breaches thereof, and (c) all rights to
sue for past, present, and future breaches thereof. 
 “Patents” means, with respect to any Person, all of such
Person’s right, title, and interest in and to: (a) any and all patents and patent applications; (b) all inventions, discoveries and improvements described and claimed therein; (c) all reissues, reexaminations, divisions,
continuations, extensions, and continuations-in-part thereof; (d) all income, royalties, damages, claims, and payments now or hereafter due or payable under and
with respect thereto, including, without limitation, damages and payments for past and future infringements thereof; and (e) all rights to sue for past, present, and future infringements thereof. 

“Perfection Certificate” shall mean that certain perfection certificate dated September 30, 2011, executed and delivered
by each Grantor to the Administrative Agent, and each other Perfection Certificate (which shall be in form and substance reasonably acceptable to the Administrative Agent) executed and delivered by the applicable Grantor to the Administrative Agent
contemporaneously with the execution and delivery of each Amendment executed in accordance with Section 4.4 hereof, in each case, as the same may be amended, amended and restated, supplemented or otherwise modified from
time to time in accordance with the Credit Agreement. 
 “Pledged Collateral” means all Pledged Debt and other Instruments
and Investment Property of the Grantors, whether or not physically delivered to the Administrative Agent pursuant to this Security Agreement. 

“Pledged Debt” means all indebtedness from time to time owed to any Grantor by any obligor that is, or becomes, a direct or
indirect Subsidiary of such Grantor, or by any obligor of which such Grantor is a direct or indirect Subsidiary, including the indebtedness set forth in Schedule 10 to the Perfection Certificate, as Schedule 10 to the Perfection
Certificate may be updated upon the execution of an Amendment to this Agreement by an additional Grantor, and issued by the obligors named therein, and the instruments evidencing such indebtedness. 

“Receivables” means the Accounts, Chattel Paper, Documents, Investment Property, Instruments and any other rights or claims
to receive money which are General Intangibles or which are otherwise included as Collateral. 
 “Required Secured Parties”
means (a) prior to an acceleration of the Obligations under the Credit Agreement, the Required Lenders, and (b) after an acceleration of the Obligations under the Credit Agreement but prior to the date upon which the Credit Agreement has
terminated by its terms and all of the obligations thereunder have been paid in full, Lender Parties holding in the aggregate at least a majority of the total of the Aggregate Credit Exposure. 

“Section” means a numbered section of this Security Agreement, unless another document is specifically referenced. 

  
 -3- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “Trademarks” means, with respect to any Person, all of such Person’s
right, title, and interest in and to the following: (a) all trademarks (including service marks), trade names, trade dress, and trade styles, domain names, including all registrations and applications for registration thereof, together with the
goodwill of the business symbolized by the foregoing (“Goodwill”); (b) all licenses or other rights to use any of the foregoing, whether as licensee or licensor; (c) all renewals of the foregoing; (d) all income,
royalties, damages, and payments now or hereafter due or payable with respect thereto, including, without limitation, damages, claims, and payments for past and future infringements, dilution or violation thereof or unfair competition with respect
thereto; and (e) all rights to sue for past, present, and future infringements, dilution, violations or unfair competition with respect to any of the foregoing, including the right to settle suits involving claims and demands for royalties
owing. 
 “UCC” means the Uniform Commercial Code, as in effect from time to time, of the State of New York or of any other
state the laws of which are required as a result thereof to be applied in connection with the attachment, perfection or priority of, or remedies with respect to, Administrative Agent’s or any Lender’s Lien on any Collateral. 

“U.S. Levi’s Copyrights” means all Copyrights associated with or used or held for use in conjunction with the U.S.
Levi’s Trademarks and registered with the United States Copyright Office, including without limitation, the Copyrights set forth on Schedule 11(b) to the Perfection Certificate. 

“U.S. Levi’s Patents” means all Patents and applications for Patents associated with or used or held for use in
conjunction with the U.S. Levi’s Trademarks and registered with the United States Patent and Trademark Office, including without limitation, the Patents and applications for Patents set forth on Schedule 11(c) to the Perfection
Certificate. 
 “U.S. Levi’s Trademarks” means the name “Levi’s”, all associated logos and
designs and all other Trademarks, in each case, associated with the Levi’s brand product lines in the United States and registered with the United States Patent and Trademark Office, including without limitation, the U.S. trademark
registrations and applications set forth on Schedule 11(a) to the Perfection Certificate. 
 The foregoing definitions shall be
equally applicable to both the singular and plural forms of the defined terms. 
 1.4. Perfection Certificate. The Grantors, the
Administrative Agent and each Lender Party agree that the Perfection Certificate and all schedules, amendments and supplements thereto are and shall at all times remain a part of this Security Agreement. 

ARTICLE II 
 GRANT OF
SECURITY INTEREST 
 Each Grantor hereby pledges, assigns and grants to the Administrative Agent, for the benefit of the Lender Parties,
a security interest in all of its right, title and interest in, to and under the personal property and other assets described in this Article II, whether now owned by or owing to, or hereafter acquired by or arising in favor of such Grantor
(including under any trade name or derivations thereof), and whether owned or consigned by or to, or leased from or to, such Grantor, and regardless of where located (all of which will be collectively referred to as the
“Collateral”): 
  

	 	(i)	 all Accounts; 

  

	 	(ii)	 all Chattel Paper; 

  

	 	(iii)	 the U.S. Levi’s Patents, U.S. Levi’s Trademarks, U.S. Levi’s Copyrights and Licenses (and all
proceeds therefrom), including without limitation all U.S. Levi’s Copyrights used in conjunction with selling, advertising and/or marketing any goods or materials bearing the U.S. Levi’s Trademarks; 

  
 -4- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

	 	(iv)	 all Documents; 

  

	 	(v)	 all General Intangibles; 

 

	 	(vi)	 all Goods; 

  

	 	(vii)	 all Pledged Debt; 

  

	 	(viii)	 all Instruments; 

  

	 	(ix)	 all Inventory; 

  

	 	(x)	 all Investment Property; 

 

	 	(xi)	 all cash or cash equivalents; 

 

	 	(xii)	 all Deposit Accounts with any bank or other financial institution; 

 

	 	(xiii)	 all Commercial Tort Claims relating to any of the foregoing; and 

 

	 	(xiv)  	 all accessions to, substitutions for and replacements, proceeds, insurance proceeds and products of the
foregoing, together with all books and records, customer lists, credit files, computer files, programs, printouts and other computer materials and records related thereto and any General Intangibles at any time evidencing or relating to any of the
foregoing; 

 to secure the prompt and complete payment and performance of the Secured Obligations. 

Notwithstanding anything herein to the contrary, in no event shall the Collateral include, and no Grantor shall be deemed to have granted a
security interest in any of such Grantor’s rights or interests in any license, contract or agreement to which such Grantor is a party or any of its rights or interests thereunder to the extent, but only to the extent, that such a grant would,
under the terms of such license, contract or agreement or otherwise, result in a breach of the terms of, or constitute a default under, any license, contract or agreement to which such Grantor is a party (other than to the extent that any such term
would be rendered ineffective pursuant to the UCC or any other applicable law (including the Bankruptcy Code) or principles of equity); provided, that immediately upon the ineffectiveness, lapse or termination of any such provision, the
Collateral shall include, and such Grantor shall be deemed to have granted a security interest in, all such rights and interests as if such provision had never been in effect. 

Notwithstanding anything herein to the contrary, neither the U.S. Borrower nor any other Grantor shall be deemed to have granted a security
interest in (i) any Equity Interests of any Subsidiary, (ii) any Pledged Debt of or issued by any Subsidiary or (iii) any Equipment. 

The security interest granted herein shall not apply to any U.S.
intent-to-use trademark application included in the U.S. Levi’s Trademarks to the extent that such grant may impair the validity or enforceability of such U.S. intent-to-use trademark application; provided, however, if a statement of use or an affidavit of use is filed and accepted by the U.S. Patent and Trademark Office with respect
to such U.S. intent-to-use trademark application, the grant of the security interest hereunder shall automatically and immediately apply to such U.S. intent-to-use trademark application without the need of any further action by the parties. 

  
 -5- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

Each Grantor represents and warrants to the Administrative Agent and the Lender Parties that: 

3.1. Title, Perfection and Priority. Such Grantor has good and valid rights in or the power to transfer the Collateral and title to the
Collateral with respect to which it has purported to grant a security interest hereunder, free and clear of all Liens except for Liens permitted under Section 4.1(e), and has full power and authority to grant to the Administrative Agent the
security interest in the Collateral pursuant hereto. When financing statements have been filed in the appropriate offices against such Grantor in the locations listed on Annex A hereto, the Administrative Agent will have a fully perfected
first priority security interest in that Collateral of the Grantor in which a security interest may be perfected by filing, subject only to Liens permitted under Section 4.1(e). 

3.2. Type and Jurisdiction of Organization, Organizational and Identification Numbers. The type of entity of such Grantor, its state of
organization, the organizational number issued to it by its state of organization and its federal employer identification number are set forth on Schedule 1(a) to the Perfection Certificate. 

3.3. Principal Location. Such Grantor’s mailing address, which shall be its address for notices and other communications provided
for herein and the location of its place of business (if it has only one) or its chief executive office (if it has more than one place of business), are disclosed in Schedule 2 to the Perfection Certificate; such Grantor has no other places
of business except those set forth in Schedule 2 to the Perfection Certificate. 
 3.4. Collateral Locations. All of such
Grantor’s locations where Collateral consisting of Inventory (other than Inventory in transit, Inventory excluded from Eligible Inventory as disclosed in the most recent Collateral Report, Inventory located at contractors’ premises or
mills in the ordinary course of business, and Inventory in the form of raw materials; provided, that the aggregate amount of all Inventory in the form of raw materials subject to this parenthetical does not exceed $10,000,000) or Fixtures owned by
such Grantor is located are listed on Schedule 2 to the Perfection Certificate. All of said locations are owned by such Grantor except for locations (i) which are leased by the Grantor as lessee and designated in Schedule 2 to the
Perfection Certificate and (ii) at which Inventory is held in a public warehouse or is otherwise held by a bailee or on consignment as designated in Schedule 14 to the Perfection Certificate. 

3.5. Deposit Accounts. All of such Grantor’s Deposit Accounts are listed on Schedule 13 to the Perfection Certificate. 

3.6. Exact Names. Such Grantor’s name in which it has executed this Security Agreement is the exact name as it appears in such
Grantor’s organizational documents, as amended, as filed with such Grantor’s jurisdiction of organization. Such Grantor has not, during the past five years, been known by or used any other corporate or fictitious name, or been a party to
any merger or consolidation, or been a party to any acquisition other than as set forth on Schedule 1(b) to the Perfection Certificate. 

3.7. Chattel Paper. Schedule 10 to the Perfection Certificate lists all Chattel Paper of such Grantor that on an individual basis
bears a face amount of at least $5,000,000. All action by such Grantor necessary or reasonably requested by the Administrative Agent to protect and perfect the Administrative Agent’s Lien on each item listed on Schedule 10 to the
Perfection Certificate (including the delivery of all originals and the placement of a legend on all Chattel Paper as required hereunder) has been duly taken. The Administrative Agent will have a fully perfected first priority security interest in
the Collateral listed on Schedule 10 to the Perfection Certificate, subject only to Liens permitted under Section 4.1(e). 

  
 -6- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 3.8. Accounts and Chattel Paper. 

(a) The names of the obligors, amounts owing, due dates and other information with respect to its Accounts and Chattel Paper are and will be
correctly stated in all material respects in all records of such Grantor relating thereto and in all invoices and Collateral Reports with respect thereto furnished to the Administrative Agent by such Grantor from time to time. 

(b) With respect to its Accounts, except as specifically disclosed on the most recent Collateral Report, (i) all Accounts are Eligible
Accounts; (ii) all Accounts represent bona fide sales of Inventory or rendering of services to Account Debtors in the ordinary course of such Grantor’s business; (iii) there are no setoffs, claims or disputes existing or asserted with
respect thereto and such Grantor has not made any agreement with any Account Debtor for any extension of time for the payment thereof, any compromise or settlement for less than the full amount thereof, any release of any Account Debtor from
liability therefor, or any deduction therefrom except a discount or allowance allowed by such Grantor in the ordinary course of its business for prompt payment and disclosed to the Administrative Agent; (iv) to such Grantor’s knowledge,
there are no facts, events or occurrences which in any way impair the validity or enforceability thereof or could reasonably be expected to reduce the amount payable thereunder as shown on such Grantor’s books and records and any invoices,
statements and Collateral Reports with respect thereto; (v) such Grantor has not received any notice of proceedings or actions which are threatened or pending against any Account Debtor which could reasonably be expected to result in any
material adverse change in such Account Debtor’s financial condition; and (vi) such Grantor has no knowledge that any Account Debtor has become insolvent or is generally unable to pay its debts as they become due. 

(c) In addition, with respect to all of its Accounts, (i) the amounts shown on all invoices, statements and Collateral Reports with
respect thereto are actually and absolutely owing to such Grantor as indicated thereon and are not in any way contingent; (ii) no payments have been or shall be made thereon except payments promptly delivered to a Collateral Deposit Account as
required pursuant to Section 7.1; and (iii) to such Grantor’s knowledge, all Account Debtors have the capacity to contract. 

3.9. Inventory. With respect to any of its Inventory scheduled or listed on the most recent Collateral Report, (a) such Inventory
(other than Inventory in transit, Inventory excluded from Eligible Inventory as disclosed in the most recent Collateral Report, Inventory located at contractors’ premises or mills in the ordinary course of business, and Inventory in the form of
raw materials; provided, that the aggregate amount of all Inventory in the form of raw materials subject to this parenthetical does not exceed $10,000,000) is located at one of such Grantor’s locations set forth on Schedule 2 or
Schedule 14 to the Perfection Certificate, (b) no Inventory (other than Inventory in transit, Inventory excluded from Eligible Inventory as disclosed in the most recent Collateral Report, Inventory located at contractors’ premises
or mills in the ordinary course of business, and Inventory in the form of raw materials; provided, that the aggregate amount of all Inventory in the form of raw materials subject to this parenthetical does not exceed $10,000,000) is now, or shall at
any time or times hereafter be stored at any other location except as permitted by Section 4.1(g), (c) such Grantor has good, indefeasible and merchantable title to such Inventory and such Inventory is not subject to any Lien or security
interest or document whatsoever except for the security interest granted to the Administrative Agent hereunder for the benefit of the Administrative Agent and Lender Parties, and Liens constituting a Permitted Encumbrance pursuant to clause (a),
(b), (f), (h) or (i) of the definition thereof and any other Permitted Encumbrance which does not have priority over the Lien in favor of the Administrative Agent and the Lender Parties, (d) except as specifically disclosed in the most
recent Collateral Report, such Inventory is Eligible Inventory of good and marketable condition, except for damaged or defective goods arising in the ordinary course of such Grantor’s business, and (e) such Inventory has been produced in
accordance with the Federal Fair Labor Standards Act of 1938, as amended, and all rules, regulations and orders thereunder. 

  
 -7- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 3.10. Intellectual Property. Schedules 11(a), 11(b) and 11(c) to
the Perfection Certificate set forth a true, correct and complete list of all U.S. Levi’s Patents, U.S. Levi’s Trademarks and U.S. Levi’s Copyrights constituting Collateral. This Security Agreement is effective to create a valid and
continuing Lien and, upon filing of appropriate financing statements in the offices listed on Schedule 11(e) to the Perfection Certificate and this Security Agreement or an appropriate instrument evidencing this Security Agreement with the
United States Copyright Office and the United States Patent and Trademark Office, fully perfected first priority security interests in favor of the Administrative Agent on the U.S. Levi’s Patents, U.S. Levi’s Trademarks, U.S. Levi’s
Copyrights and Licenses constituting Collateral, such perfected security interests are enforceable as such as against any and all creditors of and successors, assignees, mortgagees and purchasers from such Grantor; and all actions necessary or
reasonably requested by the Administrative Agent to protect and perfect the Administrative Agent’s Lien on such Grantor’s U.S. Levi’s Patents, U.S. Levi’s Trademark, U.S. Levi’s Copyrights and Licenses constituting
Collateral shall have been duly taken. 
 3.11. Filing Requirements. None of the Collateral owned by it is of a type for which
security interests or liens may be perfected by filing under any federal statute except for the U.S. Levi’s Patents, U.S. Levi’s Trademarks and the U.S. Levi’s Copyrights and the Licenses held by such Grantor and described in
Schedules 11(a), 11(b) or (11)(c) to the Perfection Certificate. 
 3.12. No Financing Statements, Security
Agreements. No financing statement or security agreement describing all or any portion of the Collateral which has not lapsed or been terminated naming such Grantor as debtor has been filed or is of record in any jurisdiction except for
financing statements or security agreements (a) naming the Administrative Agent on behalf of the Lender Parties as the secured party and (b) in respect of other Liens specifically permitted pursuant to Section 6.02 of the Credit
Agreement. 
 3.13. Pledged Collateral. 

(a) Schedule 10 to the Perfection Certificate sets forth a complete and accurate list of all Pledged Collateral owned by such Grantor
that on an individual basis bears a face amount of at least $5,000,000. Such Grantor is the direct, sole beneficial owner and sole holder of record of the Pledged Collateral listed on Schedule 10 to the Perfection Certificate as being owned
by it, free and clear of any Liens, except for the security interest granted to the Administrative Agent for the benefit of the Lender Parties hereunder and other Liens specifically permitted pursuant to Section 6.02 of the Credit Agreement.
Such Grantor further represents and warrants that, to such Grantor’s knowledge, all Pledged Collateral which represents Indebtedness owed to such Grantor has been duly authorized, authenticated or issued and delivered by the issuer of such
Indebtedness, is the legal, valid and binding obligation of such issuer and such issuer is not in default thereunder. 
 (b) In addition, to
such Grantor’s knowledge, (i) none of the Pledged Collateral owned by it has been issued or transferred in violation of the securities registration, securities disclosure or similar laws of any jurisdiction to which such issuance or
transfer may be subject, (ii) no options, warrants, calls or commitments of any character whatsoever exist relating to such Pledged Collateral, and (iii) no consent, approval, authorization, or other action by, and no giving of notice,
filing with, any governmental authority or any other Person is required for the pledge by such Grantor of such Pledged Collateral pursuant to this Security Agreement or for the execution, delivery and performance of this Security Agreement by such
Grantor, or for the exercise by the Administrative Agent of the voting or other rights provided for in this Security Agreement or for the remedies in respect of the Pledged Collateral pursuant to this Security Agreement, except as may be required in
connection with such disposition by laws affecting the offering and sale of securities generally. 

  
 -8- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 ARTICLE IV 

COVENANTS 
 From the date
of this Security Agreement (except as set forth in Section 4.13), and thereafter until this Security Agreement is terminated, each Grantor agrees that: 

4.1. General. 
 (a)
Collateral Records. Such Grantor will maintain complete and accurate books and records with respect to the Collateral owned by it, and furnish to the Administrative Agent, with sufficient copies for each of the Lender Parties, such reports
relating to such Collateral as the Administrative Agent shall from time to time reasonably request. 
 (b) Authorization to File Financing
Statements; Ratification. Such Grantor hereby authorizes the Administrative Agent to file, and if requested will deliver to the Administrative Agent, all financing statements and other documents and take such other actions as may from time to
time be reasonably requested by the Administrative Agent in order to maintain a first perfected security interest in and, if applicable, Control of, the Collateral owned by such Grantor. Any financing statement filed by the Administrative Agent may
be filed in any filing office in any UCC jurisdiction and may (i) indicate such Grantor’s Collateral by any description which reasonably approximates the description contained in this Security Agreement, and (ii) contain any other
information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing statement or amendment, including (A) whether such Grantor is an organization, the type of organization and any organization
identification number issued to such Grantor, and (B) in the case of a financing statement filed as a fixture filing, a sufficient description of real property to which the Collateral relates. Such Grantor also agrees to furnish any such
information described in the foregoing sentence to the Administrative Agent promptly upon request. Such Grantor also ratifies its authorization for the Administrative Agent to have filed in any UCC jurisdiction any like initial financing statements
or amendments thereto if filed prior to the date hereof. 
 (c) Further Assurances. Such Grantor will, if so requested by the
Administrative Agent, furnish to the Administrative Agent, as often as the Administrative Agent reasonably requests, statements and schedules further identifying and describing the Collateral owned by it and such other reports and information in
connection with its Collateral as the Administrative Agent may reasonably request, all in such detail as the Administrative Agent may specify. Such Grantor also agrees to take any and all commercially reasonable actions necessary to defend title to
the Collateral against all persons and to defend the security interest of the Administrative Agent in its Collateral and the priority thereof against any Lien not expressly permitted hereunder. 

(d) Disposition of Collateral. Such Grantor will not sell, lease or otherwise dispose of the Collateral owned by it except for
dispositions specifically permitted pursuant to Section 6.05 of the Credit Agreement. 
 (e) Liens. Such Grantor will not create,
incur, or suffer to exist any Lien on the Collateral owned by it except (i) the security interest created by this Security Agreement, and (ii) other Liens specifically permitted pursuant to Section 6.02 of the Credit Agreement. 

  
 -9- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (f) Other Financing Statements. Such Grantor will not authorize the filing of any
financing statement naming it as debtor covering all or any portion of the Collateral owned by it, except for financing statements (i) naming the Administrative Agent on behalf of the Lender Parties as the secured party, and (ii) in
respect of other Liens specifically permitted pursuant to Section 6.02 of the Credit Agreement. Such Grantor acknowledges that it is not authorized to file any financing statement or amendment or termination statement with respect to any
financing statement without the prior written consent of the Administrative Agent, subject to such Grantor’s rights under Section 9-509(d)(2) of the UCC. 

(g) Locations. Such Grantor will not (i) maintain any Collateral owned by it (other than Inventory in transit, Inventory excluded
from Eligible Inventory as disclosed in the most recent Collateral Report, Inventory located at contractors’ premises or mills in the ordinary course of business, and Inventory in the form of raw materials; provided, that the aggregate amount
of all Inventory in the form of raw materials subject to this parenthetical does not exceed $10,000,000) at any location other than those locations listed on Schedule 2 or Schedule 14 to the Perfection Certificate, (ii) otherwise
change, or add to, such locations without the Administrative Agent’s consent as and to the extent required by the Credit Agreement (and if the Administrative Agent gives such consent, such Grantor will concurrently therewith use commercially
reasonable efforts to obtain a Collateral Access Agreement for each such location to the extent required by the Credit Agreement), or (iii) change its principal place of business or chief executive office from the location identified on
Schedule 2 to the Perfection Certificate, other than as permitted by the Credit Agreement. 
 (h) Compliance with Terms. Such
Grantor will perform and comply in all material respects with all obligations in respect of the Collateral owned by it and all agreements to which it is a party or by which it is bound relating to such Collateral. 

4.2. Receivables. 
 (a)
Certain Agreements on Receivables. Upon the occurrence of and during the continuance of an Event of Default, such Grantor will not make or agree to make any discount, credit, rebate or other reduction in the original amount owing on a
Receivable or accept in satisfaction of a Receivable less than the original amount thereof without the Administrative Agent’s prior written consent, except for discounts, credits, rebates or other reductions made or given in accordance with its
present policies and in the ordinary course of business. 
 (b) Collection of Receivables. Except as otherwise provided in this
Security Agreement, such Grantor will use commercially reasonable efforts to collect and enforce, at such Grantor’s sole expense, all amounts due or hereafter due to such Grantor under the Receivables owned by it. 

(c) Disclosure of Counterclaims on Receivables. If (i) any discount, credit or agreement to make a rebate or to otherwise reduce
the amount owing on any Receivable in excess of $10,000,000 owned by such Grantor exists or (ii) if, to the knowledge of such Grantor, any dispute, setoff, claim, counterclaim or defense exists or has been asserted or threatened with respect to
any such Receivable, such Grantor will, on a monthly basis, disclose such fact to the Administrative Agent in writing. Such Grantor shall send the Administrative Agent a copy of each credit memorandum in excess of $10,000,000 on a monthly basis, and
such Grantor shall promptly report each such credit memorandum and each of the facts required to be disclosed to the Administrative Agent in accordance with this Section 4.2(c) on the Borrowing Base Certificates submitted by it. 

(d) Electronic Chattel Paper. Such Grantor shall take all steps reasonably necessary to grant the Administrative Agent Control of all
electronic chattel paper in accordance with the UCC and all “transferable records” as defined in each of the Uniform Electronic Transactions Act and the Electronic Signatures in Global and National Commerce Act. 

  
 -10- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 4.3. Inventory. 

(a) Maintenance of Goods. Such Grantor will do all things necessary to maintain, preserve, protect and keep its Inventory in saleable
condition, except for damaged or defective goods arising in the ordinary course of such Grantor’s business. 
 (b) Returned
Inventory. If an Account Debtor has an authorized return and returns any Inventory covered by such return to such Grantor when no Event of Default exists, then such Grantor shall promptly determine the reason for such return and shall issue a
credit memorandum to the Account Debtor in the appropriate amount. Such Grantor shall deliver a monthly report to the Administrative Agent setting forth all such returns involving an amount in excess of $10,000,000. Each such report shall indicate
the reasons for the returns and the locations and condition of the returned Inventory. In the event any Account Debtor returns Inventory to such Grantor when an Event of Default exists, such Grantor, upon the request of the Administrative Agent,
shall: (i) hold the returned Inventory in trust for the Administrative Agent; (ii) dispose of the returned Inventory solely according to the Administrative Agent’s written instructions; and (iii) not issue any credits or
allowances with respect thereto in an amount exceeding $500,000 in the aggregate during any Fiscal Month without the Administrative Agent’s prior written consent. All returned Inventory shall be subject to the Administrative Agent’s Liens
thereon. Whenever any Inventory is returned, the related Account shall be deemed ineligible to the extent of the amount owing by the Account Debtor with respect to such returned Inventory and such returned Inventory shall not be Eligible Inventory
unless such Inventory constitutes Third Party Logistics Goods. 
 (c) Inventory Count; Perpetual Inventory System. Such Grantor will
conduct a physical count of its Inventory at least once per fiscal year, and after and during the continuation of an Event of Default, at such other times as the Administrative Agent reasonably requests. Such Grantor, at its own expense, shall
deliver to the Administrative Agent promptly upon request the results of each physical verification, which such Grantor has made, or has caused any other Person to make on its behalf, of all or any portion of its Inventory. Such Grantor will
maintain a perpetual inventory reporting system at all times. 
 4.4. Delivery of Instruments, Securities, Chattel Paper and
Documents. Such Grantor will (a) deliver to the Administrative Agent promptly (but in any event within five Business Days) upon execution of this Security Agreement the originals of all Chattel Paper, Securities and Instruments constituting
Collateral owned by it that on an individual basis bears a face amount of at least $5,000,000 (if any then exist), (b) hold in trust for the Administrative Agent upon receipt and promptly (but in any event within five Business Days) thereafter
deliver to the Administrative Agent any such Chattel Paper, Securities and Instruments constituting Collateral owned by it that on an individual basis bears a face amount of at least $5,000,000, (c) promptly upon the Administrative Agent’s
request, deliver to the Administrative Agent (and thereafter hold in trust for the Administrative Agent upon receipt and promptly (but in any event within five Business Days) deliver to the Administrative Agent) any Document evidencing or
constituting Collateral that on an individual basis bears a face amount of at least $5,000,000 and (d) promptly upon the Administrative Agent’s request, deliver to the Administrative Agent a duly executed amendment to this Security
Agreement, in the form of Exhibit A hereto (the “Amendment”), pursuant to which such Grantor will pledge such additional Collateral. Such Grantor hereby authorizes the Administrative Agent to attach each Amendment to this
Security Agreement and agrees that all additional Collateral owned by it set forth in such Amendments shall be considered to be part of the Collateral. 

  
 -11- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 4.5. Uncertificated Pledged Collateral. Such Grantor will permit the Administrative
Agent from time to time to cause the appropriate issuers (and, if held with a securities intermediary, such securities intermediary) of uncertificated securities or other types of Pledged Collateral owned by it not represented by certificates to
mark their books and records with the numbers and face amounts of all such uncertificated securities or other types of Pledged Collateral not represented by certificates and all rollovers and replacements therefor to reflect the Lien of the
Administrative Agent granted pursuant to this Security Agreement. With respect to any Pledged Collateral owned by it, such Grantor will take any commercially reasonable actions necessary to cause (a) the issuers of uncertificated securities
which are Pledged Collateral and (b) any securities intermediary which is the holder of any such Pledged Collateral, to cause the Administrative Agent to have and retain Control over such Pledged Collateral. Without limiting the foregoing, such
Grantor will, with respect to any such Pledged Collateral held with a securities intermediary, use commercially reasonable efforts to cause such securities intermediary to enter into a control agreement with the Administrative Agent, in form and
substance satisfactory to the Administrative Agent, giving the Administrative Agent Control. 
 4.6. Pledged Collateral. 

(a) Registration of Pledged Collateral. Such Grantor will permit any registerable Pledged Collateral owned by it to be registered in the
name of the Administrative Agent or its nominee at any time at the option of the Required Secured Parties. 
 (b) Exercise of Rights in
Pledged Collateral. 
 (i) Without in any way limiting the foregoing and subject to clause (ii) below, such Grantor shall have the
right to exercise all voting rights or other rights relating to the Pledged Collateral owned by it for all purposes not inconsistent with this Security Agreement, the Credit Agreement or any other Loan Document; provided, however, that
no vote or other right shall be exercised or action taken which would have the effect of materially impairing the rights of the Administrative Agent in respect of such Pledged Collateral. 

(ii) Such Grantor will permit the Administrative Agent or its nominee at any time after the occurrence and during the continuance of an Event
of Default, upon written notice to such Grantor, to exercise all voting rights or other rights relating to the Pledged Collateral owned by it, including, without limitation, exchange, subscription or any other rights, privileges, or options
pertaining to any Investment Property constituting such Pledged Collateral as if it were the absolute owner thereof. 
 (iii) Such Grantor
shall be entitled to collect and receive for its own use, free and clear of the lien of this Security Agreement, all cash dividends and interest paid in respect of the Pledged Collateral owned by it to the extent not in violation of the Credit
Agreement other than any of the following distributions and payments (collectively referred to as the “Excluded Payments”): (A) dividends and interest paid or payable other than in cash in respect of such Pledged Collateral,
and instruments and other property received, receivable or otherwise distributed in respect of, or in exchange for, any Pledged Collateral; (B) dividends and other distributions paid or payable in cash in respect of such Pledged Collateral in
connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid-in capital of an issuer; and (C) cash paid, payable or otherwise
distributed, in respect of principal of, or in redemption of, or in exchange for, such Pledged Collateral; provided, however, that until actually paid, all rights to such distributions shall remain subject to the Lien created by this
Security Agreement; and 
 (iv) All Excluded Payments and all other distributions in respect of any Pledged Collateral owned by such
Grantor, whenever paid or made, shall be delivered to the Administrative Agent to hold as Pledged Collateral and shall, if received by such Grantor, be received in trust for the benefit of the Administrative Agent, be segregated from the other
property or funds of such Grantor, and be promptly delivered to the Administrative Agent as Pledged Collateral in the same form as so received (with any necessary endorsement). 

  
 -12- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Pledged Collateral held by a Securities Intermediary. Within 90 days of the
Effective Date (or such later date as the Administrative Agent may reasonably agree, in its sole discretion), such Grantor shall, with respect to all Pledged Collateral listed on Schedule 10 to the Perfection Certificate and held by a
securities intermediary, execute and delivery to the Administrative Agent a control agreement in form reasonably satisfactory to the Administrative Agent among such Grantor, the securities intermediary and the Administrative Agent pursuant to which
the Administrative Agent has Control. 
 4.7. Intellectual Property. 

(a) Such Grantor will use commercially reasonable efforts to secure all consents and approvals necessary or appropriate for the assignment to
or benefit of the Administrative Agent of any Licenses held by such Grantor and to enforce the security interests granted hereunder. 
 (b)
Such Grantor shall not, without the prior consent of the Administrative Agent, or unless such Grantor in its commercially reasonable judgment decides otherwise, abandon, allow to lapse or otherwise dedicate to the public any application or
registration relating to the U.S. Levi’s Trademarks, the U.S. Levi’s Patents or any U.S. Levi’s Copyrights (now or hereafter existing), and shall promptly notify the Administrative Agent of any adverse determination or development
(including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, the United States Copyright Office or any court or any administrative authority) regarding such
Grantor’s ownership of the U.S. Levi’s Trademarks, the U.S. Levi’s Patents or any U.S. Levi’s Copyrights, its right to register the same, the validity or enforceability of the same (whether in whole or in part) or to keep and
maintain the same; provided, however, that such Grantor may take such actions with respect to the U.S. Levi’s Trademarks, the U.S. Levi’s Patents or any U.S. Levi’s Copyrights or Licenses that will not cause a material reduction in
value. 
 (c) Within 45 days after the end of Grantor’s fiscal quarter during which Grantor acquires rights in any new U.S. Levi’s
Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights or Licenses, Grantor shall execute and deliver any and all security agreements as the Administrative Agent may reasonably request to evidence the Administrative Agent’s first
priority security interest in the new U.S. Levi’s Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights and Licenses and the General Intangibles of such Grantor relating thereto or represented thereby. 

(d) Such Grantor shall take all commercially reasonable actions necessary, or as requested by the Administrative Agent, to maintain and pursue
each application, to obtain the relevant registration and to maintain the registration of the U.S. Levi’s Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights and Licenses (now or hereafter existing), including the payment of all
fees, filing of applications for renewal, affidavits of use, affidavits of noncontestability and opposition and interference, derivation and cancellation proceedings and other proceedings, unless such Grantor determines in its commercially
reasonable judgment that such U.S. Levi’s Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights or Licenses are not material to the conduct of such Grantor’s business. Such Grantor shall take all commercially reasonable actions
to maintain quality control over the use (including use by its licensees) of the U.S. Levi’s Trademarks in accordance with, but no less than, the quality control standards employed by such Grantor as of the date hereof, and shall use
commercially reasonable efforts to police any unauthorized use of or any use that would impair or otherwise damage the goodwill associated with the U.S. Levi’s Trademarks, including unauthorized commercialization, counterfeiting, importation or
exportation of goods or other materials bearing the U.S. Levi’s Trademarks. 

  
 -13- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Such Grantor shall, unless it determines in its commercially reasonable judgment that
such U.S. Levi’s Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights or Licenses are not material to the conduct of its business or operations, bring suits, proceedings or other actions for infringement, misappropriation,
violation or dilution or unfair competition and to recover any and all damages for such infringement, misappropriation, violation or dilution or unfair competition, and shall take such other actions as the Administrative Agent shall deem appropriate
under the circumstances to protect such U.S. Levi’s Trademarks, U.S. Levi’s Patents, U.S. Levi’s Copyrights or Licenses. In the event that such Grantor institutes suit because the U.S. Levi’s Trademarks, U.S. Levi’s Patents
or U.S. Levi’s Copyrights, or Licenses is infringed upon, or misappropriated or diluted or breached by a third party or constitutes any unfair competition with respect thereto, such Grantor shall comply with Section 4.8. 

4.8. Commercial Tort Claims. Such Grantor shall, on a quarterly basis, notify the Administrative Agent of any commercial tort claim (as
defined in the UCC) where the amount of damages claimed is in excess of $10,000,000 relating to any Collateral that is acquired by it and, unless the Administrative Agent otherwise consents, such Grantor shall enter into an amendment to this
Security Agreement, in the form of Exhibit A hereto, granting to Administrative Agent a first priority security interest in such commercial tort claim. 

4.9. [Reserved]. 
 4.10.
Federal, State or Municipal Claims. Such Grantor will promptly notify the Administrative Agent of any Collateral which constitutes a claim against the United States government or any state or local government or any instrumentality or agency
thereof, the assignment of which claim is restricted by federal, state or municipal law. 
 4.11. No Interference. Such Grantor agrees
that it will not interfere with any right, power and remedy of the Administrative Agent provided for in this Security Agreement or now or hereafter existing at law or in equity or by statute or otherwise, or the exercise or beginning of the exercise
by the Administrative Agent of any one or more of such rights, powers or remedies. 
 4.12. Insurance. 

(a) In the event any Collateral is located in any area that has been designated by the Federal Emergency Management Agency as a “Special
Flood Hazard Area,” such Grantor shall purchase and maintain flood insurance on such Collateral (including any personal property which is located on any real property leased by such Loan Party within a “Special Flood Hazard Area”).
The amount of flood insurance required by this Section shall at a minimum comply with the applicable law, including the Flood Disaster Protection Act of 1973, as amended. 

(b) All insurance policies required hereunder and under Section 5.09 of the Credit Agreement shall name the Administrative Agent (for the
benefit of the Administrative Agent and the Lender Parties) as an additional insured or as loss payee, as applicable, and shall contain loss payable clauses or mortgagee clauses, through endorsements in form and substance reasonably satisfactory to
the Administrative Agent, which provide that: (i) all proceeds thereunder with respect to any Collateral shall be payable to the Administrative Agent; (ii) no such insurance shall be affected by any act or neglect of the insured or owner
of the property described in such policy; and (iii) such policy and loss payable or mortgagee clauses may be canceled, amended, or terminated only upon at least thirty days’ prior written notice given to the Administrative Agent. 

  
 -14- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) All premiums on any such insurance shall be paid when due by such Grantor, and copies of
the policies or certificates of insurance evidencing such policies delivered to the Administrative Agent. If such Grantor fails to obtain any insurance as required by this Section, the Administrative Agent may obtain such insurance at the
Borrower’s expense. By purchasing such insurance, the Administrative Agent shall not be deemed to have waived any Default arising from the Grantor’s failure to maintain such insurance or pay any premiums therefor. 

4.13. Collateral Access Agreements. Such Grantor shall use commercially reasonable efforts to obtain a Collateral Access Agreement, from
the lessor of each leased property, mortgagee of owned property or bailee or consignee with respect to the operator of any warehouse, processor or converter facility or other location (each of which is identified on Exhibit B hereto), where
Collateral in excess of $1,000,000 is stored or located at any given time (other than (i) company-owned facilities and (ii) retail stores), which agreement or letter shall provide access rights, contain a waiver or subordination of all
Liens or claims that the landlord, mortgagee, bailee or consignee may assert against the Collateral at that location, and shall otherwise be reasonably satisfactory in form and substance to the Administrative Agent. With respect to such locations or
warehouse space leased as of the Effective Date and thereafter where Collateral in excess of $1,000,000 is stored or located (other than (i) company-owned facilities and (ii) retail stores), if the Administrative Agent has not received a
Collateral Access Agreement as of the Effective Date (or, if later as of the date such location is acquired or leased), the Borrower’s Eligible Inventory at that location shall be subject to such Reserves as may be established by the
Administrative Agent. After the Effective Date, no real property or warehouse space shall be leased by such Grantor (other than retail stores) and no Inventory shall be shipped to a processor or converter under arrangements established after the
Effective Date, unless and until a satisfactory Collateral Access Agreement shall first have been obtained with respect to such location or if it has not been obtained, the Borrower’s Eligible Inventory at that location shall be subject to the
establishment of Reserves acceptable to the Administrative Agent. Such Grantor shall timely and fully pay and perform its obligations under all leases and other agreements with respect to each leased location or third party warehouse where any
Collateral is or may be located. 
 4.14. Deposit Account Control Agreements. Such Grantor will provide to the Administrative Agent
within 60 days of the Administrative Agent’s request, a Deposit Account Control Agreement duly executed on behalf of each financial institution holding a Deposit Account of such Grantor as set forth in this Security Agreement. 

4.15. Change of Name or Location. Such Grantor shall not (a) change its name as it appears in official filings in the state of its
incorporation or organization, (b) change its chief executive office, principal place of business, mailing address, corporate offices or warehouses or locations at which Collateral is held or stored, or the location of its records concerning
the Collateral as set forth in this Security Agreement, (c) change the type of entity that it is, (d) change its organization identification number, if any, issued by its state of incorporation or other organization, or (e) change its
state of incorporation or organization, in each case, unless the Administrative Agent shall have received at least thirty days prior written notice of such change, provided that, any new location shall be in the continental U.S. 

ARTICLE V 
 EVENTS OF
DEFAULT AND REMEDIES 
 5.1. Events of Default. The occurrence of any “Event of Default” under, and as defined in, the
Credit Agreement shall constitute an Event of Default hereunder. 
 5.2. Remedies. 

(a) Upon the occurrence of an Event of Default, the Administrative Agent may exercise any or all of the following rights and remedies: 

  
 -15- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) those rights and remedies provided in this Security Agreement, the Credit Agreement, or
any other Loan Document; provided, that, this Section 5.2(a) shall not be understood to limit any rights or remedies available to the Administrative Agent and the Lender Parties prior to an Event of Default; 

(ii) those rights and remedies available to a secured party under the UCC (whether or not the UCC applies to the affected Collateral) or under
any other applicable law (including, without limitation, any law governing the exercise of a bank’s right of setoff or bankers’ lien) when a debtor is in default under a security agreement; 

(iii) give notice of sole control or any other instruction under any Deposit Account Control Agreement or and other control agreement with any
securities intermediary and take any action therein with respect to such Collateral; 
 (iv) without notice (except as specifically provided
in Section 8.1 or elsewhere herein), demand or advertisement of any kind to any Grantor or any other Person, enter the premises of any Grantor where any Collateral is located (through self-help and without judicial process) to collect, receive,
assemble, process, appropriate, sell, lease, assign, grant an option or options to purchase or otherwise dispose of, deliver, or realize upon, the Collateral or any part thereof in one or more parcels at public or private sale or sales (which sales
may be adjourned or continued from time to time with or without notice and may take place at any Grantor’s premises or elsewhere), for cash, on credit or for future delivery without assumption of any credit risk, and upon such other terms as
the Administrative Agent may deem commercially reasonable; and 
 (v) concurrently with written notice to the applicable Grantor, transfer
and register in its name or in the name of its nominee the whole or any part of the Pledged Collateral, to exchange certificates or instruments representing or evidencing Pledged Collateral for certificates or instruments of smaller or larger
denominations, exercise the voting and all other rights as a holder with respect thereto, to collect and receive all cash dividends, interest, principal and other distributions made thereon and to otherwise act with respect to the Pledged Collateral
as though the Administrative Agent was the outright owner thereof. 
 (b) The Administrative Agent, on behalf of the Lender Parties, may
comply with any applicable state or federal law requirements in connection with a disposition of the Collateral and compliance will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. 

(c) The Administrative Agent shall have the right upon any such public sale or sales and, to the extent permitted by law, upon any such private
sale or sales, to purchase for the benefit of the Administrative Agent and the Lender Parties, the whole or any part of the Collateral so sold, free of any right of equity redemption, which equity redemption the Grantor hereby expressly releases.

 (d) Until the Administrative Agent is able to effect a sale, lease, or other disposition of Collateral, the Administrative Agent shall
have the right to hold or use Collateral, or any part thereof, to the extent that it deems appropriate for the purpose of preserving Collateral or its value or for any other purpose deemed appropriate by the Administrative Agent. The Administrative
Agent may, if it so elects, seek the appointment of a receiver or keeper to take possession of Collateral and to enforce any of the Administrative Agent’s remedies (for the benefit of the Administrative Agent and Lender Parties), with respect
to such appointment without prior notice or hearing as to such appointment. 

  
 -16- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Notwithstanding the foregoing, neither the Administrative Agent nor the Lender Parties
shall be required to (i) make any demand upon, or pursue or exhaust any of its rights or remedies against, any Grantor, any other obligor, guarantor, pledgor or any other Person with respect to the payment of the Secured Obligations or to
pursue or exhaust any of its rights or remedies with respect to any Collateral therefor or any direct or indirect guarantee thereof, (ii) marshal the Collateral or any guarantee of the Secured Obligations or to resort to the Collateral or any
such guarantee in any particular order, or (iii) effect a public sale of any Collateral. 
 (f) Each Grantor recognizes that the
Administrative Agent may be unable to effect a public sale of any or all the Pledged Collateral and may be compelled to resort to one or more private sales thereof in accordance with clause (a) above. Each Grantor also
acknowledges that any private sale may result in prices and other terms less favorable to the seller than if such sale were a public sale and, notwithstanding such circumstances, agrees that any such private sale shall not be deemed to have been
made in a commercially unreasonable manner solely by virtue of such sale being private. The Administrative Agent shall be under no obligation to delay a sale of any of the Pledged Collateral for the period of time necessary to permit any Grantor or
the issuer of the Pledged Collateral to register such securities for public sale under the Securities Act of 1933, as amended, or under applicable state securities laws, even if the applicable Grantor and the issuer would agree to do so. 

5.3. Grantor’s Obligations Upon Default. Upon the request of the Administrative Agent after the occurrence and during the
continuance of an Event of Default, each Grantor will: 
 (a) assemble and make available to the Administrative Agent the Collateral and all
books and records relating thereto at a Grantor’s premises; 
 (b) permit the Administrative Agent, by the Administrative Agent’s
representatives and agents, to enter, occupy and use any premises where all or any part of the Collateral, or the books and records relating thereto, or both, are located, to take possession of all or any part of the Collateral or the books and
records relating thereto, or both, to remove all or any part of the Collateral or the books and records relating thereto, or both, and to conduct sales of the Collateral, without any obligation to pay the Grantor for such use and occupancy; 

(c) take, or cause an issuer of Pledged Collateral to take, any and all actions necessary to enable the Administrative Agent to consummate a
public sale or other disposition of the Pledged Collateral; and 
 (d) at its own expense, cause the independent certified public accountants
then engaged by each Grantor to prepare and deliver to the Administrative Agent and each Lender Party, at any time, and from time to time, promptly upon the Administrative Agent’s request, the following reports with respect to the applicable
Grantor: (i) a reconciliation of all Accounts; (ii) an aging of all Accounts; (iii) trial balances; and (iv) a test verification of such Accounts. 

5.4. Grant of Intellectual Property License. For the purpose of enabling the Administrative Agent to exercise the rights and remedies
under this Article V at such time as the Administrative Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby, effective as of the date hereof, (a) grants to the Administrative Agent, for the benefit
of the Administrative Agent and the Lender Parties, for use upon the occurrence and during the continuance of an Event of Default, an irrevocable, nonexclusive license and sublicense (exercisable without payment of royalty or other compensation to
any Grantor or third party) to use, license or sublicense any intellectual property rights and General Intangibles of similar nature now owned, licensed by or hereafter acquired by such Grantor, and wherever the same may be located, and including in
such license access to all media in which any of the licensed items may 

  
 -17- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
be recorded or stored and to all computer software and programs used for the compilation or printout thereof; provided, however, the license granted under this Section 5.4
shall not be construed to limit such Grantor’s ability to take reasonable steps, in accordance with its then current business practices, to protect and preserve the Collateral, and (b) irrevocably agrees that the Administrative Agent may
(and shall have all rights to) sell, offer of sale, commercialize, advertise and market any of such Grantor’s Inventory to any person through any channel or method of sale, including without limitation persons who have previously purchased the
Grantor’s Inventory from such Grantor and in connection with any such sale or other enforcement of the Administrative Agent’s rights under this Security Agreement, may sell, offer for sale, commercialize, advertise and market Inventory
which bears any Trademark owned by or licensed to such Grantor and any Copyright owned by or licensed to such Grantor in conjunction therewith, and the Administrative Agent may finish or complete manufacture of any work or goods in process and affix
any Trademark owned by or licensed to such Grantor and sell such Inventory as provided herein. The Administrative Agent, in the exercise of the rights granted herein, agrees to use reasonable efforts to maintain quality control over the use of the
licensed Trademarks hereunder. 
 ARTICLE VI 

ACCOUNT VERIFICATION; ATTORNEY IN FACT; PROXY 

6.1. Account Verification. The Administrative Agent may at any time in any Grantor’s or an assumed name or, after and during the
continuance of an Event of Default, in the Administrative Agent’s own name, in the name of a nominee of the Administrative Agent, or in the name of any Grantor communicate (by mail, telephone, facsimile or otherwise) with the Account Debtors of
any such Grantor, parties to contracts with any such Grantor and obligors in respect of Instruments of any such Grantor to verify with such Persons, to the Administrative Agent’s reasonable satisfaction, the existence, amount, terms of, and any
other matter relating to, Accounts, Instruments, Chattel Paper, payment intangibles and/or other Receivables. 
 6.2. Authorization for
Administrative Agent to Take Certain Action. 
 (a) Each Grantor irrevocably authorizes the Administrative Agent at any time and from
time to time in the sole discretion of the Administrative Agent and appoints the Administrative Agent as its attorney in fact (i) to execute on behalf of such Grantor as debtor and to file financing statements necessary or desirable in the
Administrative Agent’s sole discretion to perfect and to maintain the perfection and priority of the Administrative Agent’s security interest in the Collateral, (ii) to endorse and collect any cash proceeds of the Collateral,
(iii) to file a carbon, photographic or other reproduction of this Security Agreement or any financing statement with respect to the Collateral as a financing statement and to file any other financing statement or amendment of a financing
statement (which does not add new collateral or add a debtor) in such offices as the Administrative Agent in its sole discretion deems necessary or desirable to perfect and to maintain the perfection and priority of the Administrative Agent’s
security interest in the Collateral, (iv) to contact and enter into one or more agreements with the issuers of uncertificated securities which are Pledged Collateral or with securities intermediaries holding Pledged Collateral as may be
necessary or advisable to give the Administrative Agent Control over such Pledged Collateral, (v) to apply the proceeds of any Collateral received by the Administrative Agent to the Secured Obligations as provided in Section 7.1(d), (vi)
to discharge past due taxes, assessments, charges, fees or Liens on the Collateral (except for such Liens that specifically permitted pursuant to Section 6.02 of the Credit Agreement), (vii) to contact Account Debtors for any reason in
accordance with Section 6.1 hereof, (viii) upon the occurrence and during the continuance of an Event of Default, to demand payment or enforce payment of the Receivables in the name of the Administrative Agent or such Grantor and to
endorse any and all checks, drafts, and other instruments for the payment of money relating to the Receivables, (ix) upon the occurrence and during the continuance of an Event of Default, to sign such Grantor’s name on any invoice or bill
of lading relating to the Receivables, drafts against any Account Debtor of the Grantor, assignments and 

  
 -18- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
verifications of Receivables, (x) upon the occurrence and during the continuance of an Event of Default, to exercise all of such Grantor’s rights and remedies with respect to the
collection of the Receivables and any other Collateral, (xi) upon the occurrence and during the continuance of an Event of Default, to settle, adjust, compromise, extend or renew the Receivables, (xii) upon the occurrence and during the
continuance of an Event of Default, to settle, adjust or compromise any legal proceedings brought to collect Receivables, (xiii) to prepare, file and sign such Grantor’s name on a proof of claim in bankruptcy or similar document against
any Account Debtor of such Grantor, (xiv) upon the occurrence and during the continuance of an Event of Default, to prepare, file and sign such Grantor’s name on any notice of Lien, assignment or satisfaction of Lien or similar document in
connection with the Receivables, (xv) upon the occurrence and during the continuance of an Event of Default, to change the address for delivery of mail addressed to such Grantor to such address as the Administrative Agent may designate and to
receive, open and dispose of all mail addressed to such Grantor, and (xvi) to do all other acts and things necessary to carry out this Security Agreement; and such Grantor agrees to reimburse the Administrative Agent on demand for any payment
made or any expense reasonably incurred by the Administrative Agent in connection with any of the foregoing; provided that, this authorization shall not relieve such Grantor of any of its obligations under this Security Agreement or under the Credit
Agreement. 
 (b) All acts of said attorney or designee are hereby ratified and approved. The powers conferred on the Administrative Agent,
for the benefit of the Administrative Agent and Lender Parties, under this Section 6.2 are solely to protect the Administrative Agent’s interests in the Collateral and shall not impose any duty upon the Administrative Agent or any Lender
Party to exercise any such powers. The Administrative Agent agrees that, except for the powers granted in Section 6.2(a)(i)-(vi) and Section 6.2(a)(xvi), it shall
not exercise any power or authority granted to it unless an Event of Default has occurred and is continuing. 
 6.3. Proxy. SUBJECT TO
THE LAST SENTENCE OF THIS SECTION 6.3, EACH GRANTOR HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS THE ADMINISTRATIVE AGENT AS ITS PROXY AND ATTORNEY-IN-FACT (AS SET FORTH
IN SECTION 6.2 ABOVE) WITH RESPECT TO ITS PLEDGED COLLATERAL, INCLUDING THE RIGHT TO VOTE ANY OF THE PLEDGED COLLATERAL, WITH FULL POWER OF SUBSTITUTION TO DO SO. IN ADDITION TO THE RIGHT TO VOTE ANY OF THE PLEDGED COLLATERAL, THE APPOINTMENT OF THE
ADMINISTRATIVE AGENT AS PROXY AND ATTORNEY-IN-FACT SHALL INCLUDE THE RIGHT TO EXERCISE ALL OTHER RIGHTS, POWERS, PRIVILEGES AND REMEDIES TO WHICH A HOLDER OF ANY OF THE
PLEDGED COLLATERAL WOULD BE ENTITLED (INCLUDING GIVING OR WITHHOLDING WRITTEN CONSENTS OF SHAREHOLDERS, CALLING SPECIAL MEETINGS OF SHAREHOLDERS AND VOTING AT SUCH MEETINGS). SUCH PROXY SHALL BE EFFECTIVE, AUTOMATICALLY AND WITHOUT THE NECESSITY OF
ANY ACTION (INCLUDING ANY TRANSFER OF ANY OF THE PLEDGED COLLATERAL ON THE RECORD BOOKS OF THE ISSUER THEREOF) BY ANY PERSON (INCLUDING THE ISSUER OF THE PLEDGED COLLATERAL OR ANY OFFICER OR AGENT THEREOF), UPON THE OCCURRENCE AND DURING THE
CONTINUANCE OF AN EVENT OF DEFAULT. 
 6.4. Nature of Appointment; Limitation of Duty. THE APPOINTMENT OF THE ADMINISTRATIVE AGENT AS
PROXY AND ATTORNEY-IN-FACT IN THIS ARTICLE VI IS COUPLED WITH AN INTEREST AND SHALL BE IRREVOCABLE UNTIL THE DATE ON WHICH THIS SECURITY AGREEMENT IS TERMINATED IN
ACCORDANCE WITH SECTION 8.13. NOTWITHSTANDING ANYTHING CONTAINED HEREIN, NEITHER THE ADMINISTRATIVE AGENT, NOR ANY LENDER PARTY, NOR ANY OF THEIR AFFILIATES, NOR ANY OF THEIR OR THEIR AFFILIATES’ RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES,
AGENTS OR REPRESENTATIVES SHALL HAVE ANY DUTY TO EXERCISE ANY RIGHT OR POWER 

  
 -19- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
GRANTED HEREUNDER OR OTHERWISE OR TO PRESERVE THE SAME AND SHALL NOT BE LIABLE FOR ANY FAILURE TO DO SO OR FOR ANY DELAY IN DOING SO, EXCEPT IN RESPECT OF DAMAGES ATTRIBUTABLE SOLELY TO ITS OWN
GROSS NEGLIGENCE OR WILLFUL MISCONDUCT AS FINALLY DETERMINED BY A COURT OF COMPETENT JURISDICTION; PROVIDED THAT, IN NO EVENT SHALL THEY BE LIABLE FOR ANY PUNITIVE, EXEMPLARY, INDIRECT OR CONSEQUENTIAL DAMAGES. 

ARTICLE VII 
 COLLECTION
AND APPLICATION OF COLLATERAL PROCEEDS; DEPOSIT ACCOUNTS 
 7.1. Collection of Receivables. 

(a) Within 90 days of the Effective Date (or such later date as the Administrative Agent may reasonably agree, in its sole discretion), each
Grantor shall execute and deliver to the Administrative Agent Deposit Account Control Agreements for each Deposit Account maintained by such Grantor into which all cash, checks or other similar payments relating to or constituting payments made in
respect of Receivables will be deposited (each, a “Collateral Deposit Account”), which Collateral Deposit Accounts are identified as such on Schedule 13 to the Perfection Certificate. After the Effective Date, each Grantor
will comply with the terms of Section 7.1(c). 
 (b) Each Grantor shall direct all of its Account Debtors to forward payments directly
to Deposit Accounts subject to Deposit Account Control Agreements. If any Grantor should refuse or neglect to notify any Account Debtor to forward payments directly to a Deposit Account subject to a Deposit Account Control Agreement after notice
from the Administrative Agent, the Administrative Agent shall be entitled to make such notification directly to such Account Debtor. If notwithstanding the foregoing instructions, any Grantor receives any proceeds of any Receivables, such Grantor
shall receive such payments as the Administrative Agent’s trustee, and shall promptly deposit all cash, checks or other similar payments related to or constituting payments made in respect of Receivables received by it to a Collateral Deposit
Account. 
 (c) Covenant Regarding New Deposit Accounts; Lock Boxes. Before opening or replacing any Collateral Deposit Account or
other Deposit Account, each Grantor shall (a) obtain the Administrative Agent’s consent in writing to the opening of such Collateral Deposit Account or other Deposit Account, and (b) cause each bank or financial institution in which
it seeks to open (i) a Collateral Deposit Account or other Deposit Account having assets of at least $5,000,000, to enter into a Deposit Account Control Agreement with the Administrative Agent in order to give the Administrative Agent Control
of such Collateral Deposit Account or other Deposit Account. In the case of Deposit Accounts maintained with Lender Parties, the terms of such letter shall be subject to the provisions of the Credit Agreement regarding setoffs. 

(d) Application of Proceeds; Deficiency. During any period commencing when (i) Availability has been less than the Minimum Excess
Availability Amount for five consecutive Business Days or (ii) an Event of Default has occurred and is continuing and ending on the date when no Event of Default is continuing and Availability has been greater than the Minimum Excess
Availability Amount for at least 60 consecutive days, the Administrative Agent shall instruct each bank with which a Collateral Deposit Account is maintained to transfer available balances on deposit in such Collateral Deposit Accounts to an account
of the Administrative Agent (a “Collection Account”) pending application in accordance with Section 2.10(b) of the Credit Agreement. The Administrative Agent shall require all other cash proceeds of the Collateral received
during the continuance of an Event of Default, which are not required to be applied to the Obligations pursuant to Section 2.10(b) of the Credit Agreement, to be deposited in a special non-interest
bearing cash collateral account with the Administrative Agent and held there as security for the 

  
 -20- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
Secured Obligations. No Grantor shall have any control whatsoever over said cash collateral account. Any such proceeds of the Collateral shall be applied in the order set forth in
Section 2.18 of the Credit Agreement unless a court of competent jurisdiction shall otherwise direct. The balance, if any, after all of the Secured Obligations (other than contingent obligations) have been satisfied, shall be returned by the
Administrative Agent to the U.S. Borrower. The Grantors shall remain liable for any deficiency if the proceeds of any sale or disposition of the Collateral are insufficient to pay all Secured Obligations, including any attorneys’ fees and other
expenses incurred by Administrative Agent or any Lender Party to collect such deficiency. 
 ARTICLE VIII 

GENERAL PROVISIONS 
 8.1.
Waivers. Each Grantor hereby waives notice of the time and place of any public sale or the time after which any private sale or other disposition of all or any part of the Collateral may be made. To the extent such notice may not be waived
under applicable law, any notice made shall be deemed reasonable if sent to the Grantors, addressed as set forth in Article IX, at least ten days prior to (i) the date of any such public sale or (ii) the time after which any such private
sale or other disposition may be made. To the maximum extent permitted by applicable law, each Grantor waives all claims, damages, and demands against the Administrative Agent or any Lender Party arising out of the repossession, retention or sale of
the Collateral, except such as arise solely out of the gross negligence or willful misconduct of the Administrative Agent or such Lender Party as finally determined by a court of competent jurisdiction. To the extent it may lawfully do so, each
Grantor absolutely and irrevocably waives and relinquishes the benefit and advantage of, and covenants not to assert against the Administrative Agent or any Lender Party, any valuation, stay, appraisal, extension, moratorium, redemption or similar
laws and any and all rights or defenses it may have as a surety now or hereafter existing which, but for this provision, might be applicable to the sale of any Collateral made under the judgment, order or decree of any court, or privately under the
power of sale conferred by this Security Agreement, or otherwise. Except as otherwise specifically provided herein, each Grantor hereby waives presentment, demand, protest or any notice (to the maximum extent permitted by applicable law) of any kind
in connection with this Security Agreement or any Collateral. 
 8.2. Limitation on Administrative Agent’s and Lender Parties’
Duty with Respect to the Collateral. The Administrative Agent shall have no obligation to clean-up or otherwise prepare the Collateral for sale. The Administrative Agent and each Lender Party shall use
reasonable care with respect to the Collateral in its possession or under its control. Neither the Administrative Agent nor any Lender Party shall have any other duty as to any Collateral in its possession or control or in the possession or control
of any agent or nominee of the Administrative Agent or such Lender Party, or any income thereon or as to the preservation of rights against prior parties or any other rights pertaining thereto. To the extent that applicable law imposes duties on the
Administrative Agent to exercise remedies in a commercially reasonable manner, each Grantor acknowledges and agrees that it is commercially reasonable for the Administrative Agent (i) to fail to incur expenses reasonably deemed significant by
the Administrative Agent to prepare Collateral for disposition or otherwise to transform raw material or work in process into finished goods or other finished products for disposition, (ii) to fail to obtain third party consents for access to
Collateral to be disposed of, or to obtain or, if not required by other law, to fail to obtain governmental or third party consents for the collection or disposition of Collateral to be collected or disposed of, (iii) to fail to exercise
collection remedies against Account Debtors or other Persons obligated on Collateral or to remove Liens on or any adverse claims against Collateral, (iv) to exercise collection remedies against Account Debtors and other Persons obligated on
Collateral directly or through the use of collection agencies and other collection specialists, (v) to advertise dispositions of Collateral through publications or media of general circulation, whether or not the Collateral is of a specialized
nature, (vi) to contact other Persons, whether or not in the same business as such Grantor, for expressions of interest in acquiring all or any portion of the Collateral, (vii) to hire one or more professional auctioneers to assist in the
disposition of Collateral, whether or not the Collateral is of a specialized nature, (viii) to dispose of Collateral by utilizing 

  
 -21- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
internet sites that provide for the auction of assets of the types included in the Collateral or that have the reasonable capacity of doing so, or that match buyers and sellers of assets,
(ix) to dispose of assets in wholesale rather than retail markets, (x) to disclaim disposition warranties, such as title, possession or quiet enjoyment, (xi) to purchase insurance or credit enhancements to insure the Administrative
Agent against risks of loss, collection or disposition of Collateral or to provide to the Administrative Agent a guaranteed return from the collection or disposition of Collateral, or (xii) to the extent reasonably deemed appropriate by the
Administrative Agent, to obtain the services of other brokers, investment bankers, consultants and other professionals to assist the Administrative Agent in the collection or disposition of any of the Collateral. Each Grantor acknowledges that the
purpose of this Section 8.2 is to provide non-exhaustive indications of what actions or omissions by the Administrative Agent would be commercially reasonable in the Administrative Agent’s exercise
of remedies against the Collateral and that other actions or omissions by the Administrative Agent shall not be deemed commercially unreasonable solely on account of not being indicated in this Section 8.2. Without limitation upon the
foregoing, nothing contained in this Section 8.2 shall be construed to grant any rights to any Grantor or to impose any duties on the Administrative Agent that would not have been granted or imposed by this Security Agreement or by applicable
law in the absence of this Section 8.2. 
 8.3. Compromises and Collection of Collateral. The Grantors and the Administrative
Agent recognize that setoffs, counterclaims, defenses and other claims may be asserted by obligors with respect to certain of the Receivables, that certain of the Receivables may be or become uncollectible in whole or in part and that the expense
and probability of success in litigating a disputed Receivable may exceed the amount that reasonably may be expected to be recovered with respect to a Receivable. In view of the foregoing, each Grantor agrees that the Administrative Agent may at any
time and from time to time, if an Event of Default has occurred and is continuing, compromise with the obligor on any Receivable, accept in full payment of any Receivable such amount as the Administrative Agent in its sole discretion shall determine
or abandon any Receivable, and any such action by the Administrative Agent shall be commercially reasonable so long as the Administrative Agent acts in good faith based on information known to it at the time it takes any such action. 

8.4. Secured Party Performance of Debtor Obligations. Without having any obligation to do so, upon and during the continuance of an
Event of Default, the Administrative Agent may perform or pay any obligation which any Grantor has agreed to perform or pay in this Security Agreement and the Grantors shall reimburse the Administrative Agent for any amounts paid by the
Administrative Agent pursuant to this Section 8.4. The Grantors’ obligation to reimburse the Administrative Agent pursuant to the preceding sentence shall be a Secured Obligation payable on demand. 

8.5. Dispositions Not Authorized. No Grantor is authorized to sell or otherwise dispose of the Collateral except as set forth in
Section 4.1(d) and notwithstanding any course of dealing between any Grantor and the Administrative Agent or other conduct of the Administrative Agent, no authorization to sell or otherwise dispose of the Collateral (except as set forth in
Section 4.1(d)) shall be binding upon the Administrative Agent or the Lender Parties unless such authorization is in writing signed by the Administrative Agent with the consent or at the direction of the Required Secured Parties. 

8.6. No Waiver; Amendments; Cumulative Remedies. No delay or omission of the Administrative Agent or any Lender Party to exercise any
right or remedy granted under this Security Agreement shall impair such right or remedy or be construed to be a waiver of any Default or an acquiescence therein, and any single or partial exercise of any such right or remedy shall not preclude any
other or further exercise thereof or the exercise of any other right or remedy. No waiver, amendment or other variation of the terms, conditions or provisions of this Security Agreement whatsoever shall be valid unless in writing signed by the
Administrative Agent with the concurrence or at the direction of the Lender Parties required under Section 9.02 of the Credit Agreement and then only to the extent in such writing specifically set forth. All rights and remedies contained in
this Security Agreement or by law afforded shall be cumulative and all shall be available to the Administrative Agent and the Lender Parties until the Secured Obligations have been paid in full. 

  
 -22- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 8.7. Limitation by Law; Severability of Provisions. All rights, remedies and powers
provided in this Security Agreement may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and all the provisions of this Security Agreement are intended to be subject to all applicable
mandatory provisions of law that may be controlling and to be limited to the extent necessary so that they shall not render this Security Agreement invalid, unenforceable or not entitled to be recorded or registered, in whole or in part. Any
provision in any this Security Agreement that is held to be inoperative, unenforceable, or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable, or invalid without affecting the remaining provisions in that
jurisdiction or the operation, enforceability, or validity of that provision in any other jurisdiction, and to this end the provisions of this Security Agreement are declared to be severable. 

8.8. Reinstatement. This Security Agreement shall remain in full force and effect and continue to be effective should any petition be
filed by or against any Grantor for liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors or should a receiver or trustee be appointed for all or any significant part of
any Grantor’s assets, and shall continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Secured Obligations, or any part thereof, is, pursuant to applicable law, rescinded or reduced in
amount, or must otherwise be restored or returned by any obligee of the Secured Obligations, whether as a “voidable preference,” “fraudulent conveyance,” or otherwise, all as though such payment or performance had
not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Secured Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or
returned. 
 8.9. Benefit of Agreement. The terms and provisions of this Security Agreement shall be binding upon and inure to the
benefit of the Grantors, the Administrative Agent and the Lender Parties and their respective successors and assigns (including all persons who become bound as a debtor to this Security Agreement), except that no Grantor shall have the right to
assign its rights or delegate its obligations under this Security Agreement or any interest herein, without the prior written consent of the Administrative Agent. No sales of participations, assignments, transfers, or other dispositions of any
agreement governing the Secured Obligations or any portion thereof or interest therein shall in any manner impair the Lien granted to the Administrative Agent, for the benefit of the Administrative Agent and the Lender Parties, hereunder. 

8.10. Survival of Representations. All representations and warranties of the Grantors contained in this Security Agreement shall survive
the execution and delivery of this Security Agreement. 
 8.11. Taxes and Expenses. Any taxes (including income taxes) payable or
ruled payable by Federal or State authority in respect of this Security Agreement shall be paid by the Grantors, together with interest and penalties, if any. The Grantors shall reimburse the Administrative Agent for any and all reasonable and
documented out-of-pocket expenses and charges (including reasonable and documented attorneys’, auditors’ and accountants’ fees) paid or incurred by the
Administrative Agent in connection with the preparation, execution, delivery, administration, collection and enforcement of this Security Agreement and in the audit, analysis, administration, collection, preservation or sale of the Collateral
(including the reasonable and documented expenses and charges associated with any periodic or special audit of the Collateral). Any and all costs and expenses incurred by the Grantors in the performance of actions required pursuant to the terms
hereof shall be borne solely by the Grantors. 

  
 -23- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 8.12. Headings. The title of and section headings in this Security Agreement are for
convenience of reference only, and shall not govern the interpretation of any of the terms and provisions of this Security Agreement. 

8.13. Termination. This Security Agreement shall continue in effect (notwithstanding the fact that from time to time there may be no
Secured Obligations outstanding) until (i) the Credit Agreement has terminated pursuant to its express terms and (ii) all of the Secured Obligations (other than contingent indemnification obligations) have been indefeasibly paid and
performed in full (or with respect to any outstanding Letters of Credit, a cash deposit or at the discretion of the Administrative Agent, a back up standby Letter of Credit satisfactory to the Administrative Agent has been delivered to the
Administrative Agent as required by the Credit Agreement) and no commitments of the Administrative Agent or the Lender Parties which would give rise to any Secured Obligations are outstanding. 

8.14. Entire Agreement. This Security Agreement embodies the entire agreement and understanding between the Grantors and the
Administrative Agent relating to the Collateral and supersedes all prior agreements and understandings between the Grantors and the Administrative Agent relating to the Collateral. 

8.15. CHOICE OF LAW. THIS SECURITY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS (AND
NOT THE LAW OF CONFLICTS) OF THE STATE OF NEW YORK, BUT GIVING EFFECT TO FEDERAL LAWS APPLICABLE TO NATIONAL BANKS. 
 8.16.
CONSENT TO JURISDICTION. EACH GRANTOR HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF ANY U.S. FEDERAL OR NEW YORK STATE COURT SITTING IN NEW YORK COUNTY, NEW YORK IN ANY
ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT AND EACH GRANTOR HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT
AND IRREVOCABLY WAIVES ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM. NOTHING HEREIN SHALL LIMIT THE RIGHT OF THE ADMINISTRATIVE
AGENT OR ANY LENDER PARTY TO BRING PROCEEDINGS AGAINST ANY GRANTOR IN THE COURTS OF ANY OTHER JURISDICTION. ANY JUDICIAL PROCEEDING BY ANY GRANTOR AGAINST THE ADMINISTRATIVE AGENT OR ANY LENDER PARTY OR ANY AFFILIATE OF THE AGENT OR ANY LENDER PARTY
INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT SHALL BE BROUGHT ONLY IN A COURT IN NEW YORK COUNTY, NEW YORK. 

8.17. WAIVER OF JURY TRIAL. EACH GRANTOR, THE ADMINISTRATIVE AGENT AND EACH LENDER PARTY HEREBY WAIVE TRIAL BY JURY IN ANY
JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE RELATIONSHIP
ESTABLISHED THEREUNDER. 

  
 -24- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 8.18. Indemnity. Each Grantor hereby agrees to indemnify the Administrative Agent and
the Lender Parties, and their respective successors, assigns, agents and employees, from and against any and all liabilities, damages, penalties, suits, costs, and expenses of any kind and nature (including, without limitation, all expenses of
litigation or preparation therefor whether or not the Administrative Agent or any Lender Party is a party thereto) imposed on, incurred by or asserted against the Administrative Agent or the Lender Parties, or their respective successors, assigns,
agents and employees, in any way relating to or arising out of this Security Agreement, or the manufacture, purchase, acceptance, rejection, ownership, delivery, lease, possession, use, operation, condition, sale, return or other disposition of any
Collateral (including, without limitation, latent and other defects, whether or not discoverable by the Administrative Agent or the Lender Parties or any Grantor, and any claim for patent, Trademark or Copyright infringement); provided that
such indemnity shall not, as to any indemnitee, be available to the extent that such liabilities, damages, penalties, suits, costs, and expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted
from the gross negligence or willful misconduct of such indemnitee. 
 8.19. Counterparts. This Security Agreement may be executed in
any number of counterparts, all of which taken together shall constitute one agreement, and any of the parties hereto may execute this Security Agreement by signing any such counterpart. Delivery of an executed counterpart of a signature page of
this Security Agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Security Agreement. 

8.20. Lien Absolute. All rights of the Administrative Agent hereunder, and all obligations of the Grantors hereunder, shall be absolute
and unconditional irrespective of: 
 (a) any lack of validity or enforceability of the Credit Agreement, any other Loan Document or any
other agreement or instrument governing or evidencing any Secured Obligations; 
 (b) any change in the time, manner or place of payment of,
or in any other term of, all or any part of the Secured Obligations, or any other amendment or waiver of or any consent to any departure from the Credit Agreement, any other Loan Document or any other agreement or instrument governing or evidencing
any Secured Obligations; 
 (c) any exchange, release or non-perfection of any Collateral, or any
release or amendment or waiver of or consent to departure from any guaranty, for all or any of the Secured Obligations; 
 (d) the insolvency
of any Person; or 
 (e) any other circumstance which might otherwise constitute a defense available to, or a discharge of, any Grantor. 

ARTICLE IX 
 NOTICES

 9.1. Sending Notices. Any notice required or permitted to be given under this Security Agreement shall be sent in accordance
with Section 9.01 of the Credit Agreement; provided that notices to any Grantor shall be sent to such Grantor at its mailing address set forth in Schedule 2 to the Perfection Certificate. 

9.2. Change in Address for Notices. Each of the Grantors, the Administrative Agent and the Lender Parties may change the address for
service of notice upon it by a notice in writing to the other parties. 

  
 -25- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 ARTICLE X 

THE ADMINISTRATIVE AGENT 

JPMorgan Chase Bank, N.A. has been appointed Administrative Agent for the Lender Parties hereunder pursuant to Article VIII of the Credit
Agreement. It is expressly understood and agreed by the parties to this Security Agreement that any authority conferred upon the Administrative Agent hereunder is subject to the terms of the delegation of authority made by the Lender Parties to the
Administrative Agent pursuant to the Credit Agreement, and that the Administrative Agent has agreed to act (and any successor Administrative Agent shall act) as such hereunder only on the express conditions contained in such Article VIII. Any
successor Administrative Agent appointed pursuant to Article VIII of the Credit Agreement shall be entitled to all the rights, interests and benefits of the Administrative Agent hereunder. 

[Signature Pages Follow] 

  
 -26- 

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the Grantors and the Administrative Agent have executed this Security
Agreement as of the date first above written. 
  

			
	 LEVI STRAUSS & CO.,
 as
Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Vice President and Global Treasurer
	
	 LEVI’S ONLY STORES, INC.,
 as
Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Treasurer
	
	 LEVI STRAUSS INTERNATIONAL, INC.,

as Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Vice President and Treasurer
	
	LVC, LLC, as Grantor
		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Treasurer
	
	 LEVI’S ONLY STORES GEORGETOWN, LLC,

as Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Treasurer

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
			
	 LEVI STRAUSS, U.S.A., LLC,
 as
Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Vice President and Treasurer
	
	 LEVI STRAUSS-ARGENTINA, LLC,
 as
Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Vice President and Treasurer
	
	 LEVI STRAUSS INTERNATIONAL,
 as
Grantor

		
	By:	 	 /s/ Johan Nystedt

	Name:	 	Johan Nystedt
	Title:	 	Vice President and Treasurer
	
	 JPMORGAN CHASE BANK, N.A.,
 as
Administrative Agent

		
	By:	 	 /s/ Annaliese Fisher

	Name:	 	Annaliese Fisher
	Title:	 	Vice President

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT A 

(See Sections 4.4 and 4.8 of Security Agreement) 

AMENDMENT 
 This Amendment,
dated         ,         is delivered pursuant to Section 4.4 of the Security Agreement referred to below. All initially capitalized terms herein shall have the
meanings ascribed thereto or incorporated by reference in the Security Agreement. The undersigned hereby certifies that the representations and warranties in Article III of the Security Agreement are and continue to be true and correct. The
undersigned further agrees that this Amendment may be attached to that certain U.S. Security Agreement, dated September 30, 2011, between the undersigned, as the Grantors, and JPMorgan Chase Bank, N.A., as the Administrative Agent (as amended
or modified from time to time prior to the date hereof, the “Security Agreement”) and that the Collateral listed on Schedule I to this Amendment shall be and become a part of the Collateral referred to in said Security
Agreement and shall secure all Secured Obligations referred to in the Security Agreement. 
  

			
	  

		
	By:	 	  

	Name:	 	
	Title:	 	

  

 Confidential Treatment Requested by Levi Strauss & Co. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT B 

COLLATERAL ACCESS AGREEMENTS’ LOCATIONS 

Collateral Access Agreements Schedule 
  

			
	 Vendor Name
	  	Services provided
	 Triangle International
	  	Transload and Store Delivery
	 Performance Team
	  	Transload and Store Delivery
	 Genco
	  	Warehouse

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]